Document_and_Entity_Informatio
Document and Entity Information | 9 Months Ended | |
Sep. 30, 2013 | Oct. 30, 2013 | |
Entity Registrant Name | MB FINANCIAL INC /MD | |
Entity Central Index Key | 1139812 | |
Document Type | 10-Q | |
Document Period End Date | 30-Sep-13 | |
Amendment Flag | FALSE | |
Current Fiscal Year End Date | -19 | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Common Stock, Shares Outstanding | 54,961,540 | |
Document Fiscal Year Focus | 2013 | |
Document Fiscal Period Focus | Q3 |
CONSOLIDATED_BALANCE_SHEETS
CONSOLIDATED BALANCE SHEETS (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
ASSETS | ||
Cash and due from banks | $215,017 | $176,010 |
Interest earning deposits with banks | 41,700 | 111,533 |
Total cash and cash equivalents | 256,717 | 287,543 |
Federal funds sold | 47,500 | 0 |
Investment securities: | ||
Securities available for sale, at fair value | 1,090,123 | 1,868,171 |
Securities held to maturity, at amortized cost ($1,212,748 and $535,681 fair value at September 30, 2013 and December 31, 2012, respectively) | 1,193,544 | 493,421 |
Non-marketable securities - FHLB and FRB stock | 50,870 | 55,385 |
Total investment securities | 2,334,537 | 2,416,977 |
Loans held for sale | 1,120 | 7,492 |
Loans: | ||
Total loans, excluding covered loans | 5,313,235 | 5,317,080 |
Covered loans | 273,497 | 449,850 |
Total loans | 5,586,732 | 5,766,930 |
Less: Allowance for loan losses | 118,031 | 124,204 |
Net loans | 5,468,701 | 5,642,726 |
Lease investment, net | 112,491 | 129,823 |
Premises and equipment, net | 220,574 | 221,533 |
Cash surrender value of life insurance | 129,332 | 128,879 |
Goodwill | 423,369 | 423,369 |
Other intangibles | 24,917 | 29,512 |
Other real estate owned, net | 31,356 | 36,977 |
Other real estate owned related to FDIC-assisted transactions | 24,792 | 22,478 |
FDIC indemnification asset | 11,074 | 39,345 |
Other assets | 171,138 | 185,151 |
Total assets | 9,257,618 | 9,571,805 |
Deposits: | ||
Noninterest bearing | 2,269,367 | 2,164,547 |
Interest bearing | 5,029,319 | 5,378,150 |
Total | 7,298,686 | 7,542,697 |
Short-term borrowings | 240,600 | 220,602 |
Long-term borrowings | 62,428 | 116,050 |
Junior subordinated notes issued to capital trusts | 152,065 | 152,065 |
Accrued expenses and other liabilities | 194,371 | 264,621 |
Total liabilities | 7,948,150 | 8,296,035 |
STOCKHOLDERS’ EQUITY | ||
Common stock, ($0.01 par value; authorized 70,000,000 shares at September 30, 2013 and December 31, 2012; issued 55,141,834 shares at September 30, 2013 and 54,955,284 shares at December 31, 2012) | 551 | 550 |
Additional paid-in capital | 736,294 | 732,771 |
Retained earnings | 564,779 | 507,933 |
Accumulated other comprehensive income | 9,918 | 36,326 |
Less: 180,296 and 170,567 shares of treasury stock, at cost, at September 30, 2013 and December 31, 2012, respectively | -3,525 | -3,293 |
Controlling interest stockholders’ equity | 1,308,017 | 1,274,287 |
Noncontrolling interest | 1,451 | 1,483 |
Total stockholders’ equity | 1,309,468 | 1,275,770 |
Total liabilities and stockholders’ equity | $9,257,618 | $9,571,805 |
CONSOLIDATED_BALANCE_SHEETS_Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, except Share data, unless otherwise specified | ||
Securities held to maturity, at amortized cost, fair value (in dollars) | $1,212,748 | $535,681 |
Common stock, par value (in dollars per share) | $0.01 | $0.01 |
Common stock, authorized shares | 70,000,000 | 70,000,000 |
Common stock, issued shares | 55,141,834 | 54,955,284 |
Treasury stock, shares | 180,296 | 170,567 |
CONSOLIDATED_STATEMENTS_OF_OPE
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, except Share data, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Interest income: | ||||
Loans | $60,115 | $67,482 | $180,489 | $208,380 |
Investment securities: | ||||
Taxable | 6,330 | 7,287 | 18,749 | 27,053 |
Nontaxable | 8,175 | 7,582 | 24,399 | 21,624 |
Federal funds sold | 7 | 0 | 9 | 0 |
Other interest earning accounts | 193 | 312 | 420 | 639 |
Total interest income | 74,820 | 82,663 | 224,066 | 257,696 |
Interest expense: | ||||
Deposits | 4,433 | 7,374 | 15,274 | 24,192 |
Short-term borrowings | 112 | 342 | 395 | 910 |
Long-term borrowings and junior subordinated notes | 1,367 | 2,872 | 4,324 | 9,322 |
Total interest expense | 5,912 | 10,588 | 19,993 | 34,424 |
Net interest income | 68,908 | 72,075 | 204,073 | 223,272 |
Provision for credit losses | -3,304 | -13,000 | -2,804 | -9,900 |
Net interest income after provision for credit losses | 72,212 | 85,075 | 206,877 | 233,172 |
Non-interest income: | ||||
Capital markets and international banking fees | 972 | 1,400 | 2,719 | 2,700 |
Commercial deposit and treasury management fees | 6,327 | 5,860 | 18,322 | 17,541 |
Lease financing, net | 14,070 | 9,671 | 45,435 | 23,963 |
Trust and asset management fees | 4,799 | 4,428 | 14,167 | 13,367 |
Card fees | 2,745 | 2,388 | 8,175 | 6,863 |
Loan service fees | 1,427 | 1,075 | 4,349 | 3,409 |
Consumer and other deposit service fees | 3,648 | 3,786 | 10,487 | 10,773 |
Brokerage fees | 1,289 | 1,185 | 3,680 | 3,704 |
Net gain on investment securities | 1 | 281 | 14 | 244 |
Increase in cash surrender value of life insurance | 851 | 890 | 2,537 | 2,677 |
Net loss on sale of assets | 0 | -12 | 0 | -37 |
Accretion of FDIC indemnification asset | 64 | 204 | 307 | 901 |
Net (loss) gain recognized on other real estate owned | -791 | -3,938 | 894 | -15,968 |
Net gain on sale of loans | 177 | 575 | 1,322 | 1,503 |
Other operating income | 1,337 | 760 | 3,835 | 3,674 |
Total non-interest income | 36,916 | 28,553 | 116,243 | 75,314 |
Non-interest expenses: | ||||
Salaries and employee benefits | 44,918 | 42,083 | 132,341 | 122,658 |
Occupancy and equipment expense | 8,797 | 8,274 | 27,609 | 27,032 |
Computer services and telecommunication expense | 4,870 | 3,777 | 13,374 | 11,339 |
Advertising and marketing expense | 1,917 | 1,936 | 6,187 | 5,848 |
Professional and legal expense | 3,102 | 1,554 | 5,750 | 4,470 |
Other intangibles amortization expense | 1,513 | 1,251 | 4,595 | 3,759 |
Branch impairment charges | 0 | 758 | 0 | 758 |
Other real estate expense, net | 240 | 874 | 572 | 2,541 |
Prepayment fees on interest bearing liabilities | 0 | 12,682 | 0 | 12,682 |
Other operating expenses | 10,117 | 7,976 | 28,413 | 24,243 |
Total non-interest expenses | 75,474 | 81,165 | 218,841 | 215,330 |
Income before income taxes | 33,654 | 32,463 | 104,279 | 93,156 |
Income tax expense | 9,254 | 9,330 | 29,680 | 26,794 |
Net income | 24,400 | 23,133 | 74,599 | 66,362 |
Dividends and discount accretion on preferred shares | 0 | 0 | 0 | 3,269 |
Net income available to common stockholders | $24,400 | $23,133 | $74,599 | $63,093 |
Common share data: | ||||
Basic earnings per common share | $0.45 | $0.43 | $1.37 | $1.16 |
Diluted earnings per common share | $0.44 | $0.42 | $1.36 | $1.16 |
Weighted average common shares outstanding for basic earnings per common share | 54,565,089 | 54,346,827 | 54,471,541 | 54,226,241 |
Diluted weighted average common shares outstanding for diluted earnings per common share | 55,130,653 | 54,556,517 | 54,912,352 | 54,472,617 |
CONSOLIDATED_STATEMENTS_OF_COM
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Net income | $24,400 | $23,133 | $74,599 | $66,362 |
Unrealized holding (losses) gains on investment securities, net of tax and reclassification adjustments | -3,701 | 2,118 | -25,788 | 1,981 |
Reclassification adjustment for amortization of unrealized gains on investment securities transferred to held to maturity from available for sale, net of tax | -612 | 0 | -612 | 0 |
Reclassification adjustments for gains included in net income, net of tax | 0 | -168 | -8 | -146 |
Other comprehensive (loss) income, net of tax | -4,313 | 1,950 | -26,408 | 1,835 |
Comprehensive income | $20,087 | $25,083 | $48,191 | $68,197 |
CONSOLIDATED_STATEMENTS_OF_CHA
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (USD $) | Total | Preferred Stock | Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss), Net of Tax | Treasury Stock | Noncontrolling Interest |
In Thousands, unless otherwise specified | ||||||||
Balance at Dec. 31, 2011 | $1,393,027 | $194,719 | $548 | $731,248 | $427,956 | $39,150 | ($3,044) | $2,450 |
Increase (Decrease) in Stockholders' Equity | ||||||||
Net income | 66,546 | 66,362 | 184 | |||||
Other comprehensive loss, net of tax | 1,835 | 1,835 | ||||||
Cash dividends declared on common stock | -1,643 | -1,643 | ||||||
Dividends and discount accretion on preferred shares | -1,988 | 1,281 | -3,269 | |||||
Repurchase of preferred shares and warrant | -197,518 | -196,000 | 0 | -1,518 | 0 | 0 | 0 | 0 |
Restricted common stock activity, net of tax | 1,071 | 2 | -722 | 17 | 1,774 | |||
Stock option activity, net of tax | -277 | -625 | 3 | 345 | ||||
Repurchase of common shares in connection with employee benefit plans and held in trust for deferred compensation plan | -1,928 | 451 | -2,379 | |||||
Stock-based compensation expense | 3,581 | 3,581 | ||||||
Adjustments To Additional Paid In Capital Investment In Subsidiary | -1,640 | 0 | 0 | -736 | 0 | 0 | 0 | -904 |
Distributions to noncontrolling interest | -236 | -236 | ||||||
Balance at Sep. 30, 2012 | 1,260,830 | 0 | 550 | 731,679 | 489,426 | 40,985 | -3,304 | 1,494 |
Balance at Dec. 31, 2012 | 1,275,770 | 550 | 732,771 | 507,933 | 36,326 | -3,293 | 1,483 | |
Increase (Decrease) in Stockholders' Equity | ||||||||
Net income | 74,736 | 74,599 | 137 | |||||
Other comprehensive loss, net of tax | -26,408 | -26,408 | ||||||
Cash dividends declared on common stock | -17,653 | -17,653 | ||||||
Restricted common stock activity, net of tax | 869 | 1 | -757 | -100 | 1,725 | |||
Stock option activity, net of tax | 616 | 117 | 499 | |||||
Repurchase of common shares in connection with employee benefit plans and held in trust for deferred compensation plan | -2,153 | 303 | -2,456 | |||||
Stock-based compensation expense | 3,860 | 3,860 | ||||||
Distributions to noncontrolling interest | -169 | -169 | ||||||
Balance at Sep. 30, 2013 | $1,309,468 | $0 | $551 | $736,294 | $564,779 | $9,918 | ($3,525) | $1,451 |
CONSOLIDATED_STATEMENTS_OF_CHA1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) (USD $) | 9 Months Ended | |
Sep. 30, 2013 | Sep. 30, 2012 | |
Cash dividends declared | $0.32 | $0.03 |
CONSOLIDATED_STATEMENTS_OF_CAS
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) | 9 Months Ended | |
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 |
Cash Flows From Operating Activities | ||
Net income (loss) | $74,599 | $66,362 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation of premises and equipment | 13,165 | 11,450 |
Depreciation of leased equipment | 24,933 | 28,107 |
Impairment charges on branch facilities | 0 | 758 |
Compensation expense for restricted stock awards | 3,013 | 2,586 |
Compensation expense for stock option grants | 847 | 995 |
Gain on sales of premises and equipment and leased equipment | -192 | -2,746 |
Amortization of other intangibles | 4,595 | 3,759 |
Provision for credit losses | -2,804 | -9,900 |
Deferred income tax expense | 13,067 | 19,763 |
Amortization of premiums and discounts on investment securities, net | 35,364 | 31,838 |
Accretion of premiums and discounts on loans, net | -5,462 | -13,000 |
Accretion of FDIC indemnification asset | -307 | -901 |
Net gain on sale of investment securities available for sale | -14 | -244 |
Proceeds from sale of loans held for sale | 74,395 | 64,124 |
Origination of loans held for sale | -66,667 | -64,980 |
Net gain on sale of loans held for sale | -1,322 | -1,503 |
Net gain on sales of other real estate owned | -977 | -1,264 |
Fair value adjustments on other real estate owned | -80 | 13,919 |
Net loss on sales of other real estate owned related to FDIC-assisted transactions | 163 | 3,313 |
Increase in cash surrender value of life insurance | -2,537 | -2,677 |
Decrease (increase) in other assets, net | 30,976 | -45,242 |
(Decrease) increase in other liabilities, net | -68,428 | 7,944 |
Net cash provided by operating activities | 126,327 | 112,461 |
Cash Flows From Investing Activities | ||
Increase in federal funds sold | -47,500 | 0 |
Proceeds from sales of investment securities available for sale | 989 | 12,573 |
Proceeds from maturities and calls of investment securities available for sale | 415,780 | 432,162 |
Purchases of investment securities available for sale | -364,550 | -350,669 |
Proceeds from maturities and calls of investment securities held to maturity | 5,079 | 960 |
Purchases of investment securities held to maturity | -55,409 | -1,923 |
Purchases of non-marketable securities - FHLB and FRB stock | 0 | -24 |
Redemption of non-marketable securities - FHLB and FRB stock | 4,515 | 23,203 |
Net decrease in loans | 170,586 | 329,773 |
Purchases of premises and equipment | -11,342 | -16,952 |
Purchases of leased equipment | -18,359 | -19,836 |
Proceeds from sales of premises and equipment | 1,498 | |
Proceeds from sales of leased equipment | 6,672 | 11,108 |
Capital improvements on other real estate owned | -53 | -2,304 |
Proceeds from sale of other real estate owned | 12,791 | 28,398 |
Proceeds from sale of other real estate owned related to FDIC-assisted transactions | 7,535 | 29,008 |
Principal paid on lease investments | -1,127 | -1,878 |
Life insurance death benefit | 2,083 | |
Net proceeds from FDIC related covered assets | 11,347 | 79,247 |
Net cash provided by investing activities | 139,037 | 554,344 |
Cash Flows From Financing Activities | ||
Net decrease in deposits | -244,011 | -168,260 |
Net increase in short-term borrowings | 19,998 | 69,659 |
Proceeds from long-term borrowings | 5,457 | 5,740 |
Principal paid on long-term borrowings | -59,079 | -153,206 |
Redemption of junior subordinated notes issued to capital trusts | -6,186 | |
Repurchase of preferred stock | 0 | -197,518 |
Treasury stock transactions, net | -1,653 | -260 |
Stock options exercised | 1,014 | 154 |
Excess tax benefits from share-based payment arrangements | -402 | |
Dividends paid on preferred stock | -3,239 | |
Dividends paid on common stock | -17,514 | -1,627 |
Net cash used in financing activities | -296,190 | -454,743 |
Net (decrease) increase in cash and cash equivalents | -30,826 | 212,062 |
Cash and cash equivalents: | ||
Beginning of period | 287,543 | 244,565 |
End of period | 256,717 | 456,627 |
Cash payments for: | ||
Interest paid to depositors and other borrowed funds | 20,913 | 36,156 |
Net income tax payments, net | 35,141 | 4,230 |
Supplemental Schedule of Noncash Investing Activities: | ||
Investment securities available for sale purchased not settled | 1,797 | 3,919 |
Transfer of investment securities available for sale to investment securities held to maturity | 656,617 | 0 |
Loans transferred to other real estate owned | 6,060 | 2,724 |
Loans transferred to other real estate owned related to FDIC-assisted transactions | 11,580 | 17,923 |
Loans transferred to repossessed vehicles | 606 | 607 |
Operating leases rewritten as direct finance leases included as loans | $6,541 | $7,593 |
Basis_of_Presentation_Notes
Basis of Presentation (Notes) | 9 Months Ended |
Sep. 30, 2013 | |
Accounting Policies [Abstract] | |
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] | Basis of Presentation |
These unaudited consolidated financial statements include the accounts of MB Financial, Inc., a Maryland corporation (the “Company”), and its subsidiaries, including its wholly owned national bank subsidiary, MB Financial Bank, N.A. (“MB Financial Bank”), based in Chicago, Illinois. In the opinion of management, all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods have been made. The results of operations for the three and nine months ended September 30, 2013 are not necessarily indicative of the results to be expected for the entire fiscal year. | |
These unaudited interim financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) and industry practice. Certain information in footnote disclosure normally included in financial statements prepared in accordance with U.S. GAAP and industry practice has been condensed or omitted pursuant to rules and regulations of the Securities and Exchange Commission. These financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s December 31, 2012 audited financial statements filed on Form 10-K. | |
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions which affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements, as well as the reported amounts of income and expenses during the reported periods. Actual results could differ from those estimates. | |
Certain prior period amounts have been reclassified to conform to current period presentation. These reclassifications did not result in any changes to previously reported net income or stockholders’ equity. |
New_Authoritative_Accounting_G
New Authoritative Accounting Guidance (Notes) | 9 Months Ended |
Sep. 30, 2013 | |
New Authoritative Accounting Guidance [Abstract] | |
New Authoritative Accounting Guidance | New Authoritative Accounting Guidance |
ASC Topic 805 “Business Combinations.” New authoritative accounting guidance under ASC Topic 805, “Business Combinations” amended prior guidance on the subsequent accounting for an indemnification asset recognized at the acquisition date as a result of a government-assisted (Federal Deposit Insurance Corporation) acquisition of a financial institution that includes a loss-sharing agreement. The new authoritative guidance requires that at each subsequent reporting date, an acquirer measure an indemnification asset on the same basis as the indemnified liability or asset, subject to any contractual limitations on its amount, and, for an indemnification asset that is not subsequently measured at fair value, management's assessment of the collectability of the indemnification asset. Any amortization of changes in value should be limited to the contractual term of the indemnification agreement (that is, the lesser of the term of the indemnification agreement and the remaining life of the indemnified assets). The Company adopted this new authoritative guidance on January 1, 2013, and it did not have an impact on the Company's statements of operations and financial condition. | |
ASC Topic 210 “Disclosures about Offsetting Assets and Liabilities.” New authoritative accounting guidance under ASC Topic 210, “Disclosures about Offsetting Assets and Liabilities” amended prior guidance to require an entity to disclose both gross and net information about both instruments and transactions eligible for offset in the statement of financial position and instruments and transactions subject to an agreement similar to a master netting arrangement. The instruments and transactions would include derivatives, sale and repurchase agreements and reverse sale and repurchase agreements, and securities borrowing and securities lending arrangements. This new authoritative guidance was further amended to clarify the scope of offsetting disclosures. The Company adopted the new authoritative guidance on January 1, 2013, and it did not have an impact on the Company's statements of operations and financial condition. See disclosures in Note 15. | |
ASC Topic 220 “Comprehensive Income.” New authoritative accounting guidance under ASC Topic 220, “Comprehensive Income” amended prior guidance to improve the reporting of reclassifications out of accumulated other comprehensive income by requiring an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the statement or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income if the amount reclassified is required under U.S. GAAP. The Company adopted this new authoritative guidance on January 1, 2013, and it did not have an impact on the Company's statements of operations and financial condition. | |
ASC Topic 815 “Derivatives and Hedging.” New authoritative accounting guidance under ASC Topic 815, “Derivatives and Hedging” amended prior guidance to permit the Fed Funds Effective Swap Rate (OIS) to be used as a U.S. benchmark interest rate for hedge accounting purposes, in addition to U.S. government treasury obligation rates and London Interbank Offered Rate swap rate. The amendments also remove the restriction on using different benchmark rates for similar hedges. The new authoritative guidance will be effective prospectively for new and redesignated hedging relationships entered into on or after July 17, 2013 and is not expected to have an impact on the Company's statements of operations and financial condition. | |
ASC Topic 740 “Income Taxes.” New authoritative accounting guidance under ASC Topic 740, “Income Taxes” amended prior guidance to include explicit guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. An unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as follows. To the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. The new authoritative guidance will be for reporting periods after January 1, 2014 and is not expected to have an impact on the Company's statements of operations and financial condition. |
Earnings_Per_Common_Share
Earnings Per Common Share | 9 Months Ended | ||||||||||||||||
Sep. 30, 2013 | |||||||||||||||||
Accounting Policies [Abstract] | |||||||||||||||||
Earnings Per Common Share | Earnings Per Common Share | ||||||||||||||||
Earnings per common share is computed using the two-class method. Basic earnings per common share is computed by dividing net income available to common stockholders by the weighted-average number of common shares outstanding during the applicable period, excluding outstanding participating securities. Participating securities include non-vested restricted stock awards and restricted stock units, though no actual shares of common stock related to restricted stock units are issued until the settlement of such units, to the extent holders of these securities receive non-forfeitable dividends or dividend equivalents at the same rate as holders of the Company's common stock. Diluted earnings per common share is computed using the weighted-average number of shares determined for the basic earnings per common share computation plus the dilutive effect of stock compensation using the treasury stock method. | |||||||||||||||||
The following table presents a reconciliation of the number of shares used in the calculation of basic and diluted earnings per common share (amounts in thousands, except share and per share data). | |||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||
September 30, | September 30, | ||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||
Distributed earnings allocated to common stock | $ | 6,636 | $ | 548 | $ | 17,653 | $ | 1,643 | |||||||||
Undistributed earnings | 17,764 | 22,585 | 56,946 | 64,719 | |||||||||||||
Net income | 24,400 | 23,133 | 74,599 | 66,362 | |||||||||||||
Less: preferred stock dividends and discount accretion | — | — | — | 3,269 | |||||||||||||
Net income available to common stockholders | 24,400 | 23,133 | 74,599 | 63,093 | |||||||||||||
Less: earnings allocated to participating securities | 1 | 1 | 2 | 2 | |||||||||||||
Earnings allocated to common stockholders | $ | 24,399 | $ | 23,132 | $ | 74,597 | $ | 63,091 | |||||||||
Weighted average shares outstanding for basic earnings per common share | 54,565,089 | 54,346,827 | 54,471,541 | 54,226,241 | |||||||||||||
Dilutive effect of equity awards | 565,564 | 209,690 | 440,811 | 246,376 | |||||||||||||
Weighted average shares outstanding for diluted earnings per common share | 55,130,653 | 54,556,517 | 54,912,352 | 54,472,617 | |||||||||||||
Basic earnings per common share | $ | 0.45 | $ | 0.43 | $ | 1.37 | $ | 1.16 | |||||||||
Diluted earnings per common share | 0.44 | 0.42 | 1.36 | 1.16 | |||||||||||||
Business_Combinations
Business Combinations | 9 Months Ended | ||||
Sep. 30, 2013 | |||||
Business Combinations [Abstract] | |||||
Business Combinations | Business Combinations | ||||
The following business combination was accounted for under the acquisition method of accounting. Accordingly, the results of operations of the acquired company have been included in the Company’s results of operations since the date of acquisition. Under this method of accounting, assets and liabilities acquired are recorded at their estimated fair values, net of applicable income tax effects. The excess cost over fair value of net assets acquired is recorded as goodwill. In the event that the fair value of net assets acquired exceeds the cost, the Company will record a gain on the acquisition. | |||||
On December 28, 2012, MB Financial Bank acquired a 100% equity interest in Celtic Leasing Corp. (“Celtic”), a privately held, mid-ticket equipment leasing company. Celtic specializes in solutions for the health care, legal, technology, and manufacturing industries. MB Financial Bank estimated contingent consideration related to the transaction which may be paid out at future dates. This consideration is based on the performance of lease residual values which will be determined in future years over an earn-out period. As the consideration paid for Celtic exceeded the net assets acquired, goodwill was recorded on the acquisition. Goodwill recorded in the transaction is not tax deductible. The purchase accounting entries are preliminary for lease loans, goodwill and other intangibles, as MB Financial Bank continues to analyze the portfolios and the underlying risks and collateral values of the assets. After the purchase accounting is finalized, the impact of any future changes to the amount of contingent consideration will be reflected in the statement of operations. | |||||
Estimated fair values of the assets acquired and liabilities assumed in the Celtic transaction, as of the closing date of the transaction were as follows (in thousands): | |||||
Assets Acquired and Liabilities Assumed | |||||
(Dollar Amounts in Thousands) | |||||
Celtic | |||||
December 28, | |||||
2012 | |||||
ASSETS | |||||
Cash and cash equivalents | $ | 31,647 | |||
Investment securities available for sale | 635 | ||||
Loans and leases | 32,933 | ||||
Premises and equipment | 81 | ||||
Goodwill | 36,300 | ||||
Other intangibles | 5,028 | ||||
Other assets | 27,323 | ||||
Total assets | $ | 133,947 | |||
LIABILITIES | |||||
Accrued expenses and other liabilities | $ | 75,290 | |||
Total liabilities | $ | 75,290 | |||
Cash paid on acquisition | $ | 58,657 | |||
Net gain recorded on acquisition | $ | — | |||
On July 14, 2013, the Company and Taylor Capital Group, Inc. (“Taylor Capital”) entered into an Agreement and Plan of Merger (the "Merger Agreement") whereby the Company will acquire Taylor Capital. The Merger Agreement provides that, upon the terms and subject to the conditions set forth therein, Taylor Capital will merge with and into the Company, with the Company as the surviving corporation in the merger. Immediately following the Merger, Taylor Capital's wholly owned subsidiary bank, Cole Taylor Bank, will merge with the Company's wholly owned subsidiary bank, MB Financial Bank. Cole Taylor Bank is a commercial bank headquartered in Chicago with $5.9 billion in assets, $3.3 billion in loans and $3.7 billion in deposits as of June 30, 2013. | |||||
Subject to the terms and conditions of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of Taylor Capital common stock and each share of Taylor Capital nonvoting convertible preferred stock ("non-voting preferred stock") will be converted into the right to receive, promptly following the Effective Time, (1) 0.64318 of a share of the Company's common stock and (2) $4.08 in cash. All "in-the-money" Taylor Capital stock options and warrants outstanding immediately prior to the Effective Time will be canceled in exchange for a cash payment as provided in the Merger Agreement, as will all then-outstanding unvested restricted stock awards of Taylor Capital; however, the cash consideration paid for such restricted stock awards will remain subject to vesting or other lapse restrictions. Each share of Taylor Capital's Perpetual Non-Cumulative Preferred Stock, Series A, will be exchanged for a share of a series of preferred stock of the Company with substantially identical terms. The Merger Agreement provides that any shares of Taylor Capital's Fixed Rate Cumulative Perpetual Preferred Stock, Series B, that are not repurchased or redeemed by Taylor Capital prior to the Merger will be exchanged for a series of preferred stock of the Company with substantially identical terms and repurchased or redeemed by the Company at or promptly after the Effective Time. | |||||
The merger is subject to regulatory approvals, approval by the Company's stockholders, approval by Taylor Capital stockholders and certain other customary closing conditions and is expected to close in the first half of 2014. In addition, it is a condition to the Company's obligation to complete the Merger that the shares of Taylor Capital common stock and Taylor Capital nonvoting preferred stock whose holders have perfected appraisal rights under Delaware law represent less than nine percent of the total number of outstanding shares of Taylor Capital common stock and Taylor Capital nonvoting preferred stock. |
Investment_Securities
Investment Securities | 9 Months Ended | ||||||||||||||||||||||||
Sep. 30, 2013 | |||||||||||||||||||||||||
Investments Securities [Abstract] | |||||||||||||||||||||||||
Investment Securities | Investment Securities | ||||||||||||||||||||||||
Carrying amounts and fair values of investment securities were as follows (in thousands): | |||||||||||||||||||||||||
Amortized | Gross | Gross | Fair | ||||||||||||||||||||||
Cost | Unrealized | Unrealized | Value | ||||||||||||||||||||||
Gains | Losses | ||||||||||||||||||||||||
30-Sep-13 | |||||||||||||||||||||||||
Available for Sale | |||||||||||||||||||||||||
U.S. Government sponsored agencies and enterprises | $ | 50,678 | $ | 1,849 | $ | — | $ | 52,527 | |||||||||||||||||
States and political subdivisions | 19,461 | 52 | (201 | ) | 19,312 | ||||||||||||||||||||
Residential mortgage-backed securities | 685,126 | 8,659 | (2,509 | ) | 691,276 | ||||||||||||||||||||
Commercial mortgage-backed securities | 50,944 | 2,502 | — | 53,446 | |||||||||||||||||||||
Corporate bonds | 265,293 | 927 | (3,199 | ) | 263,021 | ||||||||||||||||||||
Equity securities | 10,574 | — | (33 | ) | 10,541 | ||||||||||||||||||||
1,082,076 | 13,989 | (5,942 | ) | 1,090,123 | |||||||||||||||||||||
Held to Maturity | |||||||||||||||||||||||||
States and political subdivisions | 941,273 | 8,517 | (3,481 | ) | 946,309 | ||||||||||||||||||||
Residential mortgage-backed securities | 252,271 | 14,168 | — | 266,439 | |||||||||||||||||||||
1,193,544 | 22,685 | (3,481 | ) | 1,212,748 | |||||||||||||||||||||
Total | $ | 2,275,620 | $ | 36,674 | $ | (9,423 | ) | $ | 2,302,871 | ||||||||||||||||
December 31, 2012 | |||||||||||||||||||||||||
Available for Sale | |||||||||||||||||||||||||
U.S. Government sponsored agencies and enterprises | $ | 38,605 | $ | 2,710 | $ | — | $ | 41,315 | |||||||||||||||||
States and political subdivisions | 679,991 | 45,571 | (543 | ) | 725,019 | ||||||||||||||||||||
Residential mortgage-backed securities | 930,413 | 14,038 | (5,249 | ) | 939,202 | ||||||||||||||||||||
Commercial mortgage-backed securities | 51,100 | 3,026 | — | 54,126 | |||||||||||||||||||||
Corporate bonds | 97,014 | 213 | (553 | ) | 96,674 | ||||||||||||||||||||
Equity securities | 11,398 | 447 | (10 | ) | 11,835 | ||||||||||||||||||||
1,808,521 | 66,005 | (6,355 | ) | 1,868,171 | |||||||||||||||||||||
Held to Maturity | |||||||||||||||||||||||||
States and political subdivisions | 237,563 | 21,039 | — | 258,602 | |||||||||||||||||||||
Residential mortgage-backed securities | 255,858 | 21,221 | — | 277,079 | |||||||||||||||||||||
493,421 | 42,260 | — | 535,681 | ||||||||||||||||||||||
Total | $ | 2,301,942 | $ | 108,265 | $ | (6,355 | ) | $ | 2,403,852 | ||||||||||||||||
Securities of states and political subdivisions with a fair value of $656.6 million were transferred from available for sale to held to maturity during the third quarter of 2013, which is the new cost basis. As of the date of the transfer, the resulting unrealized holding gain continues to be reported as a separate component of stockholders’ equity as accumulated other comprehensive income, net of tax. This unrealized gain will be amortized over the remaining life of the securities as a yield adjustment. | |||||||||||||||||||||||||
We do not have any meaningful direct or indirect holdings of subprime residential mortgage loans, home equity lines of credit, or any Fannie Mae or Freddie Mac preferred or common equity securities in our investment portfolio. | |||||||||||||||||||||||||
The Company has no direct exposure to the State of Illinois, but approximately 27% of the state and political subdivisions portfolio consists of securities issued by municipalities located in Illinois as of September 30, 2013. Approximately 90% of such securities were general obligation issues as of September 30, 2013. | |||||||||||||||||||||||||
Unrealized losses on investment securities and the fair value of the related securities at September 30, 2013 were as follows (in thousands): | |||||||||||||||||||||||||
Less Than 12 Months | 12 Months or More | Total | |||||||||||||||||||||||
Fair | Unrealized | Fair | Unrealized | Fair | Unrealized | ||||||||||||||||||||
Value | Losses | Value | Losses | Value | Losses | ||||||||||||||||||||
Available for Sale | |||||||||||||||||||||||||
States and political subdivisions | $ | 9,050 | $ | (201 | ) | $ | — | $ | — | $ | 9,050 | $ | (201 | ) | |||||||||||
Residential mortgage-backed securities | 206,562 | (2,040 | ) | 49,104 | (469 | ) | 255,666 | (2,509 | ) | ||||||||||||||||
Corporate bonds | 147,181 | (3,199 | ) | — | — | 147,181 | (3,199 | ) | |||||||||||||||||
Equity securities | 10,541 | (33 | ) | — | — | 10,541 | (33 | ) | |||||||||||||||||
373,334 | (5,473 | ) | 49,104 | (469 | ) | 422,438 | (5,942 | ) | |||||||||||||||||
Held to Maturity | |||||||||||||||||||||||||
States and political subdivisions | 207,613 | (3,481 | ) | — | — | 207,613 | (3,481 | ) | |||||||||||||||||
207,613 | (3,481 | ) | — | — | 207,613 | (3,481 | ) | ||||||||||||||||||
Totals | $ | 580,947 | $ | (8,954 | ) | $ | 49,104 | $ | (469 | ) | $ | 630,051 | $ | (9,423 | ) | ||||||||||
Unrealized losses on investment securities and the fair value of the related securities at December 31, 2012 were as follows (in thousands): | |||||||||||||||||||||||||
Less Than 12 Months | 12 Months or More | Total | |||||||||||||||||||||||
Fair | Unrealized | Fair | Unrealized | Fair | Unrealized | ||||||||||||||||||||
Value | Losses | Value | Losses | Value | Losses | ||||||||||||||||||||
Available for Sale | |||||||||||||||||||||||||
States and political subdivisions | $ | 57,540 | $ | (543 | ) | $ | — | $ | — | $ | 57,540 | $ | (543 | ) | |||||||||||
Residential mortgage-backed securities | 270,539 | (5,083 | ) | 16,434 | (166 | ) | 286,973 | (5,249 | ) | ||||||||||||||||
Corporate bonds | 58,241 | (553 | ) | — | — | 58,241 | (553 | ) | |||||||||||||||||
Equity securities | 30 | (10 | ) | — | — | 30 | (10 | ) | |||||||||||||||||
Totals | $ | 386,350 | $ | (6,189 | ) | $ | 16,434 | $ | (166 | ) | $ | 402,784 | $ | (6,355 | ) | ||||||||||
The total number of security positions in the investment portfolio in an unrealized loss position at September 30, 2013 was 353 compared to 117 at December 31, 2012. Declines in the fair value of available for sale securities below their cost that are deemed to be other than temporary are reflected in earnings as realized losses to the extent the impairment is related to credit losses. The amount of the impairment related to other factors is recognized in other comprehensive income. In estimating other-than-temporary impairment losses, management considers, among other things, (i) the length of time and the extent to which the fair value has been less than cost, (ii) the financial condition and near-term prospects of the issuer, and (iii) whether or not the Company is more likely than not to sell the security before recovery of its cost basis. | |||||||||||||||||||||||||
As of September 30, 2013, management does not have the intent to sell any of the securities in the table above and believes that it is more likely than not that the Company will not have to sell any such securities before a recovery of cost. The fair value is expected to recover as the bonds approach their maturity date or repricing date or if market yields for such investments decline. Accordingly, as of September 30, 2013, management believes the impairments detailed in the table above are temporary. | |||||||||||||||||||||||||
Changes in market interest rates can significantly influence the fair value of securities, and the fair value of our municipal security portfolio would decline substantially if interest rates increase materially. | |||||||||||||||||||||||||
Net gains (losses) recognized on investment securities available for sale were as follows (in thousands): | |||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||
September 30, | September 30, | ||||||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||||||||||
Realized gains | $ | 1 | $ | 282 | $ | 15 | $ | 472 | |||||||||||||||||
Realized losses | — | (1 | ) | (1 | ) | (4 | ) | ||||||||||||||||||
Impairment charges | — | — | — | (224 | ) | ||||||||||||||||||||
Net gains (losses) | $ | 1 | $ | 281 | $ | 14 | $ | 244 | |||||||||||||||||
The amortized cost and fair value of investment securities as of September 30, 2013 by contractual maturity are shown below. Maturities may differ from contractual maturities in mortgage-backed securities because the mortgages underlying the securities may be called or repaid without any penalties. Therefore, mortgage-backed securities are not included in the maturity categories in the following maturity summary. | |||||||||||||||||||||||||
Amortized | Fair | ||||||||||||||||||||||||
(In thousands) | Cost | Value | |||||||||||||||||||||||
Available for sale: | |||||||||||||||||||||||||
Due in one year or less | $ | — | $ | — | |||||||||||||||||||||
Due after one year through five years | 319,032 | 318,598 | |||||||||||||||||||||||
Due after five years through ten years | 7,695 | 7,711 | |||||||||||||||||||||||
Due after ten years | 8,705 | 8,551 | |||||||||||||||||||||||
Equity securities | 10,574 | 10,541 | |||||||||||||||||||||||
Residential and commercial mortgage-backed securities | 736,070 | 744,722 | |||||||||||||||||||||||
1,082,076 | 1,090,123 | ||||||||||||||||||||||||
Held to maturity: | |||||||||||||||||||||||||
Due in one year or less | 28,222 | 28,221 | |||||||||||||||||||||||
Due after one year through five years | 245,125 | 245,545 | |||||||||||||||||||||||
Due after five years through ten years | 122,547 | 122,533 | |||||||||||||||||||||||
Due after ten years | 545,379 | 550,010 | |||||||||||||||||||||||
Residential mortgage-backed securities | 252,271 | 266,439 | |||||||||||||||||||||||
1,193,544 | 1,212,748 | ||||||||||||||||||||||||
Total | $ | 2,275,620 | $ | 2,302,871 | |||||||||||||||||||||
Investment securities available for sale with carrying amounts of $1.0 billion and $989.6 million at September 30, 2013 and December 31, 2012, respectively, were pledged as collateral on public deposits and for other purposes as required or permitted by law. |
Loans
Loans | 9 Months Ended | ||||||||||||||||||||||||||||||||||||||||
Sep. 30, 2013 | |||||||||||||||||||||||||||||||||||||||||
Receivables [Abstract] | |||||||||||||||||||||||||||||||||||||||||
Loans | Loans | ||||||||||||||||||||||||||||||||||||||||
Loans consist of the following at (in thousands): | |||||||||||||||||||||||||||||||||||||||||
September 30, | December 31, 2012 | ||||||||||||||||||||||||||||||||||||||||
2013 | |||||||||||||||||||||||||||||||||||||||||
Commercial loans | $ | 1,169,009 | $ | 1,220,472 | |||||||||||||||||||||||||||||||||||||
Commercial loans collateralized by assignment of lease payments | 1,468,814 | 1,303,020 | |||||||||||||||||||||||||||||||||||||||
Commercial real estate | 1,638,368 | 1,761,832 | |||||||||||||||||||||||||||||||||||||||
Residential real estate | 311,256 | 314,359 | |||||||||||||||||||||||||||||||||||||||
Construction real estate | 136,146 | 110,261 | |||||||||||||||||||||||||||||||||||||||
Indirect vehicle | 257,740 | 208,633 | |||||||||||||||||||||||||||||||||||||||
Home equity | 274,484 | 305,186 | |||||||||||||||||||||||||||||||||||||||
Other consumer loans | 57,418 | 93,317 | |||||||||||||||||||||||||||||||||||||||
Gross loans, excluding covered loans | 5,313,235 | 5,317,080 | |||||||||||||||||||||||||||||||||||||||
Covered loans | 273,497 | 449,850 | |||||||||||||||||||||||||||||||||||||||
Total loans(1) | $ | 5,586,732 | $ | 5,766,930 | |||||||||||||||||||||||||||||||||||||
(1) Gross loan balances at September 30, 2013 and December 31, 2012 are net of unearned income, including net deferred loan fees of $1.5 million and $1.1 million, respectively. | |||||||||||||||||||||||||||||||||||||||||
Loans are made to individuals as well as commercial and tax exempt entities. Specific loan terms vary as to interest rate, repayment, and collateral requirements based on the type of loan requested and the credit worthiness of the prospective borrower. Credit risk tends to be geographically concentrated in that a majority of the loan customers are located in the markets serviced by MB Financial Bank. | |||||||||||||||||||||||||||||||||||||||||
The Company's extension of credit is governed by its Credit Risk Policy which was established to control the quality of the Company's loans. These policies and procedures are reviewed and approved by the Board of Directors on a regular basis. | |||||||||||||||||||||||||||||||||||||||||
Commercial Loans. Commercial credit is extended primarily to middle market customers. Such credits are typically comprised of working capital loans, loans for physical asset expansion, asset acquisition loans and other business loans. Loans to closely held businesses will generally be guaranteed in full or for a significant amount by the businesses' principal owners. Commercial loans are made based primarily on the historical and projected cash flow of the borrower and secondarily on the underlying collateral provided by the borrower. The cash flows of borrowers, however, may not behave as forecasted and collateral securing loans may fluctuate in value due to economic or individual performance factors. Minimum standards and underwriting guidelines have been established for all commercial loan types. | |||||||||||||||||||||||||||||||||||||||||
Lease Loans. The Company makes lease loans to both investment grade and non-investment grade companies. Investment grade lessees are companies rated in one of the four highest categories by Moody's Investor Services or Standard & Poor's Rating Services or, in the event the related lessee has not received any such rating, where the related lessee would be viewed under the underwriting polices of the Company as an investment grade company. Whether or not companies fall into this category, each lease loan is considered on its individual merit based on financial information available at the time of underwriting. | |||||||||||||||||||||||||||||||||||||||||
Commercial Real Estate Loans. Commercial real estate loans are subject to underwriting standards and processes similar to commercial loans. These loans are viewed primarily as cash flow loans and the repayment of these loans is largely dependent on the successful operation of the property. Loan performance may be adversely affected by factors impacting the general economy or conditions specific to the real estate market such as geographic location and/or property type. | |||||||||||||||||||||||||||||||||||||||||
Construction Real Estate Loans. The Company defines construction loans as loans where the loan proceeds are controlled by the Company and used exclusively for the improvement of real estate in which the Company holds a mortgage. Due to the inherent risk in this type of loan, they are subject to other industry specific policy guidelines outlined in the Company's Credit Risk Policy. | |||||||||||||||||||||||||||||||||||||||||
Consumer Related Loans. The Company originates direct and indirect consumer loans, including primarily residential real estate, home equity lines and loans, credit cards, and indirect motorcycle loans, using a matrix-based credit analysis as part of the underwriting process. Each loan type has a separate matrix which consists of several factors including debt to income, type of collateral and loan to collateral value, credit history and Company relationship with the borrower. Indirect loan and credit card underwriting involves the use of risk-based pricing in the underwriting process. | |||||||||||||||||||||||||||||||||||||||||
The following table presents the contractual aging of the recorded investment in past due loans by class of loans as of September 30, 2013 and December 31, 2012 (in thousands): | |||||||||||||||||||||||||||||||||||||||||
Current | 30-59 Days | 60-89 Days | Loans Past Due | Total | Total | ||||||||||||||||||||||||||||||||||||
Past Due | Past Due | 90 Days or More | Past Due | ||||||||||||||||||||||||||||||||||||||
30-Sep-13 | |||||||||||||||||||||||||||||||||||||||||
Commercial | $ | 1,158,326 | $ | 2,392 | $ | 2,580 | $ | 5,711 | $ | 10,683 | $ | 1,169,009 | |||||||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | 1,455,296 | 10,761 | 1,816 | 941 | 13,518 | 1,468,814 | |||||||||||||||||||||||||||||||||||
Commercial real estate | |||||||||||||||||||||||||||||||||||||||||
Healthcare | 212,659 | — | — | 3,164 | 3,164 | 215,823 | |||||||||||||||||||||||||||||||||||
Industrial | 371,940 | 161 | 2,101 | 1,394 | 3,656 | 375,596 | |||||||||||||||||||||||||||||||||||
Multifamily | 316,495 | 2,808 | — | 2,387 | 5,195 | 321,690 | |||||||||||||||||||||||||||||||||||
Retail | 344,390 | 236 | 449 | 8,632 | 9,317 | 353,707 | |||||||||||||||||||||||||||||||||||
Office | 139,251 | 412 | 579 | 2,106 | 3,097 | 142,348 | |||||||||||||||||||||||||||||||||||
Other | 223,385 | 3,443 | 229 | 2,147 | 5,819 | 229,204 | |||||||||||||||||||||||||||||||||||
Residential real estate | 298,878 | 1,103 | 1,059 | 10,216 | 12,378 | 311,256 | |||||||||||||||||||||||||||||||||||
Construction real estate | 133,742 | — | 89 | 2,315 | 2,404 | 136,146 | |||||||||||||||||||||||||||||||||||
Indirect vehicle | 255,177 | 1,638 | 687 | 238 | 2,563 | 257,740 | |||||||||||||||||||||||||||||||||||
Home equity | 260,055 | 4,505 | 2,911 | 7,013 | 14,429 | 274,484 | |||||||||||||||||||||||||||||||||||
Other consumer | 57,357 | 54 | 1 | 6 | 61 | 57,418 | |||||||||||||||||||||||||||||||||||
Gross loans, excluding covered loans | 5,226,951 | 27,513 | 12,501 | 46,270 | 86,284 | 5,313,235 | |||||||||||||||||||||||||||||||||||
Covered loans | 138,876 | 12,091 | 5,681 | 116,849 | 134,621 | 273,497 | |||||||||||||||||||||||||||||||||||
Total loans (1) | $ | 5,365,827 | $ | 39,604 | $ | 18,182 | $ | 163,119 | $ | 220,905 | $ | 5,586,732 | |||||||||||||||||||||||||||||
Nonperforming loan aging | $ | 53,271 | $ | 3,596 | $ | 6,111 | $ | 39,474 | $ | 49,181 | $ | 102,452 | |||||||||||||||||||||||||||||
Non-covered loans related to FDIC transactions (2) | $ | 11,339 | $ | 222 | $ | 146 | $ | 6,796 | $ | 7,164 | $ | 18,503 | |||||||||||||||||||||||||||||
December 31, 2012 | |||||||||||||||||||||||||||||||||||||||||
Commercial | $ | 1,215,957 | $ | 639 | $ | 754 | $ | 3,122 | $ | 4,515 | $ | 1,220,472 | |||||||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | 1,288,341 | 11,252 | 2,847 | 580 | 14,679 | 1,303,020 | |||||||||||||||||||||||||||||||||||
Commercial real estate | |||||||||||||||||||||||||||||||||||||||||
Healthcare | 192,039 | — | — | 3,238 | 3,238 | 195,277 | |||||||||||||||||||||||||||||||||||
Industrial | 402,813 | 548 | 424 | 7,700 | 8,672 | 411,485 | |||||||||||||||||||||||||||||||||||
Multifamily | 353,966 | 1,282 | — | 3,103 | 4,385 | 358,351 | |||||||||||||||||||||||||||||||||||
Retail | 375,900 | 6,933 | 518 | 9,331 | 16,782 | 392,682 | |||||||||||||||||||||||||||||||||||
Office | 186,665 | 742 | 280 | 1,125 | 2,147 | 188,812 | |||||||||||||||||||||||||||||||||||
Other | 210,456 | 851 | 1,837 | 2,081 | 4,769 | 215,225 | |||||||||||||||||||||||||||||||||||
Residential real estate | 306,927 | 382 | 1,248 | 5,802 | 7,432 | 314,359 | |||||||||||||||||||||||||||||||||||
Construction real estate | 106,158 | 1,139 | 97 | 2,867 | 4,103 | 110,261 | |||||||||||||||||||||||||||||||||||
Indirect vehicle | 206,126 | 1,588 | 498 | 421 | 2,507 | 208,633 | |||||||||||||||||||||||||||||||||||
Home equity | 291,737 | 3,557 | 1,888 | 8,004 | 13,449 | 305,186 | |||||||||||||||||||||||||||||||||||
Other consumer | 93,266 | 47 | — | 4 | 51 | 93,317 | |||||||||||||||||||||||||||||||||||
Gross loans, excluding covered loans | 5,230,351 | 28,960 | 10,391 | 47,378 | 86,729 | 5,317,080 | |||||||||||||||||||||||||||||||||||
Covered loans | 301,260 | 5,831 | 7,478 | 135,281 | 148,590 | 449,850 | |||||||||||||||||||||||||||||||||||
Total loans (1) | $ | 5,531,611 | $ | 34,791 | $ | 17,869 | $ | 182,659 | $ | 235,319 | $ | 5,766,930 | |||||||||||||||||||||||||||||
Nonperforming loan aging | $ | 69,836 | $ | 3,171 | $ | 3,718 | $ | 40,261 | $ | 47,150 | $ | 116,986 | |||||||||||||||||||||||||||||
Non-covered loans related to FDIC transactions (2) | $ | 12,752 | $ | 312 | $ | 1,542 | $ | 7,115 | $ | 8,969 | $ | 21,721 | |||||||||||||||||||||||||||||
(1) Includes loans related to the InBank FDIC-assisted transaction completed by MB Financial Bank in 2009. | |||||||||||||||||||||||||||||||||||||||||
(2) Loans related to the InBank FDIC-assisted transaction completed by MB Financial Bank in 2009. | |||||||||||||||||||||||||||||||||||||||||
The following table presents the recorded investment in nonaccrual loans and loans past due ninety days or more and still accruing by class of loans as of September 30, 2013 and December 31, 2012 (in thousands): | |||||||||||||||||||||||||||||||||||||||||
September 30, 2013 | December 31, 2012 | ||||||||||||||||||||||||||||||||||||||||
Loans past due | Loans past due | ||||||||||||||||||||||||||||||||||||||||
Nonaccrual | 90 days or more | Nonaccrual | 90 days or more | ||||||||||||||||||||||||||||||||||||||
and still accruing | and still accruing | ||||||||||||||||||||||||||||||||||||||||
Commercial | $ | 19,948 | $ | — | $ | 23,886 | $ | 229 | |||||||||||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | 2,130 | 215 | 1,180 | 222 | |||||||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Healthcare | 3,164 | — | 3,238 | — | |||||||||||||||||||||||||||||||||||||
Industrial | 9,754 | — | 19,179 | 147 | |||||||||||||||||||||||||||||||||||||
Multifamily | 5,087 | 195 | 7,225 | — | |||||||||||||||||||||||||||||||||||||
Office | 10,916 | — | 3,263 | — | |||||||||||||||||||||||||||||||||||||
Retail | 3,740 | — | 17,019 | — | |||||||||||||||||||||||||||||||||||||
Other | 21,420 | — | 9,437 | — | |||||||||||||||||||||||||||||||||||||
Residential real estate | 13,041 | — | 10,943 | — | |||||||||||||||||||||||||||||||||||||
Construction real estate | 496 | — | 1,028 | — | |||||||||||||||||||||||||||||||||||||
Indirect vehicle | 1,516 | — | 1,494 | — | |||||||||||||||||||||||||||||||||||||
Home equity | 10,818 | — | 17,486 | 1,000 | |||||||||||||||||||||||||||||||||||||
Other consumer | 12 | — | 9 | 1 | |||||||||||||||||||||||||||||||||||||
Total | $ | 102,042 | $ | 410 | $ | 115,387 | $ | 1,599 | |||||||||||||||||||||||||||||||||
The Company utilizes an internal asset classification system as a means of reporting problem and potential problem loans. Under the Company's risk rating system, the Company classifies potential problem and problem loans as “Special Mention,” “Substandard,” and “Doubtful.” Substandard loans include those characterized by the distinct possibility that the Company will sustain some loss if the deficiencies are not corrected. Loans classified as Doubtful have all the weaknesses inherent in those classified as Substandard with the added characteristic that the weaknesses present make collection or liquidation in full, on the basis of currently existing facts, conditions and values, highly questionable and improbable. Loans that do not currently expose the Company to sufficient risk to warrant classification in one of the aforementioned categories but possess weaknesses that deserve management's close attention are deemed to be Special Mention. Risk ratings are updated at least annually and any time the situation warrants. | |||||||||||||||||||||||||||||||||||||||||
Loans listed as not rated are included in groups of homogeneous loans with similar risk and loss characteristics. The following tables present the risk category of loans by class of loans based on the most recent analysis performed as of September 30, 2013 and December 31, 2012 (in thousands): | |||||||||||||||||||||||||||||||||||||||||
Pass | Special | Substandard | Doubtful | Total | |||||||||||||||||||||||||||||||||||||
Mention | |||||||||||||||||||||||||||||||||||||||||
30-Sep-13 | |||||||||||||||||||||||||||||||||||||||||
Commercial | $ | 1,091,129 | $ | 17,720 | $ | 60,160 | $ | — | $ | 1,169,009 | |||||||||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | 1,457,577 | 4,814 | 6,423 | — | 1,468,814 | ||||||||||||||||||||||||||||||||||||
Commercial real estate | |||||||||||||||||||||||||||||||||||||||||
Healthcare | 188,946 | 21,556 | 2,157 | 3,164 | 215,823 | ||||||||||||||||||||||||||||||||||||
Industrial | 335,274 | 7,384 | 32,938 | — | 375,596 | ||||||||||||||||||||||||||||||||||||
Multifamily | 306,691 | — | 14,999 | — | 321,690 | ||||||||||||||||||||||||||||||||||||
Retail | 324,558 | 10,373 | 18,776 | — | 353,707 | ||||||||||||||||||||||||||||||||||||
Office | 132,490 | 2,732 | 7,126 | — | 142,348 | ||||||||||||||||||||||||||||||||||||
Other | 201,971 | 3,088 | 24,145 | — | 229,204 | ||||||||||||||||||||||||||||||||||||
Construction real estate | 126,902 | 6,264 | 2,980 | — | 136,146 | ||||||||||||||||||||||||||||||||||||
Total | $ | 4,165,538 | $ | 73,931 | $ | 169,704 | $ | 3,164 | $ | 4,412,337 | |||||||||||||||||||||||||||||||
December 31, 2012 | |||||||||||||||||||||||||||||||||||||||||
Commercial | $ | 1,136,294 | $ | 33,068 | $ | 50,895 | $ | 215 | $ | 1,220,472 | |||||||||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | 1,292,241 | 3,322 | 7,457 | — | 1,303,020 | ||||||||||||||||||||||||||||||||||||
Commercial real estate | |||||||||||||||||||||||||||||||||||||||||
Healthcare | 170,265 | 21,774 | — | 3,238 | 195,277 | ||||||||||||||||||||||||||||||||||||
Industrial | 355,218 | 15,243 | 41,024 | — | 411,485 | ||||||||||||||||||||||||||||||||||||
Multifamily | 318,991 | 25,297 | 14,063 | — | 358,351 | ||||||||||||||||||||||||||||||||||||
Retail | 340,919 | 25,096 | 26,667 | — | 392,682 | ||||||||||||||||||||||||||||||||||||
Office | 159,056 | 7,120 | 22,636 | — | 188,812 | ||||||||||||||||||||||||||||||||||||
Other | 193,824 | 2,553 | 18,848 | — | 215,225 | ||||||||||||||||||||||||||||||||||||
Construction real estate | 97,724 | 552 | 11,985 | — | 110,261 | ||||||||||||||||||||||||||||||||||||
Total | $ | 4,064,532 | $ | 134,025 | $ | 193,575 | $ | 3,453 | $ | 4,395,585 | |||||||||||||||||||||||||||||||
Approximately $76.5 million and $85.5 million of the substandard and doubtful loans were non-performing as of September 30, 2013 and December 31, 2012, respectively. | |||||||||||||||||||||||||||||||||||||||||
For residential real estate, home equity, indirect vehicle and other consumer loan classes, the Company also evaluates credit quality based on the aging status of the loan, which was previously presented, and by payment activity. The following table presents the recorded investment in those loan classes based on payment activity as of September 30, 2013 and December 31, 2012 (in thousands): | |||||||||||||||||||||||||||||||||||||||||
Performing | Non-performing | Total | |||||||||||||||||||||||||||||||||||||||
30-Sep-13 | |||||||||||||||||||||||||||||||||||||||||
Residential real estate | $ | 298,215 | $ | 13,041 | $ | 311,256 | |||||||||||||||||||||||||||||||||||
Indirect vehicle | 256,224 | 1,516 | 257,740 | ||||||||||||||||||||||||||||||||||||||
Home equity | 263,666 | 10,818 | 274,484 | ||||||||||||||||||||||||||||||||||||||
Other consumer | 57,406 | 12 | 57,418 | ||||||||||||||||||||||||||||||||||||||
Total | $ | 875,511 | $ | 25,387 | $ | 900,898 | |||||||||||||||||||||||||||||||||||
December 31, 2012 | |||||||||||||||||||||||||||||||||||||||||
Residential real estate | $ | 303,416 | $ | 10,943 | $ | 314,359 | |||||||||||||||||||||||||||||||||||
Indirect vehicle | 207,139 | 1,494 | 208,633 | ||||||||||||||||||||||||||||||||||||||
Home equity | 286,700 | 18,486 | 305,186 | ||||||||||||||||||||||||||||||||||||||
Other consumer | 93,307 | 10 | 93,317 | ||||||||||||||||||||||||||||||||||||||
Total | $ | 890,562 | $ | 30,933 | $ | 921,495 | |||||||||||||||||||||||||||||||||||
The following tables present loans individually evaluated for impairment by class of loans as of September 30, 2013 and December 31, 2012 (in thousands): | |||||||||||||||||||||||||||||||||||||||||
30-Sep-13 | |||||||||||||||||||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||
Unpaid | Recorded | Partial | Allowance for | Average | Interest | Average | Interest | ||||||||||||||||||||||||||||||||||
Principal | Investment | Charge-offs | Loan Losses | Recorded | Income | Recorded | Income | ||||||||||||||||||||||||||||||||||
Balance | Allocated | Investment | Recognized | Investment | Recognized | ||||||||||||||||||||||||||||||||||||
With no related allowance recorded: | |||||||||||||||||||||||||||||||||||||||||
Commercial | $ | 6,236 | $ | 5,364 | $ | 872 | $ | — | $ | 6,509 | $ | — | $ | 7,378 | $ | — | |||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | 681 | 681 | — | — | 666 | 6 | 256 | 6 | |||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Healthcare | — | — | — | — | — | — | 3,608 | — | |||||||||||||||||||||||||||||||||
Industrial | 7,547 | 6,927 | 620 | — | 7,902 | — | 9,316 | — | |||||||||||||||||||||||||||||||||
Multifamily | 546 | 546 | — | — | 665 | — | 739 | — | |||||||||||||||||||||||||||||||||
Retail | 3,002 | 3,002 | — | — | 3,233 | — | 3,123 | — | |||||||||||||||||||||||||||||||||
Office | 685 | 527 | 158 | — | 705 | — | 986 | — | |||||||||||||||||||||||||||||||||
Other | 3,149 | 3,139 | 10 | — | 3,353 | — | 4,785 | — | |||||||||||||||||||||||||||||||||
Residential real estate | 4,174 | 3,788 | 386 | — | 4,082 | — | 2,835 | — | |||||||||||||||||||||||||||||||||
Construction real estate | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||
Indirect vehicle | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||
Home equity | 577 | 577 | — | — | 577 | — | 872 | — | |||||||||||||||||||||||||||||||||
Other consumer | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||
With an allowance recorded: | |||||||||||||||||||||||||||||||||||||||||
Commercial | 14,472 | 14,472 | — | 4,389 | 15,680 | — | 14,839 | — | |||||||||||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | 1,649 | 1,649 | — | 285 | 1,659 | 109 | 1,347 | 158 | |||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Healthcare | 10,868 | 3,164 | 7,704 | 495 | 10,869 | — | 7,302 | — | |||||||||||||||||||||||||||||||||
Industrial | 2,826 | 2,826 | — | 1,047 | 3,078 | — | 3,611 | — | |||||||||||||||||||||||||||||||||
Multifamily | 6,334 | 5,944 | 390 | 1,876 | 6,408 | 115 | 6,642 | 224 | |||||||||||||||||||||||||||||||||
Retail | 15,323 | 13,031 | 2,292 | 1,855 | 13,778 | — | 13,572 | — | |||||||||||||||||||||||||||||||||
Office | 3,607 | 3,214 | 393 | 1,047 | 3,735 | — | 4,391 | — | |||||||||||||||||||||||||||||||||
Other | 18,493 | 18,280 | 213 | 1,144 | 19,790 | 8 | 11,104 | 16 | |||||||||||||||||||||||||||||||||
Residential real estate | 12,690 | 12,063 | 627 | 3,033 | 12,494 | — | 12,965 | — | |||||||||||||||||||||||||||||||||
Construction real estate | 3,990 | 1,622 | 2,368 | 240 | 1,736 | — | 1,938 | — | |||||||||||||||||||||||||||||||||
Indirect vehicle | 138 | 106 | 32 | — | 146 | — | 54 | — | |||||||||||||||||||||||||||||||||
Home equity | 23,171 | 22,701 | 470 | 781 | 23,558 | — | 24,341 | — | |||||||||||||||||||||||||||||||||
Other consumer | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||
Total | $ | 140,158 | $ | 123,623 | $ | 16,535 | $ | 16,192 | $ | 140,623 | $ | 238 | $ | 136,004 | $ | 404 | |||||||||||||||||||||||||
December 31, 2012 | |||||||||||||||||||||||||||||||||||||||||
Unpaid | Recorded | Partial | Allowance for | Average | Interest | ||||||||||||||||||||||||||||||||||||
Principal | Investment | Charge-offs | Loan Losses | Recorded | Income | ||||||||||||||||||||||||||||||||||||
Balance | Allocated | Investment | Recognized | ||||||||||||||||||||||||||||||||||||||
With no related allowance recorded: | |||||||||||||||||||||||||||||||||||||||||
Commercial | $ | 10,993 | $ | 9,505 | $ | 1,488 | $ | — | $ | 14,089 | $ | 105 | |||||||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | 390 | 390 | — | — | 278 | 9 | |||||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Healthcare | 10,943 | 3,238 | 7,705 | — | 2,751 | — | |||||||||||||||||||||||||||||||||||
Industrial | 16,891 | 14,940 | 1,951 | — | 16,374 | 29 | |||||||||||||||||||||||||||||||||||
Multifamily | 800 | 800 | — | — | 1,340 | 14 | |||||||||||||||||||||||||||||||||||
Retail | 5,372 | 4,917 | 455 | — | 9,241 | — | |||||||||||||||||||||||||||||||||||
Office | 1,568 | 1,568 | — | — | 1,151 | — | |||||||||||||||||||||||||||||||||||
Other | 4,860 | 4,860 | — | — | 6,005 | — | |||||||||||||||||||||||||||||||||||
Residential real estate | 3,097 | 2,711 | 386 | — | 6,476 | — | |||||||||||||||||||||||||||||||||||
Construction real estate | — | — | — | — | 577 | — | |||||||||||||||||||||||||||||||||||
Indirect vehicle | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Home equity | 2,558 | 2,558 | — | — | 8,976 | — | |||||||||||||||||||||||||||||||||||
Other consumer | — | — | — | — | 182 | — | |||||||||||||||||||||||||||||||||||
With an allowance recorded: | |||||||||||||||||||||||||||||||||||||||||
Commercial | 14,484 | 14,381 | 103 | 3,620 | 8,455 | — | |||||||||||||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | 885 | 885 | — | 188 | 1,130 | 73 | |||||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Healthcare | — | — | — | — | 3,901 | — | |||||||||||||||||||||||||||||||||||
Industrial | 5,525 | 4,238 | 1,287 | 1,255 | 2,443 | — | |||||||||||||||||||||||||||||||||||
Multifamily | 8,233 | 7,249 | 984 | 2,284 | 5,847 | 130 | |||||||||||||||||||||||||||||||||||
Retail | 23,144 | 17,257 | 5,887 | 3,604 | 10,058 | — | |||||||||||||||||||||||||||||||||||
Office | 1,706 | 1,695 | 11 | 522 | 1,904 | — | |||||||||||||||||||||||||||||||||||
Other | 4,661 | 4,577 | 84 | 1,263 | 6,082 | 16 | |||||||||||||||||||||||||||||||||||
Residential real estate | 10,565 | 10,565 | — | 2,858 | 3,417 | — | |||||||||||||||||||||||||||||||||||
Construction real estate | 4,552 | 2,167 | 2,385 | 497 | 3,775 | — | |||||||||||||||||||||||||||||||||||
Indirect vehicle | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Home equity | 13,765 | 13,763 | 2 | 850 | 4,800 | — | |||||||||||||||||||||||||||||||||||
Other consumer | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Total | $ | 144,992 | $ | 122,264 | $ | 22,728 | $ | 16,941 | $ | 119,252 | $ | 376 | |||||||||||||||||||||||||||||
Impaired loans included accruing restructured loans of $29.9 million and $21.3 million that have been modified and are performing in accordance with those modified terms as of September 30, 2013 and December 31, 2012, respectively. In addition, impaired loans included $22.3 million and $28.4 million of non-performing, restructured loans as of September 30, 2013 and December 31, 2012, respectively. | |||||||||||||||||||||||||||||||||||||||||
Loans may be restructured in an effort to maximize collections from financially distressed borrowers. We use various restructuring techniques, including, but not limited to, deferring past due interest or principal, implementing an A/B note structure, redeeming past due taxes, reducing interest rates, extending maturities and modifying amortization schedules. Residential real estate loans are restructured in an effort to minimize losses while allowing borrowers to remain in their primary residences when possible. Programs that we offer to residential real estate borrowers include the Home Affordable Refinance Program (“HARP”), a restructuring program similar to the Home Affordable Modification Program (“HAMP”) for first mortgage borrowers, the Second Lien Modification Program (“2MP”) and similar programs for home equity borrowers in keeping with the restructuring techniques discussed above. | |||||||||||||||||||||||||||||||||||||||||
Periodically, the Company will restructure a note into two separate notes (A/B structure), charging off the entire B portion of the note. The A note is structured with appropriate loan-to-value and cash flow coverage ratios that provide for a high likelihood of repayment. The A note is classified as a non-performing note until the borrower has displayed a historical payment performance for a reasonable time prior to and subsequent to the restructuring. A period of sustained repayment for at least six months generally is required to return the note to accrual status provided that management has determined that the performance is reasonably expected to continue. The A note will be classified as a restructured note (either performing or nonperforming) through the calendar year of the restructuring that the historical payment performance has been established. As of September 30, 2013, there were no A/B structures. As of December 31, 2012 there was approximately $3.1 million in recorded investment in relation to one A/B structure. | |||||||||||||||||||||||||||||||||||||||||
A loan classified as a troubled debt restructuring will no longer be included in the troubled debt restructuring disclosures in the years after the restructuring if the loan performs in accordance with the terms specified by the restructuring agreement and the interest rate specified in the restructuring agreement represents a market rate at the time of modification. The specified interest rate is considered a market rate when the interest rate is equal to or greater than the rate the Company is willing to accept at the time of restructuring for a new loan with comparable risk. If there are concerns that the borrower will not be able to meet the modified terms of the loan, the loan will continue to be included in the troubled debt restructuring disclosures. | |||||||||||||||||||||||||||||||||||||||||
Impairment analyses on commercial-related loans classified as troubled debt restructurings are performed in conjunction with the normal allowance for loan loss process. Consumer loans classified as troubled debt restructurings are aggregated in two pools that share common risk characteristics, home equity and residential real estate loans, with impairment measured on a quarterly basis based on the present value of expected future cash flows discounted at the loan's effective interest rate. | |||||||||||||||||||||||||||||||||||||||||
The following table presents loans that have been restructured during the three months ended September 30, 2013 (dollars in thousands): | |||||||||||||||||||||||||||||||||||||||||
30-Sep-13 | |||||||||||||||||||||||||||||||||||||||||
Number of | Pre-Modification Recorded | Post-Modification Recorded | Charge-offs and | ||||||||||||||||||||||||||||||||||||||
Loans | Investment | Investment | Specific Reserves | ||||||||||||||||||||||||||||||||||||||
Performing: | |||||||||||||||||||||||||||||||||||||||||
Residential real estate | 1 | $ | 95 | $ | 95 | $ | — | ||||||||||||||||||||||||||||||||||
Home equity | 1 | 19 | 19 | — | |||||||||||||||||||||||||||||||||||||
Total | 2 | $ | 114 | $ | 114 | $ | — | ||||||||||||||||||||||||||||||||||
Non-Performing: | |||||||||||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Healthcare | 1 | $ | 3,164 | $ | 3,164 | $ | 496 | ||||||||||||||||||||||||||||||||||
Multifamily | 1 | 436 | 436 | 119 | |||||||||||||||||||||||||||||||||||||
Retail | 1 | 205 | 205 | 56 | |||||||||||||||||||||||||||||||||||||
Residential real estate | 1 | 394 | 394 | — | |||||||||||||||||||||||||||||||||||||
Indirect vehicle | 17 | 113 | 89 | 24 | |||||||||||||||||||||||||||||||||||||
Home equity | 5 | 397 | 397 | — | |||||||||||||||||||||||||||||||||||||
Total | 26 | $ | 4,709 | $ | 4,685 | $ | 695 | ||||||||||||||||||||||||||||||||||
The following table presents loans that have been restructured during the nine months ended September 30, 2013 (dollars in thousands): | |||||||||||||||||||||||||||||||||||||||||
30-Sep-13 | |||||||||||||||||||||||||||||||||||||||||
Number of | Pre-Modification Recorded | Post-Modification Recorded | Charge-offs and | ||||||||||||||||||||||||||||||||||||||
Loans | Investment | Investment | Specific Reserves | ||||||||||||||||||||||||||||||||||||||
Performing: | |||||||||||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Multifamily | 1 | $ | 601 | $ | 601 | $ | — | ||||||||||||||||||||||||||||||||||
Residential real estate | 5 | 854 | 854 | — | |||||||||||||||||||||||||||||||||||||
Home equity | 7 | 723 | 723 | — | |||||||||||||||||||||||||||||||||||||
Total | 13 | $ | 2,178 | $ | 2,178 | $ | — | ||||||||||||||||||||||||||||||||||
Non-Performing: | |||||||||||||||||||||||||||||||||||||||||
Commercial | 2 | $ | 1,251 | $ | 1,251 | $ | 673 | ||||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Healthcare | 1 | 3,164 | 3,164 | 496 | |||||||||||||||||||||||||||||||||||||
Industrial | 4 | 2,570 | 2,570 | 1,425 | |||||||||||||||||||||||||||||||||||||
Multifamily | 2 | 623 | 623 | 169 | |||||||||||||||||||||||||||||||||||||
Retail | 3 | 862 | 862 | 235 | |||||||||||||||||||||||||||||||||||||
Other | 1 | 84 | 84 | 23 | |||||||||||||||||||||||||||||||||||||
Residential real estate | 6 | 1,149 | 1,149 | — | |||||||||||||||||||||||||||||||||||||
Indirect vehicle | 20 | 127 | 103 | 24 | |||||||||||||||||||||||||||||||||||||
Home equity | 25 | 3,333 | 3,333 | — | |||||||||||||||||||||||||||||||||||||
Total | 64 | $ | 13,163 | $ | 13,139 | $ | 3,045 | ||||||||||||||||||||||||||||||||||
The following table presents loans that have been restructured during the three months ended September 30, 2012 (dollars in thousands): | |||||||||||||||||||||||||||||||||||||||||
30-Sep-12 | |||||||||||||||||||||||||||||||||||||||||
Number of | Pre-Modification Recorded | Post-Modification Recorded | Charge-offs and | ||||||||||||||||||||||||||||||||||||||
Loans | Investment | Investment | Specific Reserves | ||||||||||||||||||||||||||||||||||||||
Performing: | |||||||||||||||||||||||||||||||||||||||||
Home equity | 7 | $ | 401 | $ | 325 | $ | 76 | ||||||||||||||||||||||||||||||||||
Total | 7 | $ | 401 | $ | 325 | $ | 76 | ||||||||||||||||||||||||||||||||||
Non-Performing: | |||||||||||||||||||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | 1 | $ | 202 | $ | 202 | $ | 168 | ||||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Retail | 1 | 202 | 202 | 200 | |||||||||||||||||||||||||||||||||||||
Residential real estate | 7 | 173 | 68 | 105 | |||||||||||||||||||||||||||||||||||||
Home equity | 5 | 347 | 232 | 115 | |||||||||||||||||||||||||||||||||||||
Total | 14 | $ | 924 | $ | 704 | $ | 588 | ||||||||||||||||||||||||||||||||||
The following table presents loans that have been restructured during the nine months ended September 30, 2012 (dollars in thousands): | |||||||||||||||||||||||||||||||||||||||||
30-Sep-12 | |||||||||||||||||||||||||||||||||||||||||
Number of | Pre-Modification Recorded | Post-Modification Recorded | Charge-offs and | ||||||||||||||||||||||||||||||||||||||
Loans | Investment | Investment | Specific Reserves | ||||||||||||||||||||||||||||||||||||||
Performing: | |||||||||||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Multifamily | 1 | $ | 155 | $ | 155 | $ | — | ||||||||||||||||||||||||||||||||||
Retail | 1 | 236 | 236 | — | |||||||||||||||||||||||||||||||||||||
Residential real estate | 2 | 808 | 808 | — | |||||||||||||||||||||||||||||||||||||
Home equity | 38 | 6,009 | 5,933 | 76 | |||||||||||||||||||||||||||||||||||||
Total | 42 | $ | 7,208 | $ | 7,132 | $ | 76 | ||||||||||||||||||||||||||||||||||
Non-Performing: | |||||||||||||||||||||||||||||||||||||||||
Commercial | 4 | $ | 292 | $ | 292 | $ | 96 | ||||||||||||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | 1 | 202 | 202 | 168 | |||||||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Multifamily | 1 | 149 | 149 | 40 | |||||||||||||||||||||||||||||||||||||
Retail | 4 | 923 | 923 | 232 | |||||||||||||||||||||||||||||||||||||
Other | 1 | 157 | 157 | 50 | |||||||||||||||||||||||||||||||||||||
Residential real estate | 13 | 637 | 401 | 236 | |||||||||||||||||||||||||||||||||||||
Home equity | 34 | 5,324 | 4,899 | 425 | |||||||||||||||||||||||||||||||||||||
Total | 58 | $ | 7,684 | $ | 7,023 | $ | 1,247 | ||||||||||||||||||||||||||||||||||
Of the troubled debt restructurings entered into during the past twelve months, none subsequently defaulted during the nine months ended September 30, 2013. Performing troubled debt restructurings are considered to have defaulted when they become 90 days or more past due post restructuring or are placed on non-accrual status. | |||||||||||||||||||||||||||||||||||||||||
The following tables present the troubled debt restructurings activity during the nine months ended September 30, 2013 (dollars in thousands): | |||||||||||||||||||||||||||||||||||||||||
Performing | Non-performing | ||||||||||||||||||||||||||||||||||||||||
Beginning balance | $ | 21,256 | $ | 28,418 | |||||||||||||||||||||||||||||||||||||
Additions | 2,178 | 13,163 | |||||||||||||||||||||||||||||||||||||||
Charge-offs | — | (3,127 | ) | ||||||||||||||||||||||||||||||||||||||
Principal payments, net | (883 | ) | (8,008 | ) | |||||||||||||||||||||||||||||||||||||
Removals | — | (565 | ) | ||||||||||||||||||||||||||||||||||||||
Transfer to other real estate owned | — | (206 | ) | ||||||||||||||||||||||||||||||||||||||
Transfer from/to performing | 8,458 | 1,098 | |||||||||||||||||||||||||||||||||||||||
Transfer from/to nonperforming | (1,098 | ) | (8,458 | ) | |||||||||||||||||||||||||||||||||||||
Ending balance | $ | 29,911 | $ | 22,315 | |||||||||||||||||||||||||||||||||||||
Approximately $8.5 million of non-performing troubled debt restructurings were transferred to performing status. A majority of these loans were identified as non-performing troubled debt restructurings during the first half of 2012 and have performed in accordance with the modified terms. The loans continue to be reported as performing troubled debt restructurings. The loans transferred to nonperforming in the table above were restructured in 2010 and 2011. | |||||||||||||||||||||||||||||||||||||||||
Loans removed from troubled debt restructuring status are those that were restructured in a previous calendar year at a market rate of interest and have performed in compliance with the modified terms. | |||||||||||||||||||||||||||||||||||||||||
The following table presents the type of modification for loans that have been restructured and the pre-modification recorded investment during the nine months ended September 30, 2013 (dollars in thousands): | |||||||||||||||||||||||||||||||||||||||||
30-Sep-13 | |||||||||||||||||||||||||||||||||||||||||
Extended | Extended | Extended | |||||||||||||||||||||||||||||||||||||||
Maturity, | Maturity, Delay | Extended | Maturity, Delay | Delay in | |||||||||||||||||||||||||||||||||||||
Amortization | in Payments and | Maturity and | in Payments and | Payments or | |||||||||||||||||||||||||||||||||||||
and Reduction | Reduction of | Reduction of | Reduction of | Extended | Reduction of | ||||||||||||||||||||||||||||||||||||
of Interest Rate | Interest Rate | Interest Rate | Amount | Maturity | Interest Rate | Total | |||||||||||||||||||||||||||||||||||
Commercial | $ | 42 | $ | — | $ | 1,209 | $ | — | $ | — | $ | — | $ | 1,251 | |||||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Healthcare | — | — | — | 3,164 | — | — | 3,164 | ||||||||||||||||||||||||||||||||||
Industrial | — | — | — | — | 2,570 | — | 2,570 | ||||||||||||||||||||||||||||||||||
Multifamily | 187 | — | — | — | 601 | 436 | 1,224 | ||||||||||||||||||||||||||||||||||
Retail | 256 | 205 | 401 | — | — | — | 862 | ||||||||||||||||||||||||||||||||||
Office | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
Other | 84 | — | — | — | — | — | 84 | ||||||||||||||||||||||||||||||||||
Residential real estate | 1,386 | — | — | — | — | 618 | 2,004 | ||||||||||||||||||||||||||||||||||
Construction real estate | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
Indirect vehicle | — | — | — | — | — | 127 | 127 | ||||||||||||||||||||||||||||||||||
Home equity | 1,509 | — | 708 | — | 227 | 1,611 | 4,055 | ||||||||||||||||||||||||||||||||||
Other consumer | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
Total | $ | 3,464 | $ | 205 | $ | 2,318 | $ | 3,164 | $ | 3,398 | $ | 2,792 | $ | 15,341 | |||||||||||||||||||||||||||
The following table presents the activity in the allowance for credit losses, balance in allowance for credit losses and recorded investment in loans by portfolio segment and based on impairment method as of September 30, 2013 and 2012 (in thousands): | |||||||||||||||||||||||||||||||||||||||||
Commercial | Commercial | Commercial | Residential | Construction | Indirect | Home | Other consumer | Unfunded | Total | ||||||||||||||||||||||||||||||||
collateralized by | real estate | real estate | real estate | vehicle | equity | commitments | |||||||||||||||||||||||||||||||||||
assignment of | |||||||||||||||||||||||||||||||||||||||||
lease payments | |||||||||||||||||||||||||||||||||||||||||
30-Sep-13 | |||||||||||||||||||||||||||||||||||||||||
Allowance for credit losses: | |||||||||||||||||||||||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||||||||||||||||||||
Beginning balance | $ | 27,277 | $ | 8,529 | $ | 60,014 | $ | 8,121 | $ | 8,695 | $ | 1,537 | $ | 8,206 | $ | 1,306 | $ | 1,812 | $ | 125,497 | |||||||||||||||||||||
Transfer to (from) allowance for unfunded credit commitments | — | — | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||
Charge-offs | 1,686 | — | 1,236 | 713 | 26 | 572 | 437 | 485 | — | 5,155 | |||||||||||||||||||||||||||||||
Recoveries | 579 | — | 966 | 48 | 420 | 372 | 228 | 74 | — | 2,687 | |||||||||||||||||||||||||||||||
Provision | (45 | ) | 721 | (3,983 | ) | 347 | (735 | ) | 293 | (152 | ) | 368 | (118 | ) | (3,304 | ) | |||||||||||||||||||||||||
Ending balance | $ | 26,125 | $ | 9,250 | $ | 55,761 | $ | 7,803 | $ | 8,354 | $ | 1,630 | $ | 7,845 | $ | 1,263 | $ | 1,694 | $ | 119,725 | |||||||||||||||||||||
Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||
Beginning balance | $ | 24,943 | $ | 7,755 | $ | 61,056 | $ | 6,941 | $ | 11,222 | $ | 1,324 | $ | 9,401 | $ | 1,562 | $ | 4,075 | $ | 128,279 | |||||||||||||||||||||
Transfer to (from) allowance for unfunded credit commitments | — | — | — | — | 500 | — | — | — | (500 | ) | — | ||||||||||||||||||||||||||||||
Charge-offs | 3,030 | — | 5,131 | 2,074 | 855 | 1,930 | 2,547 | 1,501 | — | 17,068 | |||||||||||||||||||||||||||||||
Recoveries | 1,808 | 1,131 | 5,353 | 461 | 827 | 1,111 | 442 | 185 | — | 11,318 | |||||||||||||||||||||||||||||||
Provision | 2,404 | 364 | (5,517 | ) | 2,475 | (3,340 | ) | 1,125 | 549 | 1,017 | (1,881 | ) | (2,804 | ) | |||||||||||||||||||||||||||
Ending balance | $ | 26,125 | $ | 9,250 | $ | 55,761 | $ | 7,803 | $ | 8,354 | $ | 1,630 | $ | 7,845 | $ | 1,263 | $ | 1,694 | $ | 119,725 | |||||||||||||||||||||
Ending allowance balance attributable to loans: | |||||||||||||||||||||||||||||||||||||||||
Individually evaluated for impairment | $ | 4,389 | $ | 285 | $ | 7,464 | $ | 3,033 | $ | 240 | $ | — | $ | 781 | $ | — | $ | 657 | $ | 16,849 | |||||||||||||||||||||
Collectively evaluated for impairment | 20,871 | 8,965 | 46,412 | 4,663 | 8,114 | 1,630 | 7,064 | 1,263 | 1,037 | 100,019 | |||||||||||||||||||||||||||||||
Acquired and accounted for under ASC 310-30 (1) | 865 | — | 1,885 | 107 | — | — | — | — | — | 2,857 | |||||||||||||||||||||||||||||||
Total ending allowance balance | $ | 26,125 | $ | 9,250 | $ | 55,761 | $ | 7,803 | $ | 8,354 | $ | 1,630 | $ | 7,845 | $ | 1,263 | $ | 1,694 | $ | 119,725 | |||||||||||||||||||||
Loans: | |||||||||||||||||||||||||||||||||||||||||
Individually evaluated for impairment | $ | 19,836 | $ | 2,330 | $ | 60,600 | $ | 15,851 | $ | 1,622 | $ | 106 | $ | 23,278 | $ | — | $ | — | $ | 123,623 | |||||||||||||||||||||
Collectively evaluated for impairment | 1,134,376 | 1,466,484 | 1,577,768 | 291,699 | 134,524 | 257,634 | 251,206 | 57,418 | — | 5,171,109 | |||||||||||||||||||||||||||||||
Acquired and accounted for under ASC 310-30 (1) | 35,649 | — | 159,799 | 5,982 | 61,446 | — | 110 | 29,014 | — | 292,000 | |||||||||||||||||||||||||||||||
Total ending loans balance | $ | 1,189,861 | $ | 1,468,814 | $ | 1,798,167 | $ | 313,532 | $ | 197,592 | $ | 257,740 | $ | 274,594 | $ | 86,432 | $ | — | $ | 5,586,732 | |||||||||||||||||||||
Commercial | Commercial | Commercial | Residential | Construction | Indirect | Home | Other consumer | Unfunded | Total | ||||||||||||||||||||||||||||||||
collateralized by | real estate | real estate | real estate | vehicle | equity | commitments | |||||||||||||||||||||||||||||||||||
assignment of | |||||||||||||||||||||||||||||||||||||||||
lease payments | |||||||||||||||||||||||||||||||||||||||||
30-Sep-12 | |||||||||||||||||||||||||||||||||||||||||
Allowance for credit losses: | |||||||||||||||||||||||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||||||||||||||||||||
Beginning balance | $ | 20,789 | $ | 7,490 | $ | 68,713 | $ | 3,592 | $ | 10,586 | $ | 1,941 | $ | 7,617 | $ | 1,028 | $ | 7,084 | $ | 128,840 | |||||||||||||||||||||
Charge-offs | 75 | — | 2,994 | 474 | 71 | 433 | 1,209 | 332 | — | 5,588 | |||||||||||||||||||||||||||||||
Recoveries | 306 | 111 | 12,893 | 8 | 752 | 224 | 303 | 77 | — | 14,674 | |||||||||||||||||||||||||||||||
Provision | 1,181 | (149 | ) | (12,253 | ) | 738 | (393 | ) | 288 | 370 | 558 | (3,340 | ) | (13,000 | ) | ||||||||||||||||||||||||||
Ending balance | $ | 22,201 | $ | 7,452 | $ | 66,359 | $ | 3,864 | $ | 10,874 | $ | 2,020 | $ | 7,081 | $ | 1,331 | $ | 3,744 | $ | 124,926 | |||||||||||||||||||||
Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||
Beginning balance | $ | 21,106 | $ | 7,561 | $ | 68,695 | $ | 3,935 | $ | 15,639 | $ | 1,834 | $ | 7,333 | $ | 695 | $ | 9,177 | $ | 135,975 | |||||||||||||||||||||
Transfer to (from) allowance for unfunded credit commitments | — | — | — | — | 1,132 | — | — | — | (1,132 | ) | — | ||||||||||||||||||||||||||||||
Charge-offs | 2,065 | 1,720 | 8,412 | 1,876 | 3,951 | 1,636 | 3,157 | 864 | — | 23,681 | |||||||||||||||||||||||||||||||
Recoveries | 2,730 | 460 | 16,116 | 230 | 1,458 | 835 | 423 | 280 | — | 22,532 | |||||||||||||||||||||||||||||||
Provision | 430 | 1,151 | (10,040 | ) | 1,575 | (3,404 | ) | 987 | 2,482 | 1,220 | (4,301 | ) | (9,900 | ) | |||||||||||||||||||||||||||
Ending balance | $ | 22,201 | $ | 7,452 | $ | 66,359 | $ | 3,864 | $ | 10,874 | $ | 2,020 | $ | 7,081 | $ | 1,331 | $ | 3,744 | $ | 124,926 | |||||||||||||||||||||
Ending allowance balance attributable to loans: | |||||||||||||||||||||||||||||||||||||||||
Individually evaluated for impairment | $ | 2,570 | $ | 180 | $ | 7,567 | $ | 401 | $ | 582 | $ | — | $ | — | $ | — | $ | 1,726 | $ | 13,026 | |||||||||||||||||||||
Collectively evaluated for impairment | 19,345 | 7,272 | 56,851 | 3,144 | 10,292 | 2,020 | 7,081 | 1,331 | 2,018 | 109,354 | |||||||||||||||||||||||||||||||
Acquired and accounted for under ASC 310-30 (1) | 286 | — | 1,941 | 319 | — | — | — | — | — | 2,546 | |||||||||||||||||||||||||||||||
Total ending allowance balance | $ | 22,201 | $ | 7,452 | $ | 66,359 | $ | 3,864 | $ | 10,874 | $ | 2,020 | $ | 7,081 | $ | 1,331 | $ | 3,744 | $ | 124,926 | |||||||||||||||||||||
Loans: | |||||||||||||||||||||||||||||||||||||||||
Individually evaluated for impairment | $ | 21,537 | $ | 1,168 | $ | 56,037 | $ | 11,127 | $ | 2,372 | $ | — | $ | 10,280 | $ | 248 | $ | — | $ | 102,769 | |||||||||||||||||||||
Collectively evaluated for impairment | 1,033,534 | 1,218,193 | 1,714,224 | 293,787 | 147,500 | 206,973 | 304,438 | 84,403 | — | 5,003,052 | |||||||||||||||||||||||||||||||
Acquired and accounted for under ASC 310-30 (1) | 78,275 | — | 269,348 | 7,116 | 125,515 | — | 568 | 38,202 | — | 519,024 | |||||||||||||||||||||||||||||||
Total ending loans balance | $ | 1,133,346 | $ | 1,219,361 | $ | 2,039,609 | $ | 312,030 | $ | 275,387 | $ | 206,973 | $ | 315,286 | $ | 122,853 | $ | — | $ | 5,624,845 | |||||||||||||||||||||
(1) Loans acquired in FDIC-assisted transactions and accounted for under ASC Subtopic 310-30 “Receivables — Loans and Debt Securities Acquired with Deteriorated Credit Quality.” | |||||||||||||||||||||||||||||||||||||||||
Purchased loans acquired in a business combination are recorded at estimated fair value on their purchase date without a carryover of the related allowance for loan losses. These acquired loans are segregated into three types: pass rated loans with no discount attributable to credit quality, non-impaired loans with a discount attributable at least in part to credit quality and impaired loans with evidence of significant credit deterioration. | |||||||||||||||||||||||||||||||||||||||||
• | Pass rated loans (typically performing loans) are accounted in accordance with ASC 310-30 "Nonrefundable Fees and Other Costs" as these loans do not have evidence of credit deterioration since origination. | ||||||||||||||||||||||||||||||||||||||||
• | Non-impaired loans (typically past-due loans, special mention loans and performing substandard loans) are accounted for in accordance with ASC 310-30 as they display at least some level of credit deterioration since origination. | ||||||||||||||||||||||||||||||||||||||||
• | Impaired loans (typically substandard loans on non-accrual status) are accounted for in accordance with ASC 310-30 as they display significant credit deterioration since origination. | ||||||||||||||||||||||||||||||||||||||||
In accordance with ASC 310-30, for both purchased non-impaired loans and purchased impaired loans, the difference between contractually required payments at acquisition and the cash flows expected to be collected is referred to as the non-accretable difference. Further, any excess of cash flows expected at acquisition over the estimated fair value is referred to as the accretable yield and is recognized into interest income over the remaining life of the loan when there is a reasonable expectation about the amount and timing of such cash flows. | |||||||||||||||||||||||||||||||||||||||||
Substantially all of the loans acquired in transactions with the FDIC displayed at least some level of credit deterioration and as such are included as non-impaired and impaired loans as described immediately above. | |||||||||||||||||||||||||||||||||||||||||
During the three and nine months ended September 30, 2013 there was a negative provision for credit losses of $1.5 million and $2.5 million, respectively, and net recoveries of $677 thousand and $830 thousand, respectively, in relation to 15 pools of purchased loans with a total carrying amount of $219.1 million as of September 30, 2013. There was $2.9 million in allowance for loan losses related to these purchased loans at September 30, 2013 and $4.5 million at December 31, 2012. The provision for credit losses and accompanying charge-offs are included in the table above. | |||||||||||||||||||||||||||||||||||||||||
Changes in the accretable yield for loans acquired in FDIC-assisted transactions and accounted for under ASC 310-30 were as follows for the three and nine months ended September 30, 2013 and 2012 (in thousands): | |||||||||||||||||||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||
September 30, | September 30, | ||||||||||||||||||||||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||||||||||||||||||||||||||
Balance at beginning of period | $ | 6,360 | $ | 9,411 | $ | 5,685 | $ | 18,703 | |||||||||||||||||||||||||||||||||
Accretion | (2,427 | ) | (3,406 | ) | (2,859 | ) | (12,812 | ) | |||||||||||||||||||||||||||||||||
Other | — | 403 | 1,107 | 517 | |||||||||||||||||||||||||||||||||||||
Balance at end of period | $ | 3,933 | $ | 6,408 | $ | 3,933 | $ | 6,408 | |||||||||||||||||||||||||||||||||
In our FDIC-assisted transactions, the fair value of purchased impaired loans, on the acquisition date, was determined based on assigned risk ratings, expected cash flows and the fair value of loan collateral. The fair value of loans that were non-impaired was determined based on estimates of losses on defaults and other market factors. Due to the loss-share agreements with the FDIC, MB Financial Bank recorded a receivable (FDIC indemnification asset) from the FDIC equal to the present value of the corresponding reimbursement percentages on the estimated losses embedded in the loan portfolio. | |||||||||||||||||||||||||||||||||||||||||
When cash flow estimates are adjusted downward for a particular loan pool, the FDIC indemnification asset is increased. An allowance for loan losses is established for the impairment of the loans. A provision for loan losses is recognized for the difference between the increase in the FDIC indemnification asset and the decrease in cash flows. | |||||||||||||||||||||||||||||||||||||||||
When cash flow estimates are adjusted upward for a particular loan pool, the FDIC indemnification asset is decreased. The difference between the decrease in the FDIC indemnification asset and the increase in cash flows is accreted over the estimated life of the loan pool. | |||||||||||||||||||||||||||||||||||||||||
When cash flow estimates are adjusted downward for covered foreclosed real estate, the FDIC indemnification asset is increased. A charge is recognized for the difference between the increase in the FDIC indemnification asset and the decrease in cash flows. | |||||||||||||||||||||||||||||||||||||||||
When cash flow estimates are adjusted upward for covered foreclosed real estate, the FDIC indemnification asset is decreased. Any write-down after the transfer to covered foreclosed real estate is reversed. | |||||||||||||||||||||||||||||||||||||||||
In both scenarios, the clawback liability (the amount the FDIC requires MB Financial Bank to pay back if certain thresholds are met) will increase or decrease accordingly. | |||||||||||||||||||||||||||||||||||||||||
The carrying amount of covered loans and other purchased non-covered loans at September 30, 2013 consisted of loans as shown in the following table (in thousands): | |||||||||||||||||||||||||||||||||||||||||
30-Sep-13 | Purchased | Purchased Non-Impaired | Total | ||||||||||||||||||||||||||||||||||||||
Impaired | Loans | ||||||||||||||||||||||||||||||||||||||||
Loans | |||||||||||||||||||||||||||||||||||||||||
Covered loans: | |||||||||||||||||||||||||||||||||||||||||
Commercial related (1) | $ | 11,130 | $ | 5,738 | $ | 16,868 | |||||||||||||||||||||||||||||||||||
Commercial | 457 | 3,527 | 3,984 | ||||||||||||||||||||||||||||||||||||||
Commercial real estate | 62,576 | 97,223 | 159,799 | ||||||||||||||||||||||||||||||||||||||
Construction real estate | 53,444 | 8,002 | 61,446 | ||||||||||||||||||||||||||||||||||||||
Other | 2,982 | 28,418 | 31,400 | ||||||||||||||||||||||||||||||||||||||
Total covered loans | $ | 130,589 | $ | 142,908 | $ | 273,497 | |||||||||||||||||||||||||||||||||||
Estimated receivable amount from the FDIC under the loss-share agreement (2) | $ | 36 | $ | 10,013 | $ | 10,049 | |||||||||||||||||||||||||||||||||||
Non covered loans: | |||||||||||||||||||||||||||||||||||||||||
Commercial related (3) | $ | 4,357 | $ | 10,440 | $ | 14,797 | |||||||||||||||||||||||||||||||||||
Other | 89 | 3,617 | 3,706 | ||||||||||||||||||||||||||||||||||||||
Total non-covered loans | $ | 4,446 | $ | 14,057 | $ | 18,503 | |||||||||||||||||||||||||||||||||||
-1 | Covered commercial related loans include commercial, commercial real estate and construction real estate loans acquired in connection with the Heritage and Benchmark FDIC-assisted transactions. | ||||||||||||||||||||||||||||||||||||||||
-2 | Estimated reimbursable amounts from the FDIC under the loss-share agreement exclude $1.0 million in reimbursable amounts related to covered other real estate owned. | ||||||||||||||||||||||||||||||||||||||||
-3 | Non covered commercial related loans include commercial, commercial real estate and construction real estate for InBank. | ||||||||||||||||||||||||||||||||||||||||
Outstanding balances on purchased loans from the FDIC were $305.0 million and $515.7 million as of September 30, 2013 and December 31, 2012, respectively. The related carrying amount on loans purchased from the FDIC was $292.0 million and $471.6 million as of September 30, 2013 and December 31, 2012, respectively. |
Goodwill_and_Intangibles
Goodwill and Intangibles | 9 Months Ended | ||||
Sep. 30, 2013 | |||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||
Goodwill and Intangibles | Goodwill and Intangibles | ||||
The excess of the cost of an acquisition over the fair value of the net assets acquired consists of goodwill, and core deposit and client relationship intangibles. Under ASC Topic 350, goodwill is subject to at least annual assessments for impairment by applying a fair value based test. The Company reviews goodwill to determine potential impairment annually, or more frequently if events and circumstances indicate that goodwill might be impaired, by comparing the carrying value of the reporting unit with the fair value of the reporting unit. | |||||
The Company's annual assessment date is as of December 31. No impairment losses were recognized during the three or nine months ended September 30, 2013 or 2012. Goodwill is tested for impairment at the reporting unit level. All of our goodwill is allocated to MB Financial, Inc., which is the Company's only applicable reporting unit for purposes of testing goodwill impairment. The carrying amount of goodwill was $423.4 million at September 30, 2013 and December 31, 2012. | |||||
The Company has other intangible assets consisting of core deposit and client relationship intangibles that had a remaining weighted average amortization period of approximately four years as of September 30, 2013. | |||||
The following table presents the changes in the carrying amount of core deposit and client relationship intangibles, gross carrying amount, accumulated amortization, and net book value as of September 30, 2013 (in thousands): | |||||
Nine Months Ended | |||||
September 30, | |||||
2013 | |||||
Balance at beginning of period | $ | 29,512 | |||
Amortization expense | (4,595 | ) | |||
Balance at end of period | $ | 24,917 | |||
Gross carrying amount | $ | 61,429 | |||
Accumulated amortization | (36,512 | ) | |||
Net book value | $ | 24,917 | |||
The following presents the estimated future amortization expense of other intangible assets (in thousands): | |||||
Year ending December 31, | Amount | ||||
2013 | $ | 1,489 | |||
2014 | 4,748 | ||||
2015 | 4,030 | ||||
2016 | 3,418 | ||||
2017 | 3,071 | ||||
Thereafter | 8,161 | ||||
$ | 24,917 | ||||
Deposits
Deposits | 9 Months Ended | ||||||||
Sep. 30, 2013 | |||||||||
Deposits [Abstract] | |||||||||
Deposits | Deposits | ||||||||
The composition of deposits was as follows (in thousands): | |||||||||
September 30, | December 31, | ||||||||
2013 | 2012 | ||||||||
Demand deposit accounts, noninterest bearing | $ | 2,269,367 | $ | 2,164,547 | |||||
NOW and money market accounts | 2,680,127 | 2,747,273 | |||||||
Savings accounts | 843,671 | 811,333 | |||||||
Certificates of deposit, $100,000 or more | 838,606 | 1,020,033 | |||||||
Other certificates of deposit | 666,915 | 799,511 | |||||||
Total | $ | 7,298,686 | $ | 7,542,697 | |||||
Certificates of deposit of $100,000 or more included $238.5 million and $294.2 million of brokered deposits at September 30, 2013 and December 31, 2012, respectively. Brokered deposits typically consist of smaller individual time certificates that have the same liquidity characteristics and yields consistent with time certificates of $100,000 or more. |
ShortTerm_Borrowings
Short-Term Borrowings | 9 Months Ended | ||||||||||||||
Sep. 30, 2013 | |||||||||||||||
Short-term Debt [Abstract] | |||||||||||||||
Short-Term Borrowings | Short-Term Borrowings | ||||||||||||||
Short-term borrowings were as follows as of September 30, 2013 and December 31, 2012 (dollars in thousands): | |||||||||||||||
30-Sep-13 | December 31, 2012 | ||||||||||||||
Weighted | Weighted | ||||||||||||||
Average | Average | ||||||||||||||
Cost | Amount | Cost | Amount | ||||||||||||
Customer repurchase agreements | 0.22 | % | $ | 240,600 | 0.23 | % | $ | 208,242 | |||||||
Federal Home Loan Bank advances | — | % | — | 3.58 | % | 12,360 | |||||||||
0.22 | % | $ | 240,600 | 0.42 | % | $ | 220,602 | ||||||||
Securities sold under agreements to repurchase are agreements in which the Company acquires funds by selling assets to another party under a simultaneous agreement to repurchase the same assets at a specified price and date. The Company enters into repurchase agreements and also offers a demand deposit account product to customers that sweeps their balances in excess of an agreed upon target amount into overnight repurchase agreements. All securities sold under agreements to repurchase are recorded on the face of the balance sheet. | |||||||||||||||
The Company had a Federal Home Loan Bank fixed rate advance with a maturity date less than one year of $12.4 million in fixed rate advances at December 31, 2012. | |||||||||||||||
On March 9, 2012, the Company entered into a $35.0 million unsecured line of credit with a correspondent bank. Interest is payable at a rate of one month LIBOR + 2.00%. As of September 30, 2013, no amount was outstanding. The line originally matured on March 8, 2013, was renewed and is scheduled to mature on March 7, 2014. |
Longterm_Borrowings
Long-term Borrowings | 9 Months Ended |
Sep. 30, 2013 | |
Long-term Debt, Unclassified [Abstract] | |
Long-term Borrowings | Long-term Borrowings |
The Company had Federal Home Loan Bank advances with remaining contractual maturities greater than one year of $4.3 million at September 30, 2013 and December 31, 2012. As of September 30, 2013, the advances had fixed terms with effective interest rates, net of discounts, ranging from 3.23% to 5.87% and maturities ranging from April 2021 to April 2035. | |
A collateral pledge agreement exists whereby at all times, the Company must keep on hand, free of all other pledges, liens, and encumbrances, first mortgage loans and home equity loans with unpaid principal balances aggregating no less than 133% for first mortgage loans and 250% for home equity loans of the outstanding advances from the Federal Home Loan Bank. The Company may also pledge certain investment securities as collateral for advances based on market value. As of September 30, 2013 and December 31, 2012, the Company had $7.3 million and $28.4 million, respectively, of loans pledged as collateral for long-term Federal Home Loan Bank advances. Additionally, as of September 30, 2013 and December 31, 2012, the Company had $29.2 million and $32.1 million, respectively, of investment securities pledged as collateral for advances from the Federal Home Loan Bank. | |
The Company had notes payable to banks totaling $17.7 million and $21.1 million at September 30, 2013 and December 31, 2012, respectively, which as of September 30, 2013, were accruing interest at rates ranging from 2.50% to 12.00%. Lease investments includes equipment with an amortized cost of $25.9 million and $29.7 million at September 30, 2013 and December 31, 2012, respectively, that is pledged as collateral on these notes. | |
The Company had a $40.0 million 10-year structured repurchase agreement as of September 30, 2013, which bears interest at a fixed rate borrowing of 4.75% and expires in 2016. | |
During the first quarter of 2013, MB Financial Bank pre-paid a $50.0 million subordinated debt facility. Interest was payable at a rate of 3-month LIBOR +1.70%. |
Junior_Subordinated_Notes_Issu
Junior Subordinated Notes Issued to Capital Trusts | 9 Months Ended | ||||||||||||||||
Sep. 30, 2013 | |||||||||||||||||
JUNIOR SUBORDINATED NOTES ISSUED TO CAPITAL TRUSTS | |||||||||||||||||
Junior Subordinated Notes Issued to Capital Trusts | Junior Subordinated Notes Issued to Capital Trusts | ||||||||||||||||
The Company has established statutory trusts for the sole purpose of issuing trust preferred securities and related trust common securities. The proceeds from such issuances were used by the trusts to purchase junior subordinated notes of the Company, which are the sole assets of each trust. Concurrently with the issuance of the trust preferred securities, the Company issued guarantees for the benefit of the holders of the trust preferred securities. The Company’s outstanding trust preferred securities qualify, and are treated by the Company, as Tier 1 regulatory capital. The Company owns all of the common securities of each trust. The trust preferred securities issued by each trust rank equally with the common securities in right of payment, except that if an event of default under the indenture governing the notes has occurred and is continuing, the preferred securities will rank senior to the common securities in right of payment. | |||||||||||||||||
The table below summarizes the outstanding junior subordinated notes and the related trust preferred securities issued by each trust as of September 30, 2013 (in thousands): | |||||||||||||||||
Coal City | MB Financial | MB Financial | MB Financial | ||||||||||||||
Capital Trust I | Capital Trust II | Capital Trust III | Capital Trust IV | ||||||||||||||
Junior Subordinated Notes: | |||||||||||||||||
Principal balance | $ | 25,774 | $ | 36,083 | $ | 10,310 | $ | 20,619 | |||||||||
Annual interest rate | 3-mo LIBOR + 1.80% | 3-mo LIBOR + 1.40% | 3-mo LIBOR + 1.50% | 3-mo LIBOR + 1.52% | |||||||||||||
Stated maturity date | September 1, 2028 | September 15, 2035 | September 23, 2036 | September 15, 2036 | |||||||||||||
Call date | September 1, 2008 | December 15, 2010 | September 23, 2011 | September 15, 2011 | |||||||||||||
Trust Preferred Securities: | |||||||||||||||||
Face Value | $ | 25,000 | $ | 35,000 | $ | 10,000 | $ | 20,000 | |||||||||
Annual distribution rate | 3-mo LIBOR + 1.80% | 3-mo LIBOR + 1.40% | 3-mo LIBOR + 1.50% | 3-mo LIBOR + 1.52% | |||||||||||||
Issuance date | July 1998 | August 2005 | July 2006 | August 2006 | |||||||||||||
Distribution dates (1) | Quarterly | Quarterly | Quarterly | Quarterly | |||||||||||||
MB Financial | MB Financial | FOBB | |||||||||||||||
Capital Trust V | Capital Trust VI | Statutory Trust III (2) | |||||||||||||||
Junior Subordinated Notes: | |||||||||||||||||
Principal balance | $ | 30,928 | $ | 23,196 | $ | 5,155 | |||||||||||
Annual interest rate | 3-mo LIBOR + 1.30% | 3-mo LIBOR + 1.30% | 3-mo LIBOR + 2.80% | ||||||||||||||
Stated maturity date | December 15, 2037 | October 30, 2037 | January 23, 2034 | ||||||||||||||
Call date | December 15, 2012 | October 30, 2012 | January 23, 2009 | ||||||||||||||
Trust Preferred Securities: | |||||||||||||||||
Face Value | $ | 30,000 | $ | 22,500 | $ | 5,000 | |||||||||||
Annual distribution rate | 3-mo LIBOR + 1.30% | 3-mo LIBOR + 1.30% | 3-mo LIBOR + 2.80% | ||||||||||||||
Issuance date | September 2007 | October 2007 | December 2003 | ||||||||||||||
Distribution dates (1) | Quarterly | Quarterly | Quarterly | ||||||||||||||
-1 | All distributions are cumulative and paid in cash. | ||||||||||||||||
-2 | FOBB Statutory Trust III was established by First Oak Brook Bancshares, Inc. (“FOBB”) prior to the Company's acquisition of FOBB, and the junior subordinated note issued by FOBB to FOBB Statutory Trust III was assumed by the Company upon completion of the acquisition. | ||||||||||||||||
The trust preferred securities are subject to mandatory redemption, in whole or in part, upon repayment of the junior subordinated notes at the stated maturity date or upon redemption on a date no earlier than the call dates noted in the table above. Prior to these respective redemption dates, the junior subordinated notes could have been redeemed by the Company (in which case the trust preferred securities would also be redeemed) after the occurrence of: certain events that would have a negative tax effect on the Company or the trusts, would cause the trust preferred securities to no longer qualify as Tier 1 capital, or would result in a trust being treated as an investment company. Each trust’s ability to pay amounts due on the trust preferred securities is solely dependent upon the Company making payment on the related junior subordinated notes. The Company’s obligation under the junior subordinated notes and other relevant trust agreements, in aggregate, constitutes a full and unconditional guarantee by the Company of each trust’s obligations under the trust preferred securities issued by each trust. The Company has the right to defer payment of interest on the notes and, therefore, distributions on the trust preferred securities, for up to five years, but not beyond the stated maturity date in the table above. During any such deferral period the Company may not pay cash dividends on its stock and generally may not repurchase its stock. |
Commitments_and_Contingencies
Commitments and Contingencies | 9 Months Ended | ||||||||
Sep. 30, 2013 | |||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||
Commitments and Contingencies | Commitments and Contingencies | ||||||||
Commitments: The Company is a party to credit-related financial instruments with off-balance-sheet risk in the normal course of business to meet the financing needs of its customers. These financial instruments include commitments to extend credit, standby letters of credit and commercial letters of credit. Such commitments involve, to varying degrees, elements of credit and interest rate risk in excess of the amount recognized in the consolidated balance sheets. | |||||||||
The Company’s exposure to credit loss is represented by the contractual amount of these commitments. The Company follows the same credit policies in making commitments as it does for on-balance-sheet instruments. | |||||||||
At September 30, 2013 and December 31, 2012, the following financial instruments were outstanding, the contractual amounts of which represent off-balance sheet credit risk (in thousands): | |||||||||
Contractual Amount | |||||||||
September 30, 2013 | December 31, 2012 | ||||||||
Commitments to extend credit: | |||||||||
Home equity lines | $ | 216,992 | $ | 239,771 | |||||
Other commitments | 1,139,255 | 911,166 | |||||||
Letters of credit: | |||||||||
Standby | 70,720 | 66,247 | |||||||
Commercial | 2,705 | 465 | |||||||
Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require a payment of a fee. The commitments for home equity lines of credit may expire without being drawn upon. Therefore, the total commitment amounts do not necessarily represent future cash requirements. The amount of collateral obtained, if it is deemed necessary by the Company, is based on management’s credit evaluation of the customer. | |||||||||
The Company, in the normal course of its business, regularly offers standby and commercial letters of credit to its bank customers. Standby and commercial letters of credit are a conditional but irrevocable form of guarantee. Under letters of credit, the Company typically guarantees payment to a third party beneficiary upon the default of payment or nonperformance by the bank customer and upon receipt of complying documentation from that beneficiary. | |||||||||
Both standby and commercial letters of credit may be issued for any length of time, but normally do not exceed a period of five years. These letters of credit may also be extended or amended from time to time depending on the bank customer’s needs. As of September 30, 2013, the maximum remaining term for any standby letters of credit was December 31, 2020. A fee is charged to the bank customer and is recognized as income over the life of the letter of credit, unless considered non-rebatable under the terms of a letter of credit application. | |||||||||
At September 30, 2013, the aggregate contractual amount of these letters of credit, which represents the maximum potential amount of future payments that the Company would be obligated to pay, increased $6.7 million to $73.4 million from $66.7 million at December 31, 2012. Of the $73.4 million in commitments outstanding at September 30, 2013, approximately $52.6 million of the letters of credit have been issued or renewed since December 31, 2012. | |||||||||
Letters of credit issued on behalf of bank customers may be done on either a secured, partially secured or an unsecured basis. If a letter of credit is secured or partially secured, the collateral can take various forms including bank accounts, investments, fixed assets, inventory, accounts receivable or real estate, among other things. The Company takes the same care in making credit decisions and obtaining collateral when it issues letters of credit on behalf of its customers as it does when making other types of loans. | |||||||||
As of September 30, 2013, the Company had approximately $1.4 million in capital expenditure commitments outstanding which relate to various projects to renovate existing branches. | |||||||||
Concentrations of credit risk: The majority of the loans, commitments to extend credit and standby letters of credit have been granted to customers in the Company’s market area. As of September 30, 2013, approximately 27% of our investments in securities issued by states and political subdivisions were within the state of Illinois. We did not hold any direct exposure to the state of Illinois as of September 30, 2013. The distribution of commitments to extend credit approximates the distribution of loans outstanding. Standby letters of credit are granted primarily to commercial borrowers. Lease banking provides banking services to lessors located throughout the United States. Our leasing subsidiaries originate leases to companies located through the United States. | |||||||||
Contingencies: In the normal course of business, the Company is involved in various legal proceedings. In the opinion of management, any liability resulting from pending proceedings would not be expected to have a material adverse effect on the Company’s consolidated financial statements. |
Fair_Value_Measurements
Fair Value Measurements | 9 Months Ended | |||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||
Fair Value Disclosures [Abstract] | ||||||||||||||||||
Fair Value Measurements | Fair Value Measurements | |||||||||||||||||
ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. A fair value measurement assumes that the transaction to sell the asset or transfer the liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability. The price in the principal (or most advantageous) market used to measure the fair value of the asset or liability shall not be adjusted for transaction costs. An orderly transaction is a transaction that assumes exposure to the market for a period prior to the measurement date to allow for marketing activities that are usual and customary for transactions involving such assets and liabilities; it is not a forced transaction. Market participants are buyers and sellers in the principal market that are (i) independent, (ii) knowledgeable, (iii) able to transact and (iv) willing to transact. | ||||||||||||||||||
ASC Topic 820 requires the use of valuation techniques that are consistent with the market approach, the income approach and/or the cost approach. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets and liabilities. The income approach uses valuation techniques to convert expected future amounts, such as cash flows or earnings, to a single present value amount on a discounted basis. The cost approach is based on the amount that currently would be required to replace the service capacity of an asset (replacement cost). Valuation techniques should be consistently applied. Inputs to valuation techniques refer to the assumptions that market participants would use in pricing the asset or liability. Inputs may be observable, meaning those that reflect the assumptions market participants would use in pricing the asset or liability developed based on market data obtained from independent sources, or unobservable, meaning those that reflect the reporting entity's own assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. In that regard, ASC Topic 820 establishes a fair value hierarchy for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as follows: | ||||||||||||||||||
Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date. | ||||||||||||||||||
Level 2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. | ||||||||||||||||||
Level 3: Significant unobservable inputs that reflect a reporting entity's own assumptions about the assumptions that market participants would use in pricing an asset or liability. | ||||||||||||||||||
A description of the valuation methodologies used for instruments measured at fair value, as well as the general classification of such instruments pursuant to the valuation hierarchy, is set forth below. | ||||||||||||||||||
In general, fair value is based upon quoted market prices, where available. If such quoted market prices are not available, fair value is based upon internally developed models that primarily use, as inputs, observable market-based parameters. Valuation adjustments may be made to ensure that financial instruments are recorded at fair value. These adjustments may include amounts to reflect counterparty credit quality, the Company's creditworthiness, among other things, as well as unobservable parameters. Any such valuation adjustments are applied consistently over time. Our valuation methodologies may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. While management believes the Company's valuation methodologies are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. Transfers between levels of the fair value hierarchy are recognized on the actual date of the event or circumstances that caused the transfer, which generally coincides with the Company's monthly and/or quarterly valuation process. | ||||||||||||||||||
Financial Instruments Recorded at Fair Value on a Recurring Basis | ||||||||||||||||||
Securities Available for Sale. The fair values of securities available for sale are determined by quoted prices in active markets, when available, and classified as Level 1. If quoted market prices are not available, the fair value is determined by a matrix pricing, which is a mathematical technique widely used in the industry to value debt securities without relying exclusively on quoted prices for the specific securities but rather by relying on the securities' relationship to other benchmark quoted securities and classified as Level 2. In cases where significant credit valuation adjustments are incorporated into the estimation of fair value, reported amounts are classified as Level 3. | ||||||||||||||||||
Loans Held for Sale. The fair value of loans held for sale is determined using quoted secondary market prices and classified as level 2. | ||||||||||||||||||
Assets Held in Trust for Deferred Compensation and Associated Liabilities. Assets held in trust for deferred compensation are recorded at fair value and included in “Other Assets” on the consolidated balance sheets. These assets are invested in mutual funds and classified as Level 1. Deferred compensation liabilities, also classified as Level 1, are carried at the fair value of the obligation to the employee, which corresponds to the fair value of the invested assets. | ||||||||||||||||||
Derivatives. Currently, we use interest rate swaps to manage our interest rate risk. The valuation of these instruments is determined using widely accepted valuation techniques including discounted cash flow analysis on the expected cash flows of each derivative and classified as Level 2. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including LIBOR rate curves. We also obtain dealer quotations for these derivatives for comparative purposes to assess the reasonableness of the model valuations. We also offer other derivatives, including foreign currency forward contracts and interest rate lock commitments, to our customers and offset our exposure from such contracts by purchasing other financial contracts, which are valued using market consensus prices. | ||||||||||||||||||
The following table summarizes financial assets and financial liabilities measured at fair value on a recurring basis as of September 30, 2013 and December 31, 2012, segregated by the level of the valuation inputs within the fair value hierarchy utilized to measure fair value (in thousands): | ||||||||||||||||||
Total | Quoted Prices in | Significant Other | Significant | |||||||||||||||
Active Markets for | Observable Inputs | Unobservable Inputs | ||||||||||||||||
Identical Assets | (Level 2) | (Level 3) | ||||||||||||||||
(Level 1) | ||||||||||||||||||
30-Sep-13 | ||||||||||||||||||
Financial assets | ||||||||||||||||||
Securities available for sale: | ||||||||||||||||||
U.S Government sponsored agencies and enterprises | $ | 52,527 | $ | — | $ | 52,527 | $ | — | ||||||||||
States and political subdivisions | 19,312 | — | 19,312 | — | ||||||||||||||
Residential mortgage-backed securities | 691,276 | — | 690,546 | 730 | ||||||||||||||
Commercial mortgage-backed securities | 53,446 | — | 53,446 | — | ||||||||||||||
Corporate bonds | 263,021 | — | 257,857 | 5,164 | ||||||||||||||
Equity securities | 10,541 | 10,541 | — | — | ||||||||||||||
Loans held for sale | 1,120 | — | 1,120 | — | ||||||||||||||
Assets held in trust for deferred compensation | 10,077 | 10,077 | — | — | ||||||||||||||
Derivative financial instruments | 19,112 | — | 19,112 | — | ||||||||||||||
Financial liabilities | ||||||||||||||||||
Other liabilities (1) | 9,892 | 9,892 | — | — | ||||||||||||||
Derivative financial instruments | 19,060 | — | 19,060 | — | ||||||||||||||
December 31, 2012 | ||||||||||||||||||
Financial assets | ||||||||||||||||||
Securities available for sale: | ||||||||||||||||||
U.S. Government sponsored agencies and enterprises | $ | 41,315 | $ | — | $ | 41,315 | $ | — | ||||||||||
States and political subdivisions | 725,019 | — | 725,019 | — | ||||||||||||||
Residential mortgage-backed securities | 939,202 | — | 938,354 | 848 | ||||||||||||||
Commercial mortgage-backed securities | 54,126 | — | 54,126 | — | ||||||||||||||
Corporate bonds | 96,674 | — | 91,451 | 5,223 | ||||||||||||||
Equity securities | 11,835 | 11,835 | — | — | ||||||||||||||
Loans held for sale | 7,492 | — | 7,492 | — | ||||||||||||||
Assets held in trust for deferred compensation | 7,746 | 7,746 | — | — | ||||||||||||||
Derivative financial instruments | 29,096 | — | 29,096 | — | ||||||||||||||
Financial liabilities | ||||||||||||||||||
Other liabilities (1) | 7,746 | 7,746 | — | — | ||||||||||||||
Derivative financial instruments | 29,055 | — | 29,055 | — | ||||||||||||||
(1) Liabilities associated with assets held in trust for deferred compensation | ||||||||||||||||||
The following table presents additional information about the unobservable inputs used in the fair value measurement of financial assets measured on a recurring basis that were categorized within the Level 3 of the fair value hierarchy: | ||||||||||||||||||
Fair Value at | Valuation | Unobservable | ||||||||||||||||
September 30, 2013 | Technique | Input | Range | |||||||||||||||
Residential mortgage-backed securities | $ | 730 | Discounted cash flows | Constant pre-payment rates | ||||||||||||||
(CPR) assumption | 1% - 3% CPR | |||||||||||||||||
Corporate bonds | 5,164 | Discounted cash flows | Credit assumption | 20% Loss | ||||||||||||||
The Company did not have any transfers between Level 1 and Level 2 of the fair value hierarchy during the three and nine months ended September 30, 2013. The Company's policy for determining transfers between levels occurs at the end of the reporting period when circumstances in the underlying valuation criteria change and result in transfer between levels. | ||||||||||||||||||
The following table presents additional information about financial assets measured at fair value on a recurring basis for which the Company used significant unobservable inputs (Level 3): | ||||||||||||||||||
Nine Months Ended | ||||||||||||||||||
September 30, | ||||||||||||||||||
(in thousands) | 2013 | 2012 | ||||||||||||||||
Balance, beginning of period | $ | 6,071 | $ | 6,992 | ||||||||||||||
Other comprehensive income | (59 | ) | 89 | |||||||||||||||
Principal payments | (118 | ) | (846 | ) | ||||||||||||||
Impairment charge | — | (117 | ) | |||||||||||||||
Balance, ending of period | $ | 5,894 | $ | 6,118 | ||||||||||||||
Financial Instruments Recorded at Fair Value on a Nonrecurring Basis | ||||||||||||||||||
The Company may be required, from time to time, to measure certain financial assets and financial liabilities at fair value on a nonrecurring basis in accordance with U.S. GAAP. These include assets that are measured at the lower of cost or fair value that were recognized at fair value below cost at the end of the period. | ||||||||||||||||||
Impaired Loans. Loans for which it is probable that payment of interest and principal will not be made in accordance with the contractual terms of the loan agreement are considered impaired. Once a loan is identified as individually impaired, management measures impairment in accordance with ASC Topic 310. The fair value of impaired loans is estimated using one of several methods, including collateral value, market value of similar debt, enterprise value, liquidation value and discounted cash flows. Those impaired loans not requiring an allowance represent loans for which the fair value of the expected repayments or collateral exceed the recorded investments in such loans. In accordance with ASC Topic 820, impaired loans where an allowance is established based on the fair value of collateral require classification in the fair value hierarchy. Collateral values are estimated using Level 3 inputs based on customized discounting criteria. For a majority of impaired real estate loans where an allowance is established based on the fair value of collateral (approximately 85%), the Company obtains a current external appraisal. Other valuation techniques are used as well, including internal valuations, comparable property analysis and contractual sales information. | ||||||||||||||||||
Non-Financial Assets and Non-Financial Liabilities Recorded at Fair Value | ||||||||||||||||||
The Company has no non-financial assets or non-financial liabilities measured at fair value on a recurring basis. Certain non-financial assets and non-financial liabilities measured at fair value on a non-recurring basis include foreclosed assets and non-financial long-lived assets. | ||||||||||||||||||
Other Real Estate and Repossessed Vehicles Owned (Foreclosed Assets). Foreclosed assets, upon initial recognition, are measured and reported at fair value through a charge-off to the allowance for loan losses based upon the fair value of the foreclosed asset. The fair value of foreclosed assets, upon initial recognition, are estimated using Level 3 inputs based on customized discounting criteria. | ||||||||||||||||||
Non-Financial Long-Lived Assets. Non-financial long-lived assets, when determined to be impaired, are measured and reported at fair value using Level 3 inputs based on customized discounting criteria. | ||||||||||||||||||
Assets measured at fair value on a nonrecurring basis as of September 30, 2013 and December 31, 2012 are included in the table below (in thousands): | ||||||||||||||||||
Total | Quoted Prices in Active | Significant Other | Significant | |||||||||||||||
Markets for Identical | Observable Inputs | Unobservable Inputs | ||||||||||||||||
Assets (Level 1) | (Level 2) | (Level 3) | ||||||||||||||||
30-Sep-13 | ||||||||||||||||||
Financial assets: | ||||||||||||||||||
Impaired loans | $ | 84,500 | $ | — | $ | — | $ | 84,500 | ||||||||||
Non-financial assets: | ||||||||||||||||||
Foreclosed assets | 57,009 | — | — | 57,009 | ||||||||||||||
December 31, 2012 | ||||||||||||||||||
Financial assets: | ||||||||||||||||||
Impaired loans | $ | 62,258 | $ | — | $ | — | $ | 62,258 | ||||||||||
Non-financial assets: | ||||||||||||||||||
Foreclosed assets | 60,228 | — | — | 60,228 | ||||||||||||||
Long-lived assets | 2,314 | — | — | 2,314 | ||||||||||||||
The following table presents additional information about the unobservable inputs used in the fair value measurement of financial assets measured on a nonrecurring basis that were categorized within the Level 3 of the fair value hierarchy: | ||||||||||||||||||
Fair Value at | Valuation | Unobservable | ||||||||||||||||
September 30, 2013 | Technique | Input | Range | |||||||||||||||
Impaired loans | $ | 84,500 | Appraisal of collateral | Appraisal adjustments - sales costs | 5% - 10% | |||||||||||||
Foreclosed assets | 57,009 | Appraisal of collateral | Appraisal adjustments - sales costs | 5% - 10% | ||||||||||||||
ASC Topic 825 requires disclosure of the fair value of financial assets and financial liabilities, including those financial assets and financial liabilities that are not measured and reported at fair value on a recurring basis or non-recurring basis. The methodologies for estimating the fair value of financial assets and financial liabilities that are measured at fair value on a recurring or non-recurring basis are discussed above. The estimated fair value approximates carrying value for cash and cash equivalents, accrued interest and the cash surrender value of life insurance policies. The methodologies for other financial assets and financial liabilities are discussed below: | ||||||||||||||||||
The following methods and assumptions were used by the Company in estimating the fair values of its other financial instruments: | ||||||||||||||||||
Cash and due from banks and interest bearing deposits with banks: The carrying amounts reported in the balance sheet approximate fair value. | ||||||||||||||||||
Securities held to maturity: The fair values of securities held to maturity are determined by quoted prices in active markets, when available, and classified as Level 1. If quoted market prices are not available, the fair value is determined by a matrix pricing, which is a mathematical technique widely used in the industry to value debt securities without relying exclusively on quoted prices for the specific securities but rather by relying on the securities' relationship to other benchmark quoted securities and classified as Level 2. In cases where significant credit valuation adjustments are incorporated into the estimation of fair value, reported amounts are classified as Level 3. | ||||||||||||||||||
Non-marketable securities - FHLB and FRB Stock: The carrying amounts reported in the balance sheet approximate fair value. | ||||||||||||||||||
Loans Held for Sale: The fair value of the loans held for sale is determined using quoted secondary market prices and classified as level 2. | ||||||||||||||||||
Loans: The fair values for loans are estimated using discounted cash flow analyses, using the corporate bond curve adjusted for liquidity for commercial loans and the swap curve adjusted for liquidity for retail loans. | ||||||||||||||||||
Non-interest bearing deposits: The fair values disclosed are equal to their balance sheet carrying amounts, which represent the amount payable on demand. | ||||||||||||||||||
Interest bearing deposits: The fair values disclosed for deposits with no defined maturities are equal to their carrying amounts, which represent the amounts payable on demand. Fair values for certificates of deposit are estimated using a discounted cash flow calculation that applies the Company's current incremental borrowing rates for similar terms. | ||||||||||||||||||
Short-term borrowings: The carrying amounts of federal funds purchased, borrowings under repurchase agreements and other short-term borrowings with maturities of 90 days or less approximate their fair values. The fair value of short-term borrowings greater than 90 days is based on the discounted value of contractual cash flows. | ||||||||||||||||||
Long-term borrowings: The fair values of the Company's long-term borrowings (other than deposits) are estimated using discounted cash flow analyses, based on the Company's current incremental borrowing rates for similar types of borrowing arrangements. | ||||||||||||||||||
Junior subordinated notes issued to capital trusts: The fair values of the Company's junior subordinated notes issued to capital trusts are estimated based on the quoted market prices, when available, of the related trust preferred security instruments or are estimated based on the quoted market prices of comparable trust preferred securities. | ||||||||||||||||||
Accrued interest: The carrying amount of accrued interest receivable and payable approximate their fair values. | ||||||||||||||||||
Off-balance-sheet instruments: Fair values for the Company’s off-balance-sheet lending commitments (guarantees, letters of credit and commitments to extend credit) are based on fees currently charged to enter into similar agreements, taking into account the remaining terms of the agreements. | ||||||||||||||||||
The estimated fair values of financial instruments are as follows (in thousands): | ||||||||||||||||||
30-Sep-13 | ||||||||||||||||||
Carrying Amount | Estimated Fair Value | Quoted Prices in Active | Significant Other | Significant | ||||||||||||||
Markets for Identical | Observable Inputs | Unobservable Inputs | ||||||||||||||||
Assets (Level 1) | (Level 2) | (Level 3) | ||||||||||||||||
Financial Assets: | ||||||||||||||||||
Cash and due from banks | $ | 215,017 | $ | 215,017 | $ | 215,017 | $ | — | $ | — | ||||||||
Interest bearing deposits with banks | 41,700 | 41,700 | 41,700 | — | — | |||||||||||||
Investment securities available for sale | 1,090,123 | 1,090,123 | 10,541 | 1,073,688 | 5,894 | |||||||||||||
Investment securities held to maturity | 1,193,544 | 1,212,748 | — | 1,212,748 | — | |||||||||||||
Non-marketable securities - FHLB and FRB stock | 50,870 | 50,870 | — | — | 50,870 | |||||||||||||
Loans held for sale | 1,120 | 1,120 | — | 1,120 | — | |||||||||||||
Loans, net | 5,468,701 | 5,470,567 | — | — | 5,470,567 | |||||||||||||
Accrued interest receivable | 35,938 | 35,938 | 35,938 | — | — | |||||||||||||
Derivative financial instruments | 19,112 | 19,112 | — | 19,112 | — | |||||||||||||
Financial Liabilities: | ||||||||||||||||||
Noninterest bearing deposits | $ | 2,269,367 | $ | 2,269,367 | $ | 2,269,367 | $ | — | $ | — | ||||||||
Interest bearing deposits | 5,029,319 | 5,039,175 | — | — | 5,039,175 | |||||||||||||
Short-term borrowings | 240,600 | 240,595 | — | — | 240,595 | |||||||||||||
Long-term borrowings | 62,428 | 67,425 | — | — | 67,425 | |||||||||||||
Junior subordinated notes issued to capital trusts | 152,065 | 105,967 | — | — | 105,967 | |||||||||||||
Accrued interest payable | 1,908 | 1,908 | 1,908 | — | — | |||||||||||||
Derivative financial instruments | 19,060 | 19,060 | — | 19,060 | — | |||||||||||||
December 31, 2012 | ||||||||||||||||||
Carrying Amount | Estimated Fair Value | Quoted Prices in Active | Significant Other | Significant | ||||||||||||||
Markets for Identical | Observable Inputs | Unobservable Inputs | ||||||||||||||||
Assets (Level 1) | (Level 2) | (Level 3) | ||||||||||||||||
Financial Assets: | ||||||||||||||||||
Cash and due from banks | $ | 176,010 | $ | 176,010 | $ | 176,010 | $ | — | $ | — | ||||||||
Interest bearing deposits with banks | 111,533 | 111,533 | 111,533 | — | — | |||||||||||||
Investment securities available for sale | 1,868,171 | 1,868,171 | 11,835 | 1,850,265 | 6,071 | |||||||||||||
Investment securities held to maturity | 493,421 | 535,681 | — | 535,681 | — | |||||||||||||
Non-marketable securities - FHLB and FRB stock | 55,385 | 55,385 | — | — | 55,385 | |||||||||||||
Loans held for sale | 7,492 | 7,492 | — | 7,492 | — | |||||||||||||
Loans, net | 5,642,726 | 5,659,598 | — | — | 5,659,598 | |||||||||||||
Accrued interest receivable | 36,040 | 36,040 | 36,040 | — | — | |||||||||||||
Derivative financial instruments | 29,096 | 29,096 | — | 29,096 | — | |||||||||||||
Financial Liabilities: | ||||||||||||||||||
Non-interest bearing deposits | $ | 2,164,547 | $ | 2,164,547 | $ | 2,164,547 | $ | — | $ | — | ||||||||
Interest bearing deposits | 5,378,150 | 5,399,709 | — | — | 5,399,709 | |||||||||||||
Short-term borrowings | 220,602 | 220,683 | — | — | 220,683 | |||||||||||||
Long-term borrowings | 116,050 | 117,809 | — | — | 117,809 | |||||||||||||
Junior subordinated notes issued to capital trusts | 152,065 | 104,009 | — | — | 104,009 | |||||||||||||
Accrued interest payable | 2,828 | 2,828 | 2,828 | — | — | |||||||||||||
Derivative financial instruments | 29,055 | 29,055 | — | 29,055 | — | |||||||||||||
Stock_Incentive_Plans
Stock Incentive Plans | 9 Months Ended | ||||||||||||||||
Sep. 30, 2013 | |||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |||||||||||||||||
Stock Incentive Plans | Stock Incentive Plans | ||||||||||||||||
ASC Topic 718 requires that the grant date fair value of equity awards to employees be recognized as compensation expense over the period during which an employee is required to provide service in exchange for such award. | |||||||||||||||||
The following table summarizes the impact of the Company’s share-based payment plans in the financial statements for the periods shown (in thousands): | |||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||
September 30, | September 30, | ||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||
Total cost of share-based payment plans during the period | $ | 1,388 | $ | 1,080 | $ | 3,860 | $ | 3,581 | |||||||||
Amount of related income tax benefit recognized in income | 548 | 430 | 1,530 | $ | 1,431 | ||||||||||||
The Company adopted the Omnibus Incentive Plan (the “Omnibus Plan”) in 1997. In June 2011, the Company’s stockholders approved an amendment and restatement of the Omnibus Plan to add 2,300,000 authorized shares for a total of 8,300,000 shares of common stock for issuance to directors, officers, and employees of the Company or any of its subsidiaries. Equity grants under the Omnibus Plan can be in the form of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance units, and other stock-based awards. Shares awarded in the form of restricted stock, restricted stock units, performance shares, performance units, or other stock-based awards generally will reduce the shares available under the Omnibus Plan on a 2-for-1 basis. As of September 30, 2013, there were 1,617,262 shares available for future grants. | |||||||||||||||||
Annual equity-based incentive awards are typically granted to selected officers and employees mid-year. Options are granted with an exercise price equal to no less than the market price of the Company’s shares at the date of grant; those option awards generally vest over four years of service and have 10-year contractual terms. Restricted shares and units typically vest over a two to four year period. Equity awards may also be granted at other times throughout the year in connection with the recruitment and retention of officers and employees. Directors currently may elect, in lieu of cash, to receive up to 70% of their fees in stock options with a five year term, which are fully vested on the grant date (provided that the director may not sell the underlying shares for at least six months after the grant date), and up to 100% of their fees in restricted shares, which vest one year after the grant date. | |||||||||||||||||
The following table summarizes stock options outstanding for the nine months ended September 30, 2013: | |||||||||||||||||
Number of | Weighted | Weighted | Aggregate | ||||||||||||||
Options | Average | Average | Intrinsic | ||||||||||||||
Exercise | Remaining | Value | |||||||||||||||
Price | Contractual | (in thousands) | |||||||||||||||
Term | |||||||||||||||||
(In Years) | |||||||||||||||||
Options outstanding as of December 31, 2012 | 2,739,753 | $ | 27.34 | ||||||||||||||
Granted | 211,501 | 27.03 | |||||||||||||||
Exercised | (330,832 | ) | 25.51 | ||||||||||||||
Expired or cancelled | (113,290 | ) | 30.91 | ||||||||||||||
Forfeited | (17,857 | ) | 20.18 | ||||||||||||||
Options outstanding as of September 30, 2013 | 2,489,275 | $ | 27.44 | 4.94 | $ | 9,407 | |||||||||||
Options exercisable as of September 30, 2013 | 1,809,183 | $ | 29.72 | 3.67 | $ | 4,764 | |||||||||||
The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model based on certain assumptions. Expected volatility is based on historical volatility and the expectations of future volatility of Company shares. The risk free interest rate for periods within the contractual term of the option is based on the U.S. Treasury yield curve in effect at the time of the grant. The expected life of options is estimated based on historical employee behavior and represents the period of time that options granted are expected to remain outstanding. | |||||||||||||||||
The following assumptions were used for options granted during the nine months ended September 30, 2013: | |||||||||||||||||
September 30, | |||||||||||||||||
2013 | |||||||||||||||||
Risk-free interest rate | 1.96 | % | |||||||||||||||
Expected volatility of Company’s stock | 25.6 | % | |||||||||||||||
Expected dividend yield | 1.74 | % | |||||||||||||||
Expected life of options | 5.6 years | ||||||||||||||||
Weighted average fair value per option of options granted during the year | $ | 5.97 | |||||||||||||||
The total intrinsic value of options exercised during the nine months ended September 30, 2013 and 2012 was $929 thousand and $203 thousand, respectively. | |||||||||||||||||
The following is a summary of changes in restricted shares and units for the nine months ended September 30, 2013: | |||||||||||||||||
Number of | Weighted | ||||||||||||||||
Shares and Units | Average | ||||||||||||||||
Grant Date | |||||||||||||||||
Fair Value | |||||||||||||||||
Shares Outstanding at December 31, 2012 | 634,211 | $ | 18.82 | ||||||||||||||
Granted | 270,983 | 26.91 | |||||||||||||||
Vested | (201,178 | ) | 16.79 | ||||||||||||||
Forfeited | (13,983 | ) | 20.52 | ||||||||||||||
Shares Outstanding at September 30, 2013 | 690,033 | $ | 22.55 | ||||||||||||||
The Company issued 56,752 and 65,333 market-based restricted stock units in 2013 and 2012, respectively, which entitle recipients to shares of common stock at the end of a three year vesting period. Recipients will earn shares, totaling between 0% and 175% of the number of units issued, based on the Company's total stockholder return relative to a specified peer group of financial institutions over the three year period. The market-based restricted stock units are included in the preceding table as if the recipients earned shares equal to 100% of the units issued. A Monte Carlo simulation model was used to value the market-based restricted stock units at the time of issuance. | |||||||||||||||||
The Company issued 92,717 shares and 66,193 shares of market-based restricted stock in 2011 and 2010, respectively. The market component of the vesting terms for each award requires that, for ten consecutive trading days, the closing price of the Company’s stock be at least $27.00 for awards issued in 2011 and $25.80 for awards issued in 2010. The market components for awards issued in 2011 and 2010 have been satisfied as of September 30, 2013. Awards issued in 2011 will vest in full in 2014, on the third anniversary of the grant date. Awards issued in 2010 vested in full in 2013. A Monte Carlo simulation model was used to value the market-based restricted stock awards at the time of issuance. | |||||||||||||||||
Effective January 1, 2010, the Company began issuing shares of common stock under the Omnibus Plan as Salary Stock, classified as other stock-based awards, to certain executive officers. This stock is fully vested as of the grant date and the related expense is included in salaries and employee benefits on the Consolidated Statements of Operations. Holders of Salary Stock have all of the rights of a stockholder, including the right to vote the shares and the right to receive any dividends that may be paid thereon. As a condition of receiving the Salary Stock, the holders entered into agreements with the Company providing that they may not sell or otherwise transfer the shares of Salary Stock for two years, except in the event of disability or death. During the three months ended March 31, 2013, the Company issued 876 shares of Salary Stock at a weighted average issuance price of $22.39 and subsequently ended the issuance of new shares of Salary Stock. | |||||||||||||||||
As of September 30, 2013, there was $14.2 million of total unrecognized compensation cost related to nonvested share-based compensation arrangements (including share option and nonvested share awards) granted under the Omnibus Plan. At September 30, 2013, the weighted-average period over which the unrecognized compensation expense is expected to be recognized was approximately 2.9 years. |
Derivative_Financial_Instrumen
Derivative Financial Instruments | 9 Months Ended | ||||||||||||||||||||||||||||||||
Sep. 30, 2013 | |||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||
Derivative Financial Instruments | Derivative Financial Instruments | ||||||||||||||||||||||||||||||||
The Company offers various derivatives, including interest rate swaps and foreign currency forward contracts, to our customers which can mitigate our exposure to market risk through the execution of off-setting positions with inter-bank dealer counterparties. This also permits the Company to offer customized risk management solutions to our customers. These customer accommodations and any offsetting financial contracts are treated as non-designated derivative instruments and carried at fair value through an adjustment to the income statement. | |||||||||||||||||||||||||||||||||
Interest rate swap and foreign currency forward contracts involve the risk of dealing with counterparties and their ability to meet contractual terms. The net amount payable or receivable under interest rate swaps is accrued as an adjustment to interest income. The net amount payable as of September 30, 2013 was approximately $24 thousand, and the net amount payable as of December 31, 2012 was approximately $30 thousand. The Company's credit exposure on interest rate swaps is limited to the Company's net favorable value and interest payments of all swaps to each counterparty. In such cases, collateral is generally required from the counterparties involved if the net value of the swaps exceeds a nominal amount. At September 30, 2013, the Company’s credit exposure relating to interest rate swaps was approximately $17.9 million, which is secured by the underlying collateral on customer loans. | |||||||||||||||||||||||||||||||||
The Company also enters into mortgage banking derivatives which are classified as non-designated derivatives. These derivatives include interest rate lock commitments provided to customers to fund certain mortgage loans to be sold into the secondary market and forward commitments for the future delivery of such loans. It is the Company's practice to enter into forward commitments for the future delivery of residential mortgage loans when interest rate lock commitments are entered into in order to economically hedge the effect of future changes in interest rates on its commitments to fund the loans as well as on its portfolio of mortgage loans held-for-sale. | |||||||||||||||||||||||||||||||||
The Company had fair value commercial loan interest rate swaps, to hedge its interest rate risk, with an aggregate notional amount of $248 thousand at September 30, 2013. For fair value hedges, the changes in fair values of both the hedging derivative and the hedged item were recorded in current earnings as other income. | |||||||||||||||||||||||||||||||||
The Company’s derivative financial instruments are summarized below as of September 30, 2013 and December 31, 2012 (in thousands): | |||||||||||||||||||||||||||||||||
Asset Derivatives | Liability Derivatives | ||||||||||||||||||||||||||||||||
30-Sep-13 | December 31, 2012 | 30-Sep-13 | December 31, 2012 | ||||||||||||||||||||||||||||||
Notional | Estimated | Notional | Estimated | Notional | Estimated | Notional | Estimated | ||||||||||||||||||||||||||
Amount | Fair Value | Amount | Fair Value | Amount | Fair Value | Amount | Fair Value | ||||||||||||||||||||||||||
Derivative instruments designated as hedges of fair value: | |||||||||||||||||||||||||||||||||
Interest rate swap contracts (1) | $ | — | $ | — | $ | — | $ | — | $ | 248 | $ | (26 | ) | $ | 3,707 | $ | (94 | ) | |||||||||||||||
Stand-alone derivative instruments (2) | |||||||||||||||||||||||||||||||||
Interest rate swap contracts | 570,472 | 17,813 | 460,956 | 27,740 | 571,445 | (17,875 | ) | 462,012 | (27,832 | ) | |||||||||||||||||||||||
Interest rate options contracts | 84,095 | 307 | 70,346 | 157 | 84,095 | (307 | ) | 70,346 | (157 | ) | |||||||||||||||||||||||
Foreign exchange contracts | 16,112 | 912 | 20,033 | 1,062 | 15,536 | (818 | ) | 19,337 | (961 | ) | |||||||||||||||||||||||
Mortgage banking derivatives | 4,794 | 80 | 11,400 | 137 | 2,603 | (34 | ) | 4,000 | (11 | ) | |||||||||||||||||||||||
Total non-hedging derivative instruments | 675,473 | 19,112 | 562,735 | 29,096 | 673,679 | (19,034 | ) | 555,695 | (28,961 | ) | |||||||||||||||||||||||
Total | $ | 675,473 | $ | 19,112 | $ | 562,735 | $ | 29,096 | $ | 673,927 | $ | (19,060 | ) | $ | 559,402 | $ | (29,055 | ) | |||||||||||||||
(1) Hedged fixed-rate commercial real estate loans | |||||||||||||||||||||||||||||||||
(2) These portfolio swaps are not designated as hedging instruments under ASC Topic 815. | |||||||||||||||||||||||||||||||||
Amounts included in the other income in the consolidated statements of operations related to derivative financial instruments were as follows (in thousands): | |||||||||||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||
September 30, | September 30, | ||||||||||||||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||||||||||||||||||
Derivative instruments designated as hedges of fair value: | |||||||||||||||||||||||||||||||||
Interest rate swap contracts | $ | (1 | ) | $ | — | $ | 9 | $ | (36 | ) | |||||||||||||||||||||||
Stand-alone derivative instruments | |||||||||||||||||||||||||||||||||
Interest rate swap contracts | 7 | 6 | 30 | 19 | |||||||||||||||||||||||||||||
Interest rate options contracts | — | — | — | — | |||||||||||||||||||||||||||||
Foreign exchange contracts | (12 | ) | 14 | (7 | ) | 44 | |||||||||||||||||||||||||||
Mortgage banking derivatives | (16 | ) | 9 | (80 | ) | 79 | |||||||||||||||||||||||||||
Total non-hedging derivative instruments | (21 | ) | 29 | (57 | ) | 142 | |||||||||||||||||||||||||||
Total | $ | (22 | ) | $ | 29 | $ | (48 | ) | $ | 106 | |||||||||||||||||||||||
Methods and assumptions used by the Company in estimating the fair value of its interest rate swaps are discussed in Note 13 to consolidated financial statements. | |||||||||||||||||||||||||||||||||
Certain instruments and transactions subject to an agreement similar to a master netting arrangement are eligible for offset in the consolidated balance sheet. The instruments and transactions would include derivatives, sale and repurchase agreements and reverse sale and repurchase agreements, and securities borrowing and securities lending arrangements. The Company’s derivative transactions with financial institution counterparties are generally executed under International Swaps and Derivative Association (“ISDA”) master agreements which include “right of set-off” provisions. Under these agreements, there is generally a legally enforceable right to offset recognized amounts, and there may be an intention to settle such amounts on a net basis. The Company, however, does not generally offset such financial instruments for financial reporting purposes. | |||||||||||||||||||||||||||||||||
Information about the Company's financial instruments that are eligible for offset in the consolidated balance sheet as of September 30, 2013 is summarized below (in thousands): | |||||||||||||||||||||||||||||||||
Financial Assets | Financial Liabilities | ||||||||||||||||||||||||||||||||
Gross Amount Recognized | Gross Amount Offset | Net Amount Recognized | Gross Amount Recognized | Gross Amount Offset | Net Amount Recognized | ||||||||||||||||||||||||||||
Derivatives: | |||||||||||||||||||||||||||||||||
Interest rate swaps, caps and floors | $ | 3,483 | $ | — | $ | 3,483 | $ | 14,724 | $ | — | $ | 14,724 | |||||||||||||||||||||
Foreign currency forward contracts | 67 | — | 67 | 764 | — | 764 | |||||||||||||||||||||||||||
Mortgage banking derivatives | — | — | — | 34 | — | 34 | |||||||||||||||||||||||||||
Total derivatives | 3,550 | — | 3,550 | 15,522 | — | 15,522 | |||||||||||||||||||||||||||
Repurchase agreements | — | — | — | 240,600 | — | 240,600 | |||||||||||||||||||||||||||
Total | $ | 3,550 | $ | — | $ | 3,550 | $ | 256,122 | $ | — | $ | 256,122 | |||||||||||||||||||||
Financial Assets | Financial Liabilities | ||||||||||||||||||||||||||||||||
Net Amount Recognized | Financial Instruments | Collateral | Net Amount | Net Amount Recognized | Financial Instruments | Collateral | Net Amount | ||||||||||||||||||||||||||
Derivatives: | |||||||||||||||||||||||||||||||||
Counterparty A | $ | 440 | $ | (440 | ) | $ | — | $ | — | $ | 12,976 | $ | (440 | ) | $ | (12,536 | ) | $ | — | ||||||||||||||
Counterparty B | 1,090 | (551 | ) | — | 539 | 551 | (551 | ) | — | — | |||||||||||||||||||||||
Counterparty C | 1,570 | (1,570 | ) | — | — | 1,949 | (1,570 | ) | (379 | ) | — | ||||||||||||||||||||||
Other counterparties | 450 | (1 | ) | — | 449 | 46 | (1 | ) | — | 45 | |||||||||||||||||||||||
Total derivatives | 3,550 | (2,562 | ) | — | 988 | 15,522 | (2,562 | ) | (12,915 | ) | 45 | ||||||||||||||||||||||
Repurchase agreements | — | — | — | — | 240,600 | — | (240,600 | ) | — | ||||||||||||||||||||||||
Total | $ | 3,550 | $ | (2,562 | ) | $ | — | $ | 988 | $ | 256,122 | $ | (2,562 | ) | $ | (253,515 | ) | $ | 45 | ||||||||||||||
Information about the Company's financial instruments that are eligible for offset in the consolidated balance sheet as of December 31, 2012 is summarized below (in thousands): | |||||||||||||||||||||||||||||||||
Financial Assets | Financial Liabilities | ||||||||||||||||||||||||||||||||
Gross Amount Recognized | Gross Amount Offset | Net Amount Recognized | Gross Amount Recognized | Gross Amount Offset | Net Amount Recognized | ||||||||||||||||||||||||||||
Derivatives: | |||||||||||||||||||||||||||||||||
Interest rate swaps, caps and floors | $ | 192 | $ | — | $ | 192 | $ | 27,890 | $ | — | $ | 27,890 | |||||||||||||||||||||
Foreign currency forward contracts | 43 | — | 43 | 929 | — | 929 | |||||||||||||||||||||||||||
Mortgage banking derivatives | 1 | — | 1 | 11 | — | 11 | |||||||||||||||||||||||||||
Total derivatives | 236 | — | 236 | 28,830 | — | 28,830 | |||||||||||||||||||||||||||
Repurchase agreements | — | — | — | 208,242 | — | 208,242 | |||||||||||||||||||||||||||
Total | $ | 236 | $ | — | $ | 236 | $ | 237,072 | $ | — | $ | 237,072 | |||||||||||||||||||||
Financial Assets | Financial Liabilities | ||||||||||||||||||||||||||||||||
Net Amount Recognized | Financial Instruments | Collateral | Net Amount | Net Amount Recognized | Financial Instruments | Collateral | Net Amount | ||||||||||||||||||||||||||
Derivatives: | |||||||||||||||||||||||||||||||||
Counterparty A | $ | 68 | $ | (68 | ) | $ | — | $ | — | $ | 25,497 | $ | (68 | ) | $ | (25,429 | ) | $ | — | ||||||||||||||
Counterparty B | 84 | (84 | ) | — | — | 633 | (84 | ) | (549 | ) | — | ||||||||||||||||||||||
Counterparty C | 36 | (36 | ) | — | — | 2,305 | (36 | ) | (2,269 | ) | — | ||||||||||||||||||||||
Other counterparties | 48 | (42 | ) | — | 6 | 395 | (42 | ) | (298 | ) | 55 | ||||||||||||||||||||||
Total derivatives | 236 | (230 | ) | — | 6 | 28,830 | (230 | ) | (28,545 | ) | 55 | ||||||||||||||||||||||
Repurchase agreements | — | — | — | — | 208,242 | — | (208,242 | ) | — | ||||||||||||||||||||||||
Total | $ | 236 | $ | (230 | ) | $ | — | $ | 6 | $ | 237,072 | $ | (230 | ) | $ | (236,787 | ) | $ | 55 | ||||||||||||||
Common_and_Preferred_Stock
Common and Preferred Stock | 9 Months Ended |
Sep. 30, 2013 | |
Equity [Abstract] | |
Common and Preferred Stock | Common and Preferred Stock |
In 2008, the Company issued 196,000 shares of Fixed Rate Cumulative Perpetual Preferred Stock, Series A ("the Series A Preferred Stock"), liquidation amount $1,000 per share, for an aggregate purchase price of $196.0 million as part of the Troubled Asset Relief Program (“TARP”) Capital Purchase Program of the United States Department of the Treasury (the “Treasury”). The Series A Preferred Stock qualified as Tier 1 capital and provided for cumulative dividends on the liquidation preference amount on a quarterly basis at a rate of 5% per annum for the first five years, and 9% per annum thereafter. Concurrent with issuing the Series A Preferred Stock, the Company issued to the Treasury a 10 year warrant (the “Warrant”) to purchase 1,012,048 shares (subsequently reduced to 506,024 shares, as described below) of the Company’s Common Stock at an exercise price of $29.05 per share. | |
On September 17, 2009, the Company completed a public offering of its common stock by issuing 12,578,125 shares of common stock for aggregate gross proceeds of $201.3 million. The net proceeds to the Company after deducting underwriting discounts and commissions and offering expenses were approximately $190.9 million. With the proceeds from this offering and the proceeds received by the Company from issuances pursuant to its Dividend Reinvestment and Stock Purchase Plan, the Company received aggregate gross proceeds from “Qualified Equity Offerings” in excess of the $196.0 million aggregate liquidation preference amount of the Series A Preferred Stock. As a result, the number of shares of the Company’s common stock underlying the Warrant was reduced by 50%, from 1,012,048 shares to 506,024 shares. | |
On March 14, 2012, the Company repurchased all $196.0 million of the Series A Preferred Stock. On May 2, 2012, the Company repurchased the Warrant in full for approximately $1.5 million. |
New_Authoritative_Accounting_G1
New Authoritative Accounting Guidance (Policies) | 9 Months Ended |
Sep. 30, 2013 | |
New Authoritative Accounting Guidance [Abstract] | |
New Authoritative Accounting Pronouncements | ASC Topic 805 “Business Combinations.” New authoritative accounting guidance under ASC Topic 805, “Business Combinations” amended prior guidance on the subsequent accounting for an indemnification asset recognized at the acquisition date as a result of a government-assisted (Federal Deposit Insurance Corporation) acquisition of a financial institution that includes a loss-sharing agreement. The new authoritative guidance requires that at each subsequent reporting date, an acquirer measure an indemnification asset on the same basis as the indemnified liability or asset, subject to any contractual limitations on its amount, and, for an indemnification asset that is not subsequently measured at fair value, management's assessment of the collectability of the indemnification asset. Any amortization of changes in value should be limited to the contractual term of the indemnification agreement (that is, the lesser of the term of the indemnification agreement and the remaining life of the indemnified assets). The Company adopted this new authoritative guidance on January 1, 2013, and it did not have an impact on the Company's statements of operations and financial condition. |
ASC Topic 210 “Disclosures about Offsetting Assets and Liabilities.” New authoritative accounting guidance under ASC Topic 210, “Disclosures about Offsetting Assets and Liabilities” amended prior guidance to require an entity to disclose both gross and net information about both instruments and transactions eligible for offset in the statement of financial position and instruments and transactions subject to an agreement similar to a master netting arrangement. The instruments and transactions would include derivatives, sale and repurchase agreements and reverse sale and repurchase agreements, and securities borrowing and securities lending arrangements. This new authoritative guidance was further amended to clarify the scope of offsetting disclosures. The Company adopted the new authoritative guidance on January 1, 2013, and it did not have an impact on the Company's statements of operations and financial condition. See disclosures in Note 15. | |
ASC Topic 220 “Comprehensive Income.” New authoritative accounting guidance under ASC Topic 220, “Comprehensive Income” amended prior guidance to improve the reporting of reclassifications out of accumulated other comprehensive income by requiring an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the statement or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income if the amount reclassified is required under U.S. GAAP. The Company adopted this new authoritative guidance on January 1, 2013, and it did not have an impact on the Company's statements of operations and financial condition. | |
ASC Topic 815 “Derivatives and Hedging.” New authoritative accounting guidance under ASC Topic 815, “Derivatives and Hedging” amended prior guidance to permit the Fed Funds Effective Swap Rate (OIS) to be used as a U.S. benchmark interest rate for hedge accounting purposes, in addition to U.S. government treasury obligation rates and London Interbank Offered Rate swap rate. The amendments also remove the restriction on using different benchmark rates for similar hedges. The new authoritative guidance will be effective prospectively for new and redesignated hedging relationships entered into on or after July 17, 2013 and is not expected to have an impact on the Company's statements of operations and financial condition. | |
ASC Topic 740 “Income Taxes.” New authoritative accounting guidance under ASC Topic 740, “Income Taxes” amended prior guidance to include explicit guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. An unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as follows. To the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. The new authoritative guidance will be for reporting periods after January 1, 2014 and is not expected to have an impact on the Company's statements of operations and financial condition. |
Earnings_Per_Common_Share_Tabl
Earnings Per Common Share (Tables) | 9 Months Ended | ||||||||||||||||
Sep. 30, 2013 | |||||||||||||||||
Accounting Policies [Abstract] | |||||||||||||||||
Reconciliation of the number of shares used in the calculation of basic and diluted earnings (loss) per common share, net income available to common stockholders, and earnings per share | The following table presents a reconciliation of the number of shares used in the calculation of basic and diluted earnings per common share (amounts in thousands, except share and per share data). | ||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||
September 30, | September 30, | ||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||
Distributed earnings allocated to common stock | $ | 6,636 | $ | 548 | $ | 17,653 | $ | 1,643 | |||||||||
Undistributed earnings | 17,764 | 22,585 | 56,946 | 64,719 | |||||||||||||
Net income | 24,400 | 23,133 | 74,599 | 66,362 | |||||||||||||
Less: preferred stock dividends and discount accretion | — | — | — | 3,269 | |||||||||||||
Net income available to common stockholders | 24,400 | 23,133 | 74,599 | 63,093 | |||||||||||||
Less: earnings allocated to participating securities | 1 | 1 | 2 | 2 | |||||||||||||
Earnings allocated to common stockholders | $ | 24,399 | $ | 23,132 | $ | 74,597 | $ | 63,091 | |||||||||
Weighted average shares outstanding for basic earnings per common share | 54,565,089 | 54,346,827 | 54,471,541 | 54,226,241 | |||||||||||||
Dilutive effect of equity awards | 565,564 | 209,690 | 440,811 | 246,376 | |||||||||||||
Weighted average shares outstanding for diluted earnings per common share | 55,130,653 | 54,556,517 | 54,912,352 | 54,472,617 | |||||||||||||
Basic earnings per common share | $ | 0.45 | $ | 0.43 | $ | 1.37 | $ | 1.16 | |||||||||
Diluted earnings per common share | 0.44 | 0.42 | 1.36 | 1.16 | |||||||||||||
Business_Combinations_Tables
Business Combinations (Tables) | 9 Months Ended | ||||
Sep. 30, 2013 | |||||
Business Combinations [Abstract] | |||||
Assets Acquired and Liabilities Assumed | Estimated fair values of the assets acquired and liabilities assumed in the Celtic transaction, as of the closing date of the transaction were as follows (in thousands): | ||||
Assets Acquired and Liabilities Assumed | |||||
(Dollar Amounts in Thousands) | |||||
Celtic | |||||
December 28, | |||||
2012 | |||||
ASSETS | |||||
Cash and cash equivalents | $ | 31,647 | |||
Investment securities available for sale | 635 | ||||
Loans and leases | 32,933 | ||||
Premises and equipment | 81 | ||||
Goodwill | 36,300 | ||||
Other intangibles | 5,028 | ||||
Other assets | 27,323 | ||||
Total assets | $ | 133,947 | |||
LIABILITIES | |||||
Accrued expenses and other liabilities | $ | 75,290 | |||
Total liabilities | $ | 75,290 | |||
Cash paid on acquisition | $ | 58,657 | |||
Net gain recorded on acquisition | $ | — | |||
Investment_Securities_Tables
Investment Securities (Tables) | 9 Months Ended | ||||||||||||||||||||||||
Sep. 30, 2013 | |||||||||||||||||||||||||
Investments Securities [Abstract] | |||||||||||||||||||||||||
Summary investment holdings | Carrying amounts and fair values of investment securities were as follows (in thousands): | ||||||||||||||||||||||||
Amortized | Gross | Gross | Fair | ||||||||||||||||||||||
Cost | Unrealized | Unrealized | Value | ||||||||||||||||||||||
Gains | Losses | ||||||||||||||||||||||||
30-Sep-13 | |||||||||||||||||||||||||
Available for Sale | |||||||||||||||||||||||||
U.S. Government sponsored agencies and enterprises | $ | 50,678 | $ | 1,849 | $ | — | $ | 52,527 | |||||||||||||||||
States and political subdivisions | 19,461 | 52 | (201 | ) | 19,312 | ||||||||||||||||||||
Residential mortgage-backed securities | 685,126 | 8,659 | (2,509 | ) | 691,276 | ||||||||||||||||||||
Commercial mortgage-backed securities | 50,944 | 2,502 | — | 53,446 | |||||||||||||||||||||
Corporate bonds | 265,293 | 927 | (3,199 | ) | 263,021 | ||||||||||||||||||||
Equity securities | 10,574 | — | (33 | ) | 10,541 | ||||||||||||||||||||
1,082,076 | 13,989 | (5,942 | ) | 1,090,123 | |||||||||||||||||||||
Held to Maturity | |||||||||||||||||||||||||
States and political subdivisions | 941,273 | 8,517 | (3,481 | ) | 946,309 | ||||||||||||||||||||
Residential mortgage-backed securities | 252,271 | 14,168 | — | 266,439 | |||||||||||||||||||||
1,193,544 | 22,685 | (3,481 | ) | 1,212,748 | |||||||||||||||||||||
Total | $ | 2,275,620 | $ | 36,674 | $ | (9,423 | ) | $ | 2,302,871 | ||||||||||||||||
December 31, 2012 | |||||||||||||||||||||||||
Available for Sale | |||||||||||||||||||||||||
U.S. Government sponsored agencies and enterprises | $ | 38,605 | $ | 2,710 | $ | — | $ | 41,315 | |||||||||||||||||
States and political subdivisions | 679,991 | 45,571 | (543 | ) | 725,019 | ||||||||||||||||||||
Residential mortgage-backed securities | 930,413 | 14,038 | (5,249 | ) | 939,202 | ||||||||||||||||||||
Commercial mortgage-backed securities | 51,100 | 3,026 | — | 54,126 | |||||||||||||||||||||
Corporate bonds | 97,014 | 213 | (553 | ) | 96,674 | ||||||||||||||||||||
Equity securities | 11,398 | 447 | (10 | ) | 11,835 | ||||||||||||||||||||
1,808,521 | 66,005 | (6,355 | ) | 1,868,171 | |||||||||||||||||||||
Held to Maturity | |||||||||||||||||||||||||
States and political subdivisions | 237,563 | 21,039 | — | 258,602 | |||||||||||||||||||||
Residential mortgage-backed securities | 255,858 | 21,221 | — | 277,079 | |||||||||||||||||||||
493,421 | 42,260 | — | 535,681 | ||||||||||||||||||||||
Total | $ | 2,301,942 | $ | 108,265 | $ | (6,355 | ) | $ | 2,403,852 | ||||||||||||||||
Unrealized losses on investment securities and the fair value of the related securities | Unrealized losses on investment securities and the fair value of the related securities at December 31, 2012 were as follows (in thousands): | ||||||||||||||||||||||||
Less Than 12 Months | 12 Months or More | Total | |||||||||||||||||||||||
Fair | Unrealized | Fair | Unrealized | Fair | Unrealized | ||||||||||||||||||||
Value | Losses | Value | Losses | Value | Losses | ||||||||||||||||||||
Available for Sale | |||||||||||||||||||||||||
States and political subdivisions | $ | 57,540 | $ | (543 | ) | $ | — | $ | — | $ | 57,540 | $ | (543 | ) | |||||||||||
Residential mortgage-backed securities | 270,539 | (5,083 | ) | 16,434 | (166 | ) | 286,973 | (5,249 | ) | ||||||||||||||||
Corporate bonds | 58,241 | (553 | ) | — | — | 58,241 | (553 | ) | |||||||||||||||||
Equity securities | 30 | (10 | ) | — | — | 30 | (10 | ) | |||||||||||||||||
Totals | $ | 386,350 | $ | (6,189 | ) | $ | 16,434 | $ | (166 | ) | $ | 402,784 | $ | (6,355 | ) | ||||||||||
Unrealized losses on investment securities and the fair value of the related securities at September 30, 2013 were as follows (in thousands): | |||||||||||||||||||||||||
Less Than 12 Months | 12 Months or More | Total | |||||||||||||||||||||||
Fair | Unrealized | Fair | Unrealized | Fair | Unrealized | ||||||||||||||||||||
Value | Losses | Value | Losses | Value | Losses | ||||||||||||||||||||
Available for Sale | |||||||||||||||||||||||||
States and political subdivisions | $ | 9,050 | $ | (201 | ) | $ | — | $ | — | $ | 9,050 | $ | (201 | ) | |||||||||||
Residential mortgage-backed securities | 206,562 | (2,040 | ) | 49,104 | (469 | ) | 255,666 | (2,509 | ) | ||||||||||||||||
Corporate bonds | 147,181 | (3,199 | ) | — | — | 147,181 | (3,199 | ) | |||||||||||||||||
Equity securities | 10,541 | (33 | ) | — | — | 10,541 | (33 | ) | |||||||||||||||||
373,334 | (5,473 | ) | 49,104 | (469 | ) | 422,438 | (5,942 | ) | |||||||||||||||||
Held to Maturity | |||||||||||||||||||||||||
States and political subdivisions | 207,613 | (3,481 | ) | — | — | 207,613 | (3,481 | ) | |||||||||||||||||
207,613 | (3,481 | ) | — | — | 207,613 | (3,481 | ) | ||||||||||||||||||
Totals | $ | 580,947 | $ | (8,954 | ) | $ | 49,104 | $ | (469 | ) | $ | 630,051 | $ | (9,423 | ) | ||||||||||
Summary of realized gains on the sale of investment securities available for sale | Net gains (losses) recognized on investment securities available for sale were as follows (in thousands): | ||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||
September 30, | September 30, | ||||||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||||||||||
Realized gains | $ | 1 | $ | 282 | $ | 15 | $ | 472 | |||||||||||||||||
Realized losses | — | (1 | ) | (1 | ) | (4 | ) | ||||||||||||||||||
Impairment charges | — | — | — | (224 | ) | ||||||||||||||||||||
Net gains (losses) | $ | 1 | $ | 281 | $ | 14 | $ | 244 | |||||||||||||||||
Schedule of remaining contractual maturities of securities included in the securities portfolio | The amortized cost and fair value of investment securities as of September 30, 2013 by contractual maturity are shown below. Maturities may differ from contractual maturities in mortgage-backed securities because the mortgages underlying the securities may be called or repaid without any penalties. Therefore, mortgage-backed securities are not included in the maturity categories in the following maturity summary. | ||||||||||||||||||||||||
Amortized | Fair | ||||||||||||||||||||||||
(In thousands) | Cost | Value | |||||||||||||||||||||||
Available for sale: | |||||||||||||||||||||||||
Due in one year or less | $ | — | $ | — | |||||||||||||||||||||
Due after one year through five years | 319,032 | 318,598 | |||||||||||||||||||||||
Due after five years through ten years | 7,695 | 7,711 | |||||||||||||||||||||||
Due after ten years | 8,705 | 8,551 | |||||||||||||||||||||||
Equity securities | 10,574 | 10,541 | |||||||||||||||||||||||
Residential and commercial mortgage-backed securities | 736,070 | 744,722 | |||||||||||||||||||||||
1,082,076 | 1,090,123 | ||||||||||||||||||||||||
Held to maturity: | |||||||||||||||||||||||||
Due in one year or less | 28,222 | 28,221 | |||||||||||||||||||||||
Due after one year through five years | 245,125 | 245,545 | |||||||||||||||||||||||
Due after five years through ten years | 122,547 | 122,533 | |||||||||||||||||||||||
Due after ten years | 545,379 | 550,010 | |||||||||||||||||||||||
Residential mortgage-backed securities | 252,271 | 266,439 | |||||||||||||||||||||||
1,193,544 | 1,212,748 | ||||||||||||||||||||||||
Total | $ | 2,275,620 | $ | 2,302,871 | |||||||||||||||||||||
Loans_Tables
Loans (Tables) | 9 Months Ended | ||||||||||||||||||||||||||||||||||||||||
Sep. 30, 2013 | |||||||||||||||||||||||||||||||||||||||||
Receivables [Abstract] | |||||||||||||||||||||||||||||||||||||||||
Schedule of composition of loans | Loans consist of the following at (in thousands): | ||||||||||||||||||||||||||||||||||||||||
September 30, | December 31, 2012 | ||||||||||||||||||||||||||||||||||||||||
2013 | |||||||||||||||||||||||||||||||||||||||||
Commercial loans | $ | 1,169,009 | $ | 1,220,472 | |||||||||||||||||||||||||||||||||||||
Commercial loans collateralized by assignment of lease payments | 1,468,814 | 1,303,020 | |||||||||||||||||||||||||||||||||||||||
Commercial real estate | 1,638,368 | 1,761,832 | |||||||||||||||||||||||||||||||||||||||
Residential real estate | 311,256 | 314,359 | |||||||||||||||||||||||||||||||||||||||
Construction real estate | 136,146 | 110,261 | |||||||||||||||||||||||||||||||||||||||
Indirect vehicle | 257,740 | 208,633 | |||||||||||||||||||||||||||||||||||||||
Home equity | 274,484 | 305,186 | |||||||||||||||||||||||||||||||||||||||
Other consumer loans | 57,418 | 93,317 | |||||||||||||||||||||||||||||||||||||||
Gross loans, excluding covered loans | 5,313,235 | 5,317,080 | |||||||||||||||||||||||||||||||||||||||
Covered loans | 273,497 | 449,850 | |||||||||||||||||||||||||||||||||||||||
Total loans(1) | $ | 5,586,732 | $ | 5,766,930 | |||||||||||||||||||||||||||||||||||||
(1) Gross loan balances at September 30, 2013 and December 31, 2012 are net of unearned income, including net deferred loan fees of $1.5 million and $1.1 million, respectively. | |||||||||||||||||||||||||||||||||||||||||
Contractual aging of the recorded investment in past due loans by class of loans | The following table presents the contractual aging of the recorded investment in past due loans by class of loans as of September 30, 2013 and December 31, 2012 (in thousands): | ||||||||||||||||||||||||||||||||||||||||
Current | 30-59 Days | 60-89 Days | Loans Past Due | Total | Total | ||||||||||||||||||||||||||||||||||||
Past Due | Past Due | 90 Days or More | Past Due | ||||||||||||||||||||||||||||||||||||||
30-Sep-13 | |||||||||||||||||||||||||||||||||||||||||
Commercial | $ | 1,158,326 | $ | 2,392 | $ | 2,580 | $ | 5,711 | $ | 10,683 | $ | 1,169,009 | |||||||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | 1,455,296 | 10,761 | 1,816 | 941 | 13,518 | 1,468,814 | |||||||||||||||||||||||||||||||||||
Commercial real estate | |||||||||||||||||||||||||||||||||||||||||
Healthcare | 212,659 | — | — | 3,164 | 3,164 | 215,823 | |||||||||||||||||||||||||||||||||||
Industrial | 371,940 | 161 | 2,101 | 1,394 | 3,656 | 375,596 | |||||||||||||||||||||||||||||||||||
Multifamily | 316,495 | 2,808 | — | 2,387 | 5,195 | 321,690 | |||||||||||||||||||||||||||||||||||
Retail | 344,390 | 236 | 449 | 8,632 | 9,317 | 353,707 | |||||||||||||||||||||||||||||||||||
Office | 139,251 | 412 | 579 | 2,106 | 3,097 | 142,348 | |||||||||||||||||||||||||||||||||||
Other | 223,385 | 3,443 | 229 | 2,147 | 5,819 | 229,204 | |||||||||||||||||||||||||||||||||||
Residential real estate | 298,878 | 1,103 | 1,059 | 10,216 | 12,378 | 311,256 | |||||||||||||||||||||||||||||||||||
Construction real estate | 133,742 | — | 89 | 2,315 | 2,404 | 136,146 | |||||||||||||||||||||||||||||||||||
Indirect vehicle | 255,177 | 1,638 | 687 | 238 | 2,563 | 257,740 | |||||||||||||||||||||||||||||||||||
Home equity | 260,055 | 4,505 | 2,911 | 7,013 | 14,429 | 274,484 | |||||||||||||||||||||||||||||||||||
Other consumer | 57,357 | 54 | 1 | 6 | 61 | 57,418 | |||||||||||||||||||||||||||||||||||
Gross loans, excluding covered loans | 5,226,951 | 27,513 | 12,501 | 46,270 | 86,284 | 5,313,235 | |||||||||||||||||||||||||||||||||||
Covered loans | 138,876 | 12,091 | 5,681 | 116,849 | 134,621 | 273,497 | |||||||||||||||||||||||||||||||||||
Total loans (1) | $ | 5,365,827 | $ | 39,604 | $ | 18,182 | $ | 163,119 | $ | 220,905 | $ | 5,586,732 | |||||||||||||||||||||||||||||
Nonperforming loan aging | $ | 53,271 | $ | 3,596 | $ | 6,111 | $ | 39,474 | $ | 49,181 | $ | 102,452 | |||||||||||||||||||||||||||||
Non-covered loans related to FDIC transactions (2) | $ | 11,339 | $ | 222 | $ | 146 | $ | 6,796 | $ | 7,164 | $ | 18,503 | |||||||||||||||||||||||||||||
December 31, 2012 | |||||||||||||||||||||||||||||||||||||||||
Commercial | $ | 1,215,957 | $ | 639 | $ | 754 | $ | 3,122 | $ | 4,515 | $ | 1,220,472 | |||||||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | 1,288,341 | 11,252 | 2,847 | 580 | 14,679 | 1,303,020 | |||||||||||||||||||||||||||||||||||
Commercial real estate | |||||||||||||||||||||||||||||||||||||||||
Healthcare | 192,039 | — | — | 3,238 | 3,238 | 195,277 | |||||||||||||||||||||||||||||||||||
Industrial | 402,813 | 548 | 424 | 7,700 | 8,672 | 411,485 | |||||||||||||||||||||||||||||||||||
Multifamily | 353,966 | 1,282 | — | 3,103 | 4,385 | 358,351 | |||||||||||||||||||||||||||||||||||
Retail | 375,900 | 6,933 | 518 | 9,331 | 16,782 | 392,682 | |||||||||||||||||||||||||||||||||||
Office | 186,665 | 742 | 280 | 1,125 | 2,147 | 188,812 | |||||||||||||||||||||||||||||||||||
Other | 210,456 | 851 | 1,837 | 2,081 | 4,769 | 215,225 | |||||||||||||||||||||||||||||||||||
Residential real estate | 306,927 | 382 | 1,248 | 5,802 | 7,432 | 314,359 | |||||||||||||||||||||||||||||||||||
Construction real estate | 106,158 | 1,139 | 97 | 2,867 | 4,103 | 110,261 | |||||||||||||||||||||||||||||||||||
Indirect vehicle | 206,126 | 1,588 | 498 | 421 | 2,507 | 208,633 | |||||||||||||||||||||||||||||||||||
Home equity | 291,737 | 3,557 | 1,888 | 8,004 | 13,449 | 305,186 | |||||||||||||||||||||||||||||||||||
Other consumer | 93,266 | 47 | — | 4 | 51 | 93,317 | |||||||||||||||||||||||||||||||||||
Gross loans, excluding covered loans | 5,230,351 | 28,960 | 10,391 | 47,378 | 86,729 | 5,317,080 | |||||||||||||||||||||||||||||||||||
Covered loans | 301,260 | 5,831 | 7,478 | 135,281 | 148,590 | 449,850 | |||||||||||||||||||||||||||||||||||
Total loans (1) | $ | 5,531,611 | $ | 34,791 | $ | 17,869 | $ | 182,659 | $ | 235,319 | $ | 5,766,930 | |||||||||||||||||||||||||||||
Nonperforming loan aging | $ | 69,836 | $ | 3,171 | $ | 3,718 | $ | 40,261 | $ | 47,150 | $ | 116,986 | |||||||||||||||||||||||||||||
Non-covered loans related to FDIC transactions (2) | $ | 12,752 | $ | 312 | $ | 1,542 | $ | 7,115 | $ | 8,969 | $ | 21,721 | |||||||||||||||||||||||||||||
(1) Includes loans related to the InBank FDIC-assisted transaction completed by MB Financial Bank in 2009. | |||||||||||||||||||||||||||||||||||||||||
(2) Loans related to the InBank FDIC-assisted transaction completed by MB Financial Bank in 2009. | |||||||||||||||||||||||||||||||||||||||||
Recorded investment in nonaccrual loans and loans past due ninety days or more and still accruing by class of loans | The following table presents the recorded investment in nonaccrual loans and loans past due ninety days or more and still accruing by class of loans as of September 30, 2013 and December 31, 2012 (in thousands): | ||||||||||||||||||||||||||||||||||||||||
September 30, 2013 | December 31, 2012 | ||||||||||||||||||||||||||||||||||||||||
Loans past due | Loans past due | ||||||||||||||||||||||||||||||||||||||||
Nonaccrual | 90 days or more | Nonaccrual | 90 days or more | ||||||||||||||||||||||||||||||||||||||
and still accruing | and still accruing | ||||||||||||||||||||||||||||||||||||||||
Commercial | $ | 19,948 | $ | — | $ | 23,886 | $ | 229 | |||||||||||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | 2,130 | 215 | 1,180 | 222 | |||||||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Healthcare | 3,164 | — | 3,238 | — | |||||||||||||||||||||||||||||||||||||
Industrial | 9,754 | — | 19,179 | 147 | |||||||||||||||||||||||||||||||||||||
Multifamily | 5,087 | 195 | 7,225 | — | |||||||||||||||||||||||||||||||||||||
Office | 10,916 | — | 3,263 | — | |||||||||||||||||||||||||||||||||||||
Retail | 3,740 | — | 17,019 | — | |||||||||||||||||||||||||||||||||||||
Other | 21,420 | — | 9,437 | — | |||||||||||||||||||||||||||||||||||||
Residential real estate | 13,041 | — | 10,943 | — | |||||||||||||||||||||||||||||||||||||
Construction real estate | 496 | — | 1,028 | — | |||||||||||||||||||||||||||||||||||||
Indirect vehicle | 1,516 | — | 1,494 | — | |||||||||||||||||||||||||||||||||||||
Home equity | 10,818 | — | 17,486 | 1,000 | |||||||||||||||||||||||||||||||||||||
Other consumer | 12 | — | 9 | 1 | |||||||||||||||||||||||||||||||||||||
Total | $ | 102,042 | $ | 410 | $ | 115,387 | $ | 1,599 | |||||||||||||||||||||||||||||||||
Risk category of loans by class of loans | The following tables present the risk category of loans by class of loans based on the most recent analysis performed as of September 30, 2013 and December 31, 2012 (in thousands): | ||||||||||||||||||||||||||||||||||||||||
Pass | Special | Substandard | Doubtful | Total | |||||||||||||||||||||||||||||||||||||
Mention | |||||||||||||||||||||||||||||||||||||||||
30-Sep-13 | |||||||||||||||||||||||||||||||||||||||||
Commercial | $ | 1,091,129 | $ | 17,720 | $ | 60,160 | $ | — | $ | 1,169,009 | |||||||||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | 1,457,577 | 4,814 | 6,423 | — | 1,468,814 | ||||||||||||||||||||||||||||||||||||
Commercial real estate | |||||||||||||||||||||||||||||||||||||||||
Healthcare | 188,946 | 21,556 | 2,157 | 3,164 | 215,823 | ||||||||||||||||||||||||||||||||||||
Industrial | 335,274 | 7,384 | 32,938 | — | 375,596 | ||||||||||||||||||||||||||||||||||||
Multifamily | 306,691 | — | 14,999 | — | 321,690 | ||||||||||||||||||||||||||||||||||||
Retail | 324,558 | 10,373 | 18,776 | — | 353,707 | ||||||||||||||||||||||||||||||||||||
Office | 132,490 | 2,732 | 7,126 | — | 142,348 | ||||||||||||||||||||||||||||||||||||
Other | 201,971 | 3,088 | 24,145 | — | 229,204 | ||||||||||||||||||||||||||||||||||||
Construction real estate | 126,902 | 6,264 | 2,980 | — | 136,146 | ||||||||||||||||||||||||||||||||||||
Total | $ | 4,165,538 | $ | 73,931 | $ | 169,704 | $ | 3,164 | $ | 4,412,337 | |||||||||||||||||||||||||||||||
December 31, 2012 | |||||||||||||||||||||||||||||||||||||||||
Commercial | $ | 1,136,294 | $ | 33,068 | $ | 50,895 | $ | 215 | $ | 1,220,472 | |||||||||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | 1,292,241 | 3,322 | 7,457 | — | 1,303,020 | ||||||||||||||||||||||||||||||||||||
Commercial real estate | |||||||||||||||||||||||||||||||||||||||||
Healthcare | 170,265 | 21,774 | — | 3,238 | 195,277 | ||||||||||||||||||||||||||||||||||||
Industrial | 355,218 | 15,243 | 41,024 | — | 411,485 | ||||||||||||||||||||||||||||||||||||
Multifamily | 318,991 | 25,297 | 14,063 | — | 358,351 | ||||||||||||||||||||||||||||||||||||
Retail | 340,919 | 25,096 | 26,667 | — | 392,682 | ||||||||||||||||||||||||||||||||||||
Office | 159,056 | 7,120 | 22,636 | — | 188,812 | ||||||||||||||||||||||||||||||||||||
Other | 193,824 | 2,553 | 18,848 | — | 215,225 | ||||||||||||||||||||||||||||||||||||
Construction real estate | 97,724 | 552 | 11,985 | — | 110,261 | ||||||||||||||||||||||||||||||||||||
Total | $ | 4,064,532 | $ | 134,025 | $ | 193,575 | $ | 3,453 | $ | 4,395,585 | |||||||||||||||||||||||||||||||
Recorded investment in loan classes based on payment activity | The following table presents the recorded investment in those loan classes based on payment activity as of September 30, 2013 and December 31, 2012 (in thousands): | ||||||||||||||||||||||||||||||||||||||||
Performing | Non-performing | Total | |||||||||||||||||||||||||||||||||||||||
30-Sep-13 | |||||||||||||||||||||||||||||||||||||||||
Residential real estate | $ | 298,215 | $ | 13,041 | $ | 311,256 | |||||||||||||||||||||||||||||||||||
Indirect vehicle | 256,224 | 1,516 | 257,740 | ||||||||||||||||||||||||||||||||||||||
Home equity | 263,666 | 10,818 | 274,484 | ||||||||||||||||||||||||||||||||||||||
Other consumer | 57,406 | 12 | 57,418 | ||||||||||||||||||||||||||||||||||||||
Total | $ | 875,511 | $ | 25,387 | $ | 900,898 | |||||||||||||||||||||||||||||||||||
December 31, 2012 | |||||||||||||||||||||||||||||||||||||||||
Residential real estate | $ | 303,416 | $ | 10,943 | $ | 314,359 | |||||||||||||||||||||||||||||||||||
Indirect vehicle | 207,139 | 1,494 | 208,633 | ||||||||||||||||||||||||||||||||||||||
Home equity | 286,700 | 18,486 | 305,186 | ||||||||||||||||||||||||||||||||||||||
Other consumer | 93,307 | 10 | 93,317 | ||||||||||||||||||||||||||||||||||||||
Total | $ | 890,562 | $ | 30,933 | $ | 921,495 | |||||||||||||||||||||||||||||||||||
Loans individually evaluated for impairment by class of loans | The following tables present loans individually evaluated for impairment by class of loans as of September 30, 2013 and December 31, 2012 (in thousands): | ||||||||||||||||||||||||||||||||||||||||
30-Sep-13 | |||||||||||||||||||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||
Unpaid | Recorded | Partial | Allowance for | Average | Interest | Average | Interest | ||||||||||||||||||||||||||||||||||
Principal | Investment | Charge-offs | Loan Losses | Recorded | Income | Recorded | Income | ||||||||||||||||||||||||||||||||||
Balance | Allocated | Investment | Recognized | Investment | Recognized | ||||||||||||||||||||||||||||||||||||
With no related allowance recorded: | |||||||||||||||||||||||||||||||||||||||||
Commercial | $ | 6,236 | $ | 5,364 | $ | 872 | $ | — | $ | 6,509 | $ | — | $ | 7,378 | $ | — | |||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | 681 | 681 | — | — | 666 | 6 | 256 | 6 | |||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Healthcare | — | — | — | — | — | — | 3,608 | — | |||||||||||||||||||||||||||||||||
Industrial | 7,547 | 6,927 | 620 | — | 7,902 | — | 9,316 | — | |||||||||||||||||||||||||||||||||
Multifamily | 546 | 546 | — | — | 665 | — | 739 | — | |||||||||||||||||||||||||||||||||
Retail | 3,002 | 3,002 | — | — | 3,233 | — | 3,123 | — | |||||||||||||||||||||||||||||||||
Office | 685 | 527 | 158 | — | 705 | — | 986 | — | |||||||||||||||||||||||||||||||||
Other | 3,149 | 3,139 | 10 | — | 3,353 | — | 4,785 | — | |||||||||||||||||||||||||||||||||
Residential real estate | 4,174 | 3,788 | 386 | — | 4,082 | — | 2,835 | — | |||||||||||||||||||||||||||||||||
Construction real estate | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||
Indirect vehicle | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||
Home equity | 577 | 577 | — | — | 577 | — | 872 | — | |||||||||||||||||||||||||||||||||
Other consumer | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||
With an allowance recorded: | |||||||||||||||||||||||||||||||||||||||||
Commercial | 14,472 | 14,472 | — | 4,389 | 15,680 | — | 14,839 | — | |||||||||||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | 1,649 | 1,649 | — | 285 | 1,659 | 109 | 1,347 | 158 | |||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Healthcare | 10,868 | 3,164 | 7,704 | 495 | 10,869 | — | 7,302 | — | |||||||||||||||||||||||||||||||||
Industrial | 2,826 | 2,826 | — | 1,047 | 3,078 | — | 3,611 | — | |||||||||||||||||||||||||||||||||
Multifamily | 6,334 | 5,944 | 390 | 1,876 | 6,408 | 115 | 6,642 | 224 | |||||||||||||||||||||||||||||||||
Retail | 15,323 | 13,031 | 2,292 | 1,855 | 13,778 | — | 13,572 | — | |||||||||||||||||||||||||||||||||
Office | 3,607 | 3,214 | 393 | 1,047 | 3,735 | — | 4,391 | — | |||||||||||||||||||||||||||||||||
Other | 18,493 | 18,280 | 213 | 1,144 | 19,790 | 8 | 11,104 | 16 | |||||||||||||||||||||||||||||||||
Residential real estate | 12,690 | 12,063 | 627 | 3,033 | 12,494 | — | 12,965 | — | |||||||||||||||||||||||||||||||||
Construction real estate | 3,990 | 1,622 | 2,368 | 240 | 1,736 | — | 1,938 | — | |||||||||||||||||||||||||||||||||
Indirect vehicle | 138 | 106 | 32 | — | 146 | — | 54 | — | |||||||||||||||||||||||||||||||||
Home equity | 23,171 | 22,701 | 470 | 781 | 23,558 | — | 24,341 | — | |||||||||||||||||||||||||||||||||
Other consumer | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||
Total | $ | 140,158 | $ | 123,623 | $ | 16,535 | $ | 16,192 | $ | 140,623 | $ | 238 | $ | 136,004 | $ | 404 | |||||||||||||||||||||||||
December 31, 2012 | |||||||||||||||||||||||||||||||||||||||||
Unpaid | Recorded | Partial | Allowance for | Average | Interest | ||||||||||||||||||||||||||||||||||||
Principal | Investment | Charge-offs | Loan Losses | Recorded | Income | ||||||||||||||||||||||||||||||||||||
Balance | Allocated | Investment | Recognized | ||||||||||||||||||||||||||||||||||||||
With no related allowance recorded: | |||||||||||||||||||||||||||||||||||||||||
Commercial | $ | 10,993 | $ | 9,505 | $ | 1,488 | $ | — | $ | 14,089 | $ | 105 | |||||||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | 390 | 390 | — | — | 278 | 9 | |||||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Healthcare | 10,943 | 3,238 | 7,705 | — | 2,751 | — | |||||||||||||||||||||||||||||||||||
Industrial | 16,891 | 14,940 | 1,951 | — | 16,374 | 29 | |||||||||||||||||||||||||||||||||||
Multifamily | 800 | 800 | — | — | 1,340 | 14 | |||||||||||||||||||||||||||||||||||
Retail | 5,372 | 4,917 | 455 | — | 9,241 | — | |||||||||||||||||||||||||||||||||||
Office | 1,568 | 1,568 | — | — | 1,151 | — | |||||||||||||||||||||||||||||||||||
Other | 4,860 | 4,860 | — | — | 6,005 | — | |||||||||||||||||||||||||||||||||||
Residential real estate | 3,097 | 2,711 | 386 | — | 6,476 | — | |||||||||||||||||||||||||||||||||||
Construction real estate | — | — | — | — | 577 | — | |||||||||||||||||||||||||||||||||||
Indirect vehicle | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Home equity | 2,558 | 2,558 | — | — | 8,976 | — | |||||||||||||||||||||||||||||||||||
Other consumer | — | — | — | — | 182 | — | |||||||||||||||||||||||||||||||||||
With an allowance recorded: | |||||||||||||||||||||||||||||||||||||||||
Commercial | 14,484 | 14,381 | 103 | 3,620 | 8,455 | — | |||||||||||||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | 885 | 885 | — | 188 | 1,130 | 73 | |||||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Healthcare | — | — | — | — | 3,901 | — | |||||||||||||||||||||||||||||||||||
Industrial | 5,525 | 4,238 | 1,287 | 1,255 | 2,443 | — | |||||||||||||||||||||||||||||||||||
Multifamily | 8,233 | 7,249 | 984 | 2,284 | 5,847 | 130 | |||||||||||||||||||||||||||||||||||
Retail | 23,144 | 17,257 | 5,887 | 3,604 | 10,058 | — | |||||||||||||||||||||||||||||||||||
Office | 1,706 | 1,695 | 11 | 522 | 1,904 | — | |||||||||||||||||||||||||||||||||||
Other | 4,661 | 4,577 | 84 | 1,263 | 6,082 | 16 | |||||||||||||||||||||||||||||||||||
Residential real estate | 10,565 | 10,565 | — | 2,858 | 3,417 | — | |||||||||||||||||||||||||||||||||||
Construction real estate | 4,552 | 2,167 | 2,385 | 497 | 3,775 | — | |||||||||||||||||||||||||||||||||||
Indirect vehicle | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Home equity | 13,765 | 13,763 | 2 | 850 | 4,800 | — | |||||||||||||||||||||||||||||||||||
Other consumer | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Total | $ | 144,992 | $ | 122,264 | $ | 22,728 | $ | 16,941 | $ | 119,252 | $ | 376 | |||||||||||||||||||||||||||||
Schedule of loans that have been restructured classified as performing and non-performing | The following table presents loans that have been restructured during the three months ended September 30, 2012 (dollars in thousands): | ||||||||||||||||||||||||||||||||||||||||
30-Sep-12 | |||||||||||||||||||||||||||||||||||||||||
Number of | Pre-Modification Recorded | Post-Modification Recorded | Charge-offs and | ||||||||||||||||||||||||||||||||||||||
Loans | Investment | Investment | Specific Reserves | ||||||||||||||||||||||||||||||||||||||
Performing: | |||||||||||||||||||||||||||||||||||||||||
Home equity | 7 | $ | 401 | $ | 325 | $ | 76 | ||||||||||||||||||||||||||||||||||
Total | 7 | $ | 401 | $ | 325 | $ | 76 | ||||||||||||||||||||||||||||||||||
Non-Performing: | |||||||||||||||||||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | 1 | $ | 202 | $ | 202 | $ | 168 | ||||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Retail | 1 | 202 | 202 | 200 | |||||||||||||||||||||||||||||||||||||
Residential real estate | 7 | 173 | 68 | 105 | |||||||||||||||||||||||||||||||||||||
Home equity | 5 | 347 | 232 | 115 | |||||||||||||||||||||||||||||||||||||
Total | 14 | $ | 924 | $ | 704 | $ | 588 | ||||||||||||||||||||||||||||||||||
The following table presents loans that have been restructured during the nine months ended September 30, 2012 (dollars in thousands): | |||||||||||||||||||||||||||||||||||||||||
30-Sep-12 | |||||||||||||||||||||||||||||||||||||||||
Number of | Pre-Modification Recorded | Post-Modification Recorded | Charge-offs and | ||||||||||||||||||||||||||||||||||||||
Loans | Investment | Investment | Specific Reserves | ||||||||||||||||||||||||||||||||||||||
Performing: | |||||||||||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Multifamily | 1 | $ | 155 | $ | 155 | $ | — | ||||||||||||||||||||||||||||||||||
Retail | 1 | 236 | 236 | — | |||||||||||||||||||||||||||||||||||||
Residential real estate | 2 | 808 | 808 | — | |||||||||||||||||||||||||||||||||||||
Home equity | 38 | 6,009 | 5,933 | 76 | |||||||||||||||||||||||||||||||||||||
Total | 42 | $ | 7,208 | $ | 7,132 | $ | 76 | ||||||||||||||||||||||||||||||||||
Non-Performing: | |||||||||||||||||||||||||||||||||||||||||
Commercial | 4 | $ | 292 | $ | 292 | $ | 96 | ||||||||||||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | 1 | 202 | 202 | 168 | |||||||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Multifamily | 1 | 149 | 149 | 40 | |||||||||||||||||||||||||||||||||||||
Retail | 4 | 923 | 923 | 232 | |||||||||||||||||||||||||||||||||||||
Other | 1 | 157 | 157 | 50 | |||||||||||||||||||||||||||||||||||||
Residential real estate | 13 | 637 | 401 | 236 | |||||||||||||||||||||||||||||||||||||
Home equity | 34 | 5,324 | 4,899 | 425 | |||||||||||||||||||||||||||||||||||||
Total | 58 | $ | 7,684 | $ | 7,023 | $ | 1,247 | ||||||||||||||||||||||||||||||||||
The following table presents loans that have been restructured during the three months ended September 30, 2013 (dollars in thousands): | |||||||||||||||||||||||||||||||||||||||||
30-Sep-13 | |||||||||||||||||||||||||||||||||||||||||
Number of | Pre-Modification Recorded | Post-Modification Recorded | Charge-offs and | ||||||||||||||||||||||||||||||||||||||
Loans | Investment | Investment | Specific Reserves | ||||||||||||||||||||||||||||||||||||||
Performing: | |||||||||||||||||||||||||||||||||||||||||
Residential real estate | 1 | $ | 95 | $ | 95 | $ | — | ||||||||||||||||||||||||||||||||||
Home equity | 1 | 19 | 19 | — | |||||||||||||||||||||||||||||||||||||
Total | 2 | $ | 114 | $ | 114 | $ | — | ||||||||||||||||||||||||||||||||||
Non-Performing: | |||||||||||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Healthcare | 1 | $ | 3,164 | $ | 3,164 | $ | 496 | ||||||||||||||||||||||||||||||||||
Multifamily | 1 | 436 | 436 | 119 | |||||||||||||||||||||||||||||||||||||
Retail | 1 | 205 | 205 | 56 | |||||||||||||||||||||||||||||||||||||
Residential real estate | 1 | 394 | 394 | — | |||||||||||||||||||||||||||||||||||||
Indirect vehicle | 17 | 113 | 89 | 24 | |||||||||||||||||||||||||||||||||||||
Home equity | 5 | 397 | 397 | — | |||||||||||||||||||||||||||||||||||||
Total | 26 | $ | 4,709 | $ | 4,685 | $ | 695 | ||||||||||||||||||||||||||||||||||
The following table presents loans that have been restructured during the nine months ended September 30, 2013 (dollars in thousands): | |||||||||||||||||||||||||||||||||||||||||
30-Sep-13 | |||||||||||||||||||||||||||||||||||||||||
Number of | Pre-Modification Recorded | Post-Modification Recorded | Charge-offs and | ||||||||||||||||||||||||||||||||||||||
Loans | Investment | Investment | Specific Reserves | ||||||||||||||||||||||||||||||||||||||
Performing: | |||||||||||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Multifamily | 1 | $ | 601 | $ | 601 | $ | — | ||||||||||||||||||||||||||||||||||
Residential real estate | 5 | 854 | 854 | — | |||||||||||||||||||||||||||||||||||||
Home equity | 7 | 723 | 723 | — | |||||||||||||||||||||||||||||||||||||
Total | 13 | $ | 2,178 | $ | 2,178 | $ | — | ||||||||||||||||||||||||||||||||||
Non-Performing: | |||||||||||||||||||||||||||||||||||||||||
Commercial | 2 | $ | 1,251 | $ | 1,251 | $ | 673 | ||||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Healthcare | 1 | 3,164 | 3,164 | 496 | |||||||||||||||||||||||||||||||||||||
Industrial | 4 | 2,570 | 2,570 | 1,425 | |||||||||||||||||||||||||||||||||||||
Multifamily | 2 | 623 | 623 | 169 | |||||||||||||||||||||||||||||||||||||
Retail | 3 | 862 | 862 | 235 | |||||||||||||||||||||||||||||||||||||
Other | 1 | 84 | 84 | 23 | |||||||||||||||||||||||||||||||||||||
Residential real estate | 6 | 1,149 | 1,149 | — | |||||||||||||||||||||||||||||||||||||
Indirect vehicle | 20 | 127 | 103 | 24 | |||||||||||||||||||||||||||||||||||||
Home equity | 25 | 3,333 | 3,333 | — | |||||||||||||||||||||||||||||||||||||
Total | 64 | $ | 13,163 | $ | 13,139 | $ | 3,045 | ||||||||||||||||||||||||||||||||||
Troubled debt restructuring activity rollforward | The following tables present the troubled debt restructurings activity during the nine months ended September 30, 2013 (dollars in thousands): | ||||||||||||||||||||||||||||||||||||||||
Performing | Non-performing | ||||||||||||||||||||||||||||||||||||||||
Beginning balance | $ | 21,256 | $ | 28,418 | |||||||||||||||||||||||||||||||||||||
Additions | 2,178 | 13,163 | |||||||||||||||||||||||||||||||||||||||
Charge-offs | — | (3,127 | ) | ||||||||||||||||||||||||||||||||||||||
Principal payments, net | (883 | ) | (8,008 | ) | |||||||||||||||||||||||||||||||||||||
Removals | — | (565 | ) | ||||||||||||||||||||||||||||||||||||||
Transfer to other real estate owned | — | (206 | ) | ||||||||||||||||||||||||||||||||||||||
Transfer from/to performing | 8,458 | 1,098 | |||||||||||||||||||||||||||||||||||||||
Transfer from/to nonperforming | (1,098 | ) | (8,458 | ) | |||||||||||||||||||||||||||||||||||||
Ending balance | $ | 29,911 | $ | 22,315 | |||||||||||||||||||||||||||||||||||||
Type of financing receivable modifications and restructuring | The following table presents the type of modification for loans that have been restructured and the pre-modification recorded investment during the nine months ended September 30, 2013 (dollars in thousands): | ||||||||||||||||||||||||||||||||||||||||
30-Sep-13 | |||||||||||||||||||||||||||||||||||||||||
Extended | Extended | Extended | |||||||||||||||||||||||||||||||||||||||
Maturity, | Maturity, Delay | Extended | Maturity, Delay | Delay in | |||||||||||||||||||||||||||||||||||||
Amortization | in Payments and | Maturity and | in Payments and | Payments or | |||||||||||||||||||||||||||||||||||||
and Reduction | Reduction of | Reduction of | Reduction of | Extended | Reduction of | ||||||||||||||||||||||||||||||||||||
of Interest Rate | Interest Rate | Interest Rate | Amount | Maturity | Interest Rate | Total | |||||||||||||||||||||||||||||||||||
Commercial | $ | 42 | $ | — | $ | 1,209 | $ | — | $ | — | $ | — | $ | 1,251 | |||||||||||||||||||||||||||
Commercial collateralized by assignment of lease payments | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
Commercial real estate: | |||||||||||||||||||||||||||||||||||||||||
Healthcare | — | — | — | 3,164 | — | — | 3,164 | ||||||||||||||||||||||||||||||||||
Industrial | — | — | — | — | 2,570 | — | 2,570 | ||||||||||||||||||||||||||||||||||
Multifamily | 187 | — | — | — | 601 | 436 | 1,224 | ||||||||||||||||||||||||||||||||||
Retail | 256 | 205 | 401 | — | — | — | 862 | ||||||||||||||||||||||||||||||||||
Office | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
Other | 84 | — | — | — | — | — | 84 | ||||||||||||||||||||||||||||||||||
Residential real estate | 1,386 | — | — | — | — | 618 | 2,004 | ||||||||||||||||||||||||||||||||||
Construction real estate | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
Indirect vehicle | — | — | — | — | — | 127 | 127 | ||||||||||||||||||||||||||||||||||
Home equity | 1,509 | — | 708 | — | 227 | 1,611 | 4,055 | ||||||||||||||||||||||||||||||||||
Other consumer | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
Total | $ | 3,464 | $ | 205 | $ | 2,318 | $ | 3,164 | $ | 3,398 | $ | 2,792 | $ | 15,341 | |||||||||||||||||||||||||||
Allowance activity for loan losses by portfolio segment based on impairment method | The following table presents the activity in the allowance for credit losses, balance in allowance for credit losses and recorded investment in loans by portfolio segment and based on impairment method as of September 30, 2013 and 2012 (in thousands): | ||||||||||||||||||||||||||||||||||||||||
Commercial | Commercial | Commercial | Residential | Construction | Indirect | Home | Other consumer | Unfunded | Total | ||||||||||||||||||||||||||||||||
collateralized by | real estate | real estate | real estate | vehicle | equity | commitments | |||||||||||||||||||||||||||||||||||
assignment of | |||||||||||||||||||||||||||||||||||||||||
lease payments | |||||||||||||||||||||||||||||||||||||||||
30-Sep-13 | |||||||||||||||||||||||||||||||||||||||||
Allowance for credit losses: | |||||||||||||||||||||||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||||||||||||||||||||
Beginning balance | $ | 27,277 | $ | 8,529 | $ | 60,014 | $ | 8,121 | $ | 8,695 | $ | 1,537 | $ | 8,206 | $ | 1,306 | $ | 1,812 | $ | 125,497 | |||||||||||||||||||||
Transfer to (from) allowance for unfunded credit commitments | — | — | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||
Charge-offs | 1,686 | — | 1,236 | 713 | 26 | 572 | 437 | 485 | — | 5,155 | |||||||||||||||||||||||||||||||
Recoveries | 579 | — | 966 | 48 | 420 | 372 | 228 | 74 | — | 2,687 | |||||||||||||||||||||||||||||||
Provision | (45 | ) | 721 | (3,983 | ) | 347 | (735 | ) | 293 | (152 | ) | 368 | (118 | ) | (3,304 | ) | |||||||||||||||||||||||||
Ending balance | $ | 26,125 | $ | 9,250 | $ | 55,761 | $ | 7,803 | $ | 8,354 | $ | 1,630 | $ | 7,845 | $ | 1,263 | $ | 1,694 | $ | 119,725 | |||||||||||||||||||||
Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||
Beginning balance | $ | 24,943 | $ | 7,755 | $ | 61,056 | $ | 6,941 | $ | 11,222 | $ | 1,324 | $ | 9,401 | $ | 1,562 | $ | 4,075 | $ | 128,279 | |||||||||||||||||||||
Transfer to (from) allowance for unfunded credit commitments | — | — | — | — | 500 | — | — | — | (500 | ) | — | ||||||||||||||||||||||||||||||
Charge-offs | 3,030 | — | 5,131 | 2,074 | 855 | 1,930 | 2,547 | 1,501 | — | 17,068 | |||||||||||||||||||||||||||||||
Recoveries | 1,808 | 1,131 | 5,353 | 461 | 827 | 1,111 | 442 | 185 | — | 11,318 | |||||||||||||||||||||||||||||||
Provision | 2,404 | 364 | (5,517 | ) | 2,475 | (3,340 | ) | 1,125 | 549 | 1,017 | (1,881 | ) | (2,804 | ) | |||||||||||||||||||||||||||
Ending balance | $ | 26,125 | $ | 9,250 | $ | 55,761 | $ | 7,803 | $ | 8,354 | $ | 1,630 | $ | 7,845 | $ | 1,263 | $ | 1,694 | $ | 119,725 | |||||||||||||||||||||
Ending allowance balance attributable to loans: | |||||||||||||||||||||||||||||||||||||||||
Individually evaluated for impairment | $ | 4,389 | $ | 285 | $ | 7,464 | $ | 3,033 | $ | 240 | $ | — | $ | 781 | $ | — | $ | 657 | $ | 16,849 | |||||||||||||||||||||
Collectively evaluated for impairment | 20,871 | 8,965 | 46,412 | 4,663 | 8,114 | 1,630 | 7,064 | 1,263 | 1,037 | 100,019 | |||||||||||||||||||||||||||||||
Acquired and accounted for under ASC 310-30 (1) | 865 | — | 1,885 | 107 | — | — | — | — | — | 2,857 | |||||||||||||||||||||||||||||||
Total ending allowance balance | $ | 26,125 | $ | 9,250 | $ | 55,761 | $ | 7,803 | $ | 8,354 | $ | 1,630 | $ | 7,845 | $ | 1,263 | $ | 1,694 | $ | 119,725 | |||||||||||||||||||||
Loans: | |||||||||||||||||||||||||||||||||||||||||
Individually evaluated for impairment | $ | 19,836 | $ | 2,330 | $ | 60,600 | $ | 15,851 | $ | 1,622 | $ | 106 | $ | 23,278 | $ | — | $ | — | $ | 123,623 | |||||||||||||||||||||
Collectively evaluated for impairment | 1,134,376 | 1,466,484 | 1,577,768 | 291,699 | 134,524 | 257,634 | 251,206 | 57,418 | — | 5,171,109 | |||||||||||||||||||||||||||||||
Acquired and accounted for under ASC 310-30 (1) | 35,649 | — | 159,799 | 5,982 | 61,446 | — | 110 | 29,014 | — | 292,000 | |||||||||||||||||||||||||||||||
Total ending loans balance | $ | 1,189,861 | $ | 1,468,814 | $ | 1,798,167 | $ | 313,532 | $ | 197,592 | $ | 257,740 | $ | 274,594 | $ | 86,432 | $ | — | $ | 5,586,732 | |||||||||||||||||||||
Commercial | Commercial | Commercial | Residential | Construction | Indirect | Home | Other consumer | Unfunded | Total | ||||||||||||||||||||||||||||||||
collateralized by | real estate | real estate | real estate | vehicle | equity | commitments | |||||||||||||||||||||||||||||||||||
assignment of | |||||||||||||||||||||||||||||||||||||||||
lease payments | |||||||||||||||||||||||||||||||||||||||||
30-Sep-12 | |||||||||||||||||||||||||||||||||||||||||
Allowance for credit losses: | |||||||||||||||||||||||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||||||||||||||||||||
Beginning balance | $ | 20,789 | $ | 7,490 | $ | 68,713 | $ | 3,592 | $ | 10,586 | $ | 1,941 | $ | 7,617 | $ | 1,028 | $ | 7,084 | $ | 128,840 | |||||||||||||||||||||
Charge-offs | 75 | — | 2,994 | 474 | 71 | 433 | 1,209 | 332 | — | 5,588 | |||||||||||||||||||||||||||||||
Recoveries | 306 | 111 | 12,893 | 8 | 752 | 224 | 303 | 77 | — | 14,674 | |||||||||||||||||||||||||||||||
Provision | 1,181 | (149 | ) | (12,253 | ) | 738 | (393 | ) | 288 | 370 | 558 | (3,340 | ) | (13,000 | ) | ||||||||||||||||||||||||||
Ending balance | $ | 22,201 | $ | 7,452 | $ | 66,359 | $ | 3,864 | $ | 10,874 | $ | 2,020 | $ | 7,081 | $ | 1,331 | $ | 3,744 | $ | 124,926 | |||||||||||||||||||||
Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||
Beginning balance | $ | 21,106 | $ | 7,561 | $ | 68,695 | $ | 3,935 | $ | 15,639 | $ | 1,834 | $ | 7,333 | $ | 695 | $ | 9,177 | $ | 135,975 | |||||||||||||||||||||
Transfer to (from) allowance for unfunded credit commitments | — | — | — | — | 1,132 | — | — | — | (1,132 | ) | — | ||||||||||||||||||||||||||||||
Charge-offs | 2,065 | 1,720 | 8,412 | 1,876 | 3,951 | 1,636 | 3,157 | 864 | — | 23,681 | |||||||||||||||||||||||||||||||
Recoveries | 2,730 | 460 | 16,116 | 230 | 1,458 | 835 | 423 | 280 | — | 22,532 | |||||||||||||||||||||||||||||||
Provision | 430 | 1,151 | (10,040 | ) | 1,575 | (3,404 | ) | 987 | 2,482 | 1,220 | (4,301 | ) | (9,900 | ) | |||||||||||||||||||||||||||
Ending balance | $ | 22,201 | $ | 7,452 | $ | 66,359 | $ | 3,864 | $ | 10,874 | $ | 2,020 | $ | 7,081 | $ | 1,331 | $ | 3,744 | $ | 124,926 | |||||||||||||||||||||
Ending allowance balance attributable to loans: | |||||||||||||||||||||||||||||||||||||||||
Individually evaluated for impairment | $ | 2,570 | $ | 180 | $ | 7,567 | $ | 401 | $ | 582 | $ | — | $ | — | $ | — | $ | 1,726 | $ | 13,026 | |||||||||||||||||||||
Collectively evaluated for impairment | 19,345 | 7,272 | 56,851 | 3,144 | 10,292 | 2,020 | 7,081 | 1,331 | 2,018 | 109,354 | |||||||||||||||||||||||||||||||
Acquired and accounted for under ASC 310-30 (1) | 286 | — | 1,941 | 319 | — | — | — | — | — | 2,546 | |||||||||||||||||||||||||||||||
Total ending allowance balance | $ | 22,201 | $ | 7,452 | $ | 66,359 | $ | 3,864 | $ | 10,874 | $ | 2,020 | $ | 7,081 | $ | 1,331 | $ | 3,744 | $ | 124,926 | |||||||||||||||||||||
Loans: | |||||||||||||||||||||||||||||||||||||||||
Individually evaluated for impairment | $ | 21,537 | $ | 1,168 | $ | 56,037 | $ | 11,127 | $ | 2,372 | $ | — | $ | 10,280 | $ | 248 | $ | — | $ | 102,769 | |||||||||||||||||||||
Collectively evaluated for impairment | 1,033,534 | 1,218,193 | 1,714,224 | 293,787 | 147,500 | 206,973 | 304,438 | 84,403 | — | 5,003,052 | |||||||||||||||||||||||||||||||
Acquired and accounted for under ASC 310-30 (1) | 78,275 | — | 269,348 | 7,116 | 125,515 | — | 568 | 38,202 | — | 519,024 | |||||||||||||||||||||||||||||||
Total ending loans balance | $ | 1,133,346 | $ | 1,219,361 | $ | 2,039,609 | $ | 312,030 | $ | 275,387 | $ | 206,973 | $ | 315,286 | $ | 122,853 | $ | — | $ | 5,624,845 | |||||||||||||||||||||
(1) Loans acquired in FDIC-assisted transactions and accounted for under ASC Subtopic 310-30 “Receivables — Loans and Debt Securities Acquired with Deteriorated Credit Quality.” | |||||||||||||||||||||||||||||||||||||||||
Changes in the accretable yield for purchased credit-impaired loans | Changes in the accretable yield for loans acquired in FDIC-assisted transactions and accounted for under ASC 310-30 were as follows for the three and nine months ended September 30, 2013 and 2012 (in thousands): | ||||||||||||||||||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||
September 30, | September 30, | ||||||||||||||||||||||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||||||||||||||||||||||||||
Balance at beginning of period | $ | 6,360 | $ | 9,411 | $ | 5,685 | $ | 18,703 | |||||||||||||||||||||||||||||||||
Accretion | (2,427 | ) | (3,406 | ) | (2,859 | ) | (12,812 | ) | |||||||||||||||||||||||||||||||||
Other | — | 403 | 1,107 | 517 | |||||||||||||||||||||||||||||||||||||
Balance at end of period | $ | 3,933 | $ | 6,408 | $ | 3,933 | $ | 6,408 | |||||||||||||||||||||||||||||||||
Purchased loans disclosures | The carrying amount of covered loans and other purchased non-covered loans at September 30, 2013 consisted of loans as shown in the following table (in thousands): | ||||||||||||||||||||||||||||||||||||||||
30-Sep-13 | Purchased | Purchased Non-Impaired | Total | ||||||||||||||||||||||||||||||||||||||
Impaired | Loans | ||||||||||||||||||||||||||||||||||||||||
Loans | |||||||||||||||||||||||||||||||||||||||||
Covered loans: | |||||||||||||||||||||||||||||||||||||||||
Commercial related (1) | $ | 11,130 | $ | 5,738 | $ | 16,868 | |||||||||||||||||||||||||||||||||||
Commercial | 457 | 3,527 | 3,984 | ||||||||||||||||||||||||||||||||||||||
Commercial real estate | 62,576 | 97,223 | 159,799 | ||||||||||||||||||||||||||||||||||||||
Construction real estate | 53,444 | 8,002 | 61,446 | ||||||||||||||||||||||||||||||||||||||
Other | 2,982 | 28,418 | 31,400 | ||||||||||||||||||||||||||||||||||||||
Total covered loans | $ | 130,589 | $ | 142,908 | $ | 273,497 | |||||||||||||||||||||||||||||||||||
Estimated receivable amount from the FDIC under the loss-share agreement (2) | $ | 36 | $ | 10,013 | $ | 10,049 | |||||||||||||||||||||||||||||||||||
Non covered loans: | |||||||||||||||||||||||||||||||||||||||||
Commercial related (3) | $ | 4,357 | $ | 10,440 | $ | 14,797 | |||||||||||||||||||||||||||||||||||
Other | 89 | 3,617 | 3,706 | ||||||||||||||||||||||||||||||||||||||
Total non-covered loans | $ | 4,446 | $ | 14,057 | $ | 18,503 | |||||||||||||||||||||||||||||||||||
-1 | Covered commercial related loans include commercial, commercial real estate and construction real estate loans acquired in connection with the Heritage and Benchmark FDIC-assisted transactions. | ||||||||||||||||||||||||||||||||||||||||
-2 | Estimated reimbursable amounts from the FDIC under the loss-share agreement exclude $1.0 million in reimbursable amounts related to covered other real estate owned. | ||||||||||||||||||||||||||||||||||||||||
-3 | Non covered commercial related loans include commercial, commercial real estate and construction real estate for InBank. |
Goodwill_and_Intangibles_Table
Goodwill and Intangibles (Tables) | 9 Months Ended | ||||
Sep. 30, 2013 | |||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||
Changes in the carrying amount of core deposit and client relationship intangibles | The following table presents the changes in the carrying amount of core deposit and client relationship intangibles, gross carrying amount, accumulated amortization, and net book value as of September 30, 2013 (in thousands): | ||||
Nine Months Ended | |||||
September 30, | |||||
2013 | |||||
Balance at beginning of period | $ | 29,512 | |||
Amortization expense | (4,595 | ) | |||
Balance at end of period | $ | 24,917 | |||
Gross carrying amount | $ | 61,429 | |||
Accumulated amortization | (36,512 | ) | |||
Net book value | $ | 24,917 | |||
Estimated future amortization expense of other intangible assets | The following presents the estimated future amortization expense of other intangible assets (in thousands): | ||||
Year ending December 31, | Amount | ||||
2013 | $ | 1,489 | |||
2014 | 4,748 | ||||
2015 | 4,030 | ||||
2016 | 3,418 | ||||
2017 | 3,071 | ||||
Thereafter | 8,161 | ||||
$ | 24,917 | ||||
Deposits_Tables
Deposits (Tables) | 9 Months Ended | ||||||||
Sep. 30, 2013 | |||||||||
Deposits [Abstract] | |||||||||
Schedule of composition of deposits | The composition of deposits was as follows (in thousands): | ||||||||
September 30, | December 31, | ||||||||
2013 | 2012 | ||||||||
Demand deposit accounts, noninterest bearing | $ | 2,269,367 | $ | 2,164,547 | |||||
NOW and money market accounts | 2,680,127 | 2,747,273 | |||||||
Savings accounts | 843,671 | 811,333 | |||||||
Certificates of deposit, $100,000 or more | 838,606 | 1,020,033 | |||||||
Other certificates of deposit | 666,915 | 799,511 | |||||||
Total | $ | 7,298,686 | $ | 7,542,697 | |||||
ShortTerm_Borrowings_Tables
Short-Term Borrowings (Tables) | 9 Months Ended | ||||||||||||||
Sep. 30, 2013 | |||||||||||||||
Short-term Debt [Abstract] | |||||||||||||||
Summary of short-term borrowings | Short-term borrowings were as follows as of September 30, 2013 and December 31, 2012 (dollars in thousands): | ||||||||||||||
30-Sep-13 | December 31, 2012 | ||||||||||||||
Weighted | Weighted | ||||||||||||||
Average | Average | ||||||||||||||
Cost | Amount | Cost | Amount | ||||||||||||
Customer repurchase agreements | 0.22 | % | $ | 240,600 | 0.23 | % | $ | 208,242 | |||||||
Federal Home Loan Bank advances | — | % | — | 3.58 | % | 12,360 | |||||||||
0.22 | % | $ | 240,600 | 0.42 | % | $ | 220,602 | ||||||||
Junior_Subordinated_Notes_Issu1
Junior Subordinated Notes Issued to Capital Trusts (Tables) | 9 Months Ended | ||||||||||||||||
Sep. 30, 2013 | |||||||||||||||||
JUNIOR SUBORDINATED NOTES ISSUED TO CAPITAL TRUSTS | |||||||||||||||||
Outstanding junior subordinated notes and the related trust preferred securities issued by each trust | The table below summarizes the outstanding junior subordinated notes and the related trust preferred securities issued by each trust as of September 30, 2013 (in thousands): | ||||||||||||||||
Coal City | MB Financial | MB Financial | MB Financial | ||||||||||||||
Capital Trust I | Capital Trust II | Capital Trust III | Capital Trust IV | ||||||||||||||
Junior Subordinated Notes: | |||||||||||||||||
Principal balance | $ | 25,774 | $ | 36,083 | $ | 10,310 | $ | 20,619 | |||||||||
Annual interest rate | 3-mo LIBOR + 1.80% | 3-mo LIBOR + 1.40% | 3-mo LIBOR + 1.50% | 3-mo LIBOR + 1.52% | |||||||||||||
Stated maturity date | September 1, 2028 | September 15, 2035 | September 23, 2036 | September 15, 2036 | |||||||||||||
Call date | September 1, 2008 | December 15, 2010 | September 23, 2011 | September 15, 2011 | |||||||||||||
Trust Preferred Securities: | |||||||||||||||||
Face Value | $ | 25,000 | $ | 35,000 | $ | 10,000 | $ | 20,000 | |||||||||
Annual distribution rate | 3-mo LIBOR + 1.80% | 3-mo LIBOR + 1.40% | 3-mo LIBOR + 1.50% | 3-mo LIBOR + 1.52% | |||||||||||||
Issuance date | July 1998 | August 2005 | July 2006 | August 2006 | |||||||||||||
Distribution dates (1) | Quarterly | Quarterly | Quarterly | Quarterly | |||||||||||||
MB Financial | MB Financial | FOBB | |||||||||||||||
Capital Trust V | Capital Trust VI | Statutory Trust III (2) | |||||||||||||||
Junior Subordinated Notes: | |||||||||||||||||
Principal balance | $ | 30,928 | $ | 23,196 | $ | 5,155 | |||||||||||
Annual interest rate | 3-mo LIBOR + 1.30% | 3-mo LIBOR + 1.30% | 3-mo LIBOR + 2.80% | ||||||||||||||
Stated maturity date | December 15, 2037 | October 30, 2037 | January 23, 2034 | ||||||||||||||
Call date | December 15, 2012 | October 30, 2012 | January 23, 2009 | ||||||||||||||
Trust Preferred Securities: | |||||||||||||||||
Face Value | $ | 30,000 | $ | 22,500 | $ | 5,000 | |||||||||||
Annual distribution rate | 3-mo LIBOR + 1.30% | 3-mo LIBOR + 1.30% | 3-mo LIBOR + 2.80% | ||||||||||||||
Issuance date | September 2007 | October 2007 | December 2003 | ||||||||||||||
Distribution dates (1) | Quarterly | Quarterly | Quarterly | ||||||||||||||
-1 | All distributions are cumulative and paid in cash. | ||||||||||||||||
-2 | FOBB Statutory Trust III was established by First Oak Brook Bancshares, Inc. (“FOBB”) prior to the Company's acquisition of FOBB, and the junior subordinated note issued by FOBB to FOBB Statutory Trust III was assumed by the Company upon completion of the acquisition. |
Commitments_and_Contingencies_
Commitments and Contingencies (Tables) | 9 Months Ended | ||||||||
Sep. 30, 2013 | |||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||
Schedule of outstanding financial instruments, contractual amounts of off-balance sheet credit risk | At September 30, 2013 and December 31, 2012, the following financial instruments were outstanding, the contractual amounts of which represent off-balance sheet credit risk (in thousands): | ||||||||
Contractual Amount | |||||||||
September 30, 2013 | December 31, 2012 | ||||||||
Commitments to extend credit: | |||||||||
Home equity lines | $ | 216,992 | $ | 239,771 | |||||
Other commitments | 1,139,255 | 911,166 | |||||||
Letters of credit: | |||||||||
Standby | 70,720 | 66,247 | |||||||
Commercial | 2,705 | 465 | |||||||
Fair_Value_Measurements_Tables
Fair Value Measurements (Tables) | 9 Months Ended | |||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||
Fair Value Disclosures [Abstract] | ||||||||||||||||||
Financial assets and financial liabilities measured at fair value on a recurring basis | The following table summarizes financial assets and financial liabilities measured at fair value on a recurring basis as of September 30, 2013 and December 31, 2012, segregated by the level of the valuation inputs within the fair value hierarchy utilized to measure fair value (in thousands): | |||||||||||||||||
Total | Quoted Prices in | Significant Other | Significant | |||||||||||||||
Active Markets for | Observable Inputs | Unobservable Inputs | ||||||||||||||||
Identical Assets | (Level 2) | (Level 3) | ||||||||||||||||
(Level 1) | ||||||||||||||||||
30-Sep-13 | ||||||||||||||||||
Financial assets | ||||||||||||||||||
Securities available for sale: | ||||||||||||||||||
U.S Government sponsored agencies and enterprises | $ | 52,527 | $ | — | $ | 52,527 | $ | — | ||||||||||
States and political subdivisions | 19,312 | — | 19,312 | — | ||||||||||||||
Residential mortgage-backed securities | 691,276 | — | 690,546 | 730 | ||||||||||||||
Commercial mortgage-backed securities | 53,446 | — | 53,446 | — | ||||||||||||||
Corporate bonds | 263,021 | — | 257,857 | 5,164 | ||||||||||||||
Equity securities | 10,541 | 10,541 | — | — | ||||||||||||||
Loans held for sale | 1,120 | — | 1,120 | — | ||||||||||||||
Assets held in trust for deferred compensation | 10,077 | 10,077 | — | — | ||||||||||||||
Derivative financial instruments | 19,112 | — | 19,112 | — | ||||||||||||||
Financial liabilities | ||||||||||||||||||
Other liabilities (1) | 9,892 | 9,892 | — | — | ||||||||||||||
Derivative financial instruments | 19,060 | — | 19,060 | — | ||||||||||||||
December 31, 2012 | ||||||||||||||||||
Financial assets | ||||||||||||||||||
Securities available for sale: | ||||||||||||||||||
U.S. Government sponsored agencies and enterprises | $ | 41,315 | $ | — | $ | 41,315 | $ | — | ||||||||||
States and political subdivisions | 725,019 | — | 725,019 | — | ||||||||||||||
Residential mortgage-backed securities | 939,202 | — | 938,354 | 848 | ||||||||||||||
Commercial mortgage-backed securities | 54,126 | — | 54,126 | — | ||||||||||||||
Corporate bonds | 96,674 | — | 91,451 | 5,223 | ||||||||||||||
Equity securities | 11,835 | 11,835 | — | — | ||||||||||||||
Loans held for sale | 7,492 | — | 7,492 | — | ||||||||||||||
Assets held in trust for deferred compensation | 7,746 | 7,746 | — | — | ||||||||||||||
Derivative financial instruments | 29,096 | — | 29,096 | — | ||||||||||||||
Financial liabilities | ||||||||||||||||||
Other liabilities (1) | 7,746 | 7,746 | — | — | ||||||||||||||
Derivative financial instruments | 29,055 | — | 29,055 | — | ||||||||||||||
(1) Liabilities associated with assets held in trust for deferred compensation | ||||||||||||||||||
Financial assest measured at fair value on a recurring and non-recurring basis, unobservable inputs used | The following table presents additional information about the unobservable inputs used in the fair value measurement of financial assets measured on a recurring basis that were categorized within the Level 3 of the fair value hierarchy: | |||||||||||||||||
Fair Value at | Valuation | Unobservable | ||||||||||||||||
September 30, 2013 | Technique | Input | Range | |||||||||||||||
Residential mortgage-backed securities | $ | 730 | Discounted cash flows | Constant pre-payment rates | ||||||||||||||
(CPR) assumption | 1% - 3% CPR | |||||||||||||||||
Corporate bonds | 5,164 | Discounted cash flows | Credit assumption | 20% Loss | ||||||||||||||
The following table presents additional information about the unobservable inputs used in the fair value measurement of financial assets measured on a nonrecurring basis that were categorized within the Level 3 of the fair value hierarchy: | ||||||||||||||||||
Fair Value at | Valuation | Unobservable | ||||||||||||||||
September 30, 2013 | Technique | Input | Range | |||||||||||||||
Impaired loans | $ | 84,500 | Appraisal of collateral | Appraisal adjustments - sales costs | 5% - 10% | |||||||||||||
Foreclosed assets | 57,009 | Appraisal of collateral | Appraisal adjustments - sales costs | 5% - 10% | ||||||||||||||
Financial assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) | The following table presents additional information about financial assets measured at fair value on a recurring basis for which the Company used significant unobservable inputs (Level 3): | |||||||||||||||||
Nine Months Ended | ||||||||||||||||||
September 30, | ||||||||||||||||||
(in thousands) | 2013 | 2012 | ||||||||||||||||
Balance, beginning of period | $ | 6,071 | $ | 6,992 | ||||||||||||||
Other comprehensive income | (59 | ) | 89 | |||||||||||||||
Principal payments | (118 | ) | (846 | ) | ||||||||||||||
Impairment charge | — | (117 | ) | |||||||||||||||
Balance, ending of period | $ | 5,894 | $ | 6,118 | ||||||||||||||
Assets measured at fair value on a nonrecurring basis | Assets measured at fair value on a nonrecurring basis as of September 30, 2013 and December 31, 2012 are included in the table below (in thousands): | |||||||||||||||||
Total | Quoted Prices in Active | Significant Other | Significant | |||||||||||||||
Markets for Identical | Observable Inputs | Unobservable Inputs | ||||||||||||||||
Assets (Level 1) | (Level 2) | (Level 3) | ||||||||||||||||
30-Sep-13 | ||||||||||||||||||
Financial assets: | ||||||||||||||||||
Impaired loans | $ | 84,500 | $ | — | $ | — | $ | 84,500 | ||||||||||
Non-financial assets: | ||||||||||||||||||
Foreclosed assets | 57,009 | — | — | 57,009 | ||||||||||||||
December 31, 2012 | ||||||||||||||||||
Financial assets: | ||||||||||||||||||
Impaired loans | $ | 62,258 | $ | — | $ | — | $ | 62,258 | ||||||||||
Non-financial assets: | ||||||||||||||||||
Foreclosed assets | 60,228 | — | — | 60,228 | ||||||||||||||
Long-lived assets | 2,314 | — | — | 2,314 | ||||||||||||||
Estimated fair values of financial instruments | The estimated fair values of financial instruments are as follows (in thousands): | |||||||||||||||||
30-Sep-13 | ||||||||||||||||||
Carrying Amount | Estimated Fair Value | Quoted Prices in Active | Significant Other | Significant | ||||||||||||||
Markets for Identical | Observable Inputs | Unobservable Inputs | ||||||||||||||||
Assets (Level 1) | (Level 2) | (Level 3) | ||||||||||||||||
Financial Assets: | ||||||||||||||||||
Cash and due from banks | $ | 215,017 | $ | 215,017 | $ | 215,017 | $ | — | $ | — | ||||||||
Interest bearing deposits with banks | 41,700 | 41,700 | 41,700 | — | — | |||||||||||||
Investment securities available for sale | 1,090,123 | 1,090,123 | 10,541 | 1,073,688 | 5,894 | |||||||||||||
Investment securities held to maturity | 1,193,544 | 1,212,748 | — | 1,212,748 | — | |||||||||||||
Non-marketable securities - FHLB and FRB stock | 50,870 | 50,870 | — | — | 50,870 | |||||||||||||
Loans held for sale | 1,120 | 1,120 | — | 1,120 | — | |||||||||||||
Loans, net | 5,468,701 | 5,470,567 | — | — | 5,470,567 | |||||||||||||
Accrued interest receivable | 35,938 | 35,938 | 35,938 | — | — | |||||||||||||
Derivative financial instruments | 19,112 | 19,112 | — | 19,112 | — | |||||||||||||
Financial Liabilities: | ||||||||||||||||||
Noninterest bearing deposits | $ | 2,269,367 | $ | 2,269,367 | $ | 2,269,367 | $ | — | $ | — | ||||||||
Interest bearing deposits | 5,029,319 | 5,039,175 | — | — | 5,039,175 | |||||||||||||
Short-term borrowings | 240,600 | 240,595 | — | — | 240,595 | |||||||||||||
Long-term borrowings | 62,428 | 67,425 | — | — | 67,425 | |||||||||||||
Junior subordinated notes issued to capital trusts | 152,065 | 105,967 | — | — | 105,967 | |||||||||||||
Accrued interest payable | 1,908 | 1,908 | 1,908 | — | — | |||||||||||||
Derivative financial instruments | 19,060 | 19,060 | — | 19,060 | — | |||||||||||||
December 31, 2012 | ||||||||||||||||||
Carrying Amount | Estimated Fair Value | Quoted Prices in Active | Significant Other | Significant | ||||||||||||||
Markets for Identical | Observable Inputs | Unobservable Inputs | ||||||||||||||||
Assets (Level 1) | (Level 2) | (Level 3) | ||||||||||||||||
Financial Assets: | ||||||||||||||||||
Cash and due from banks | $ | 176,010 | $ | 176,010 | $ | 176,010 | $ | — | $ | — | ||||||||
Interest bearing deposits with banks | 111,533 | 111,533 | 111,533 | — | — | |||||||||||||
Investment securities available for sale | 1,868,171 | 1,868,171 | 11,835 | 1,850,265 | 6,071 | |||||||||||||
Investment securities held to maturity | 493,421 | 535,681 | — | 535,681 | — | |||||||||||||
Non-marketable securities - FHLB and FRB stock | 55,385 | 55,385 | — | — | 55,385 | |||||||||||||
Loans held for sale | 7,492 | 7,492 | — | 7,492 | — | |||||||||||||
Loans, net | 5,642,726 | 5,659,598 | — | — | 5,659,598 | |||||||||||||
Accrued interest receivable | 36,040 | 36,040 | 36,040 | — | — | |||||||||||||
Derivative financial instruments | 29,096 | 29,096 | — | 29,096 | — | |||||||||||||
Financial Liabilities: | ||||||||||||||||||
Non-interest bearing deposits | $ | 2,164,547 | $ | 2,164,547 | $ | 2,164,547 | $ | — | $ | — | ||||||||
Interest bearing deposits | 5,378,150 | 5,399,709 | — | — | 5,399,709 | |||||||||||||
Short-term borrowings | 220,602 | 220,683 | — | — | 220,683 | |||||||||||||
Long-term borrowings | 116,050 | 117,809 | — | — | 117,809 | |||||||||||||
Junior subordinated notes issued to capital trusts | 152,065 | 104,009 | — | — | 104,009 | |||||||||||||
Accrued interest payable | 2,828 | 2,828 | 2,828 | — | — | |||||||||||||
Derivative financial instruments | 29,055 | 29,055 | — | 29,055 | — | |||||||||||||
Stock_Incentive_Plans_Tables
Stock Incentive Plans (Tables) | 9 Months Ended | ||||||||||||||||
Sep. 30, 2013 | |||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |||||||||||||||||
Summary of the impact of share-based payment plans in the financial statements | The following table summarizes the impact of the Company’s share-based payment plans in the financial statements for the periods shown (in thousands): | ||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||
September 30, | September 30, | ||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||
Total cost of share-based payment plans during the period | $ | 1,388 | $ | 1,080 | $ | 3,860 | $ | 3,581 | |||||||||
Amount of related income tax benefit recognized in income | 548 | 430 | 1,530 | $ | 1,431 | ||||||||||||
Additional information related to options outstanding | The following table summarizes stock options outstanding for the nine months ended September 30, 2013: | ||||||||||||||||
Number of | Weighted | Weighted | Aggregate | ||||||||||||||
Options | Average | Average | Intrinsic | ||||||||||||||
Exercise | Remaining | Value | |||||||||||||||
Price | Contractual | (in thousands) | |||||||||||||||
Term | |||||||||||||||||
(In Years) | |||||||||||||||||
Options outstanding as of December 31, 2012 | 2,739,753 | $ | 27.34 | ||||||||||||||
Granted | 211,501 | 27.03 | |||||||||||||||
Exercised | (330,832 | ) | 25.51 | ||||||||||||||
Expired or cancelled | (113,290 | ) | 30.91 | ||||||||||||||
Forfeited | (17,857 | ) | 20.18 | ||||||||||||||
Options outstanding as of September 30, 2013 | 2,489,275 | $ | 27.44 | 4.94 | $ | 9,407 | |||||||||||
Options exercisable as of September 30, 2013 | 1,809,183 | $ | 29.72 | 3.67 | $ | 4,764 | |||||||||||
Assumptions used for options granted | The expected life of options is estimated based on historical employee behavior and represents the period of time that options granted are expected to remain outstanding. | ||||||||||||||||
The following assumptions were used for options granted during the nine months ended September 30, 2013: | |||||||||||||||||
September 30, | |||||||||||||||||
2013 | |||||||||||||||||
Risk-free interest rate | 1.96 | % | |||||||||||||||
Expected volatility of Company’s stock | 25.6 | % | |||||||||||||||
Expected dividend yield | 1.74 | % | |||||||||||||||
Expected life of options | 5.6 years | ||||||||||||||||
Weighted average fair value per option of options granted during the year | $ | 5.97 | |||||||||||||||
Summary of changes in restricted shares | The following is a summary of changes in restricted shares and units for the nine months ended September 30, 2013: | ||||||||||||||||
Number of | Weighted | ||||||||||||||||
Shares and Units | Average | ||||||||||||||||
Grant Date | |||||||||||||||||
Fair Value | |||||||||||||||||
Shares Outstanding at December 31, 2012 | 634,211 | $ | 18.82 | ||||||||||||||
Granted | 270,983 | 26.91 | |||||||||||||||
Vested | (201,178 | ) | 16.79 | ||||||||||||||
Forfeited | (13,983 | ) | 20.52 | ||||||||||||||
Shares Outstanding at September 30, 2013 | 690,033 | $ | 22.55 | ||||||||||||||
Derivative_Financial_Instrumen1
Derivative Financial Instruments (Tables) | 9 Months Ended | ||||||||||||||||||||||||||||||||
Sep. 30, 2013 | |||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||
Summary of derivative financial instruments | The Company’s derivative financial instruments are summarized below as of September 30, 2013 and December 31, 2012 (in thousands): | ||||||||||||||||||||||||||||||||
Asset Derivatives | Liability Derivatives | ||||||||||||||||||||||||||||||||
30-Sep-13 | December 31, 2012 | 30-Sep-13 | December 31, 2012 | ||||||||||||||||||||||||||||||
Notional | Estimated | Notional | Estimated | Notional | Estimated | Notional | Estimated | ||||||||||||||||||||||||||
Amount | Fair Value | Amount | Fair Value | Amount | Fair Value | Amount | Fair Value | ||||||||||||||||||||||||||
Derivative instruments designated as hedges of fair value: | |||||||||||||||||||||||||||||||||
Interest rate swap contracts (1) | $ | — | $ | — | $ | — | $ | — | $ | 248 | $ | (26 | ) | $ | 3,707 | $ | (94 | ) | |||||||||||||||
Stand-alone derivative instruments (2) | |||||||||||||||||||||||||||||||||
Interest rate swap contracts | 570,472 | 17,813 | 460,956 | 27,740 | 571,445 | (17,875 | ) | 462,012 | (27,832 | ) | |||||||||||||||||||||||
Interest rate options contracts | 84,095 | 307 | 70,346 | 157 | 84,095 | (307 | ) | 70,346 | (157 | ) | |||||||||||||||||||||||
Foreign exchange contracts | 16,112 | 912 | 20,033 | 1,062 | 15,536 | (818 | ) | 19,337 | (961 | ) | |||||||||||||||||||||||
Mortgage banking derivatives | 4,794 | 80 | 11,400 | 137 | 2,603 | (34 | ) | 4,000 | (11 | ) | |||||||||||||||||||||||
Total non-hedging derivative instruments | 675,473 | 19,112 | 562,735 | 29,096 | 673,679 | (19,034 | ) | 555,695 | (28,961 | ) | |||||||||||||||||||||||
Total | $ | 675,473 | $ | 19,112 | $ | 562,735 | $ | 29,096 | $ | 673,927 | $ | (19,060 | ) | $ | 559,402 | $ | (29,055 | ) | |||||||||||||||
(1) Hedged fixed-rate commercial real estate loans | |||||||||||||||||||||||||||||||||
(2) These portfolio swaps are not designated as hedging instruments under ASC Topic 815. | |||||||||||||||||||||||||||||||||
Schedule of the amount of gains and losses on derivative contracts designated as hedges and not designated as hedges | Amounts included in the other income in the consolidated statements of operations related to derivative financial instruments were as follows (in thousands): | ||||||||||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||
September 30, | September 30, | ||||||||||||||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||||||||||||||||||
Derivative instruments designated as hedges of fair value: | |||||||||||||||||||||||||||||||||
Interest rate swap contracts | $ | (1 | ) | $ | — | $ | 9 | $ | (36 | ) | |||||||||||||||||||||||
Stand-alone derivative instruments | |||||||||||||||||||||||||||||||||
Interest rate swap contracts | 7 | 6 | 30 | 19 | |||||||||||||||||||||||||||||
Interest rate options contracts | — | — | — | — | |||||||||||||||||||||||||||||
Foreign exchange contracts | (12 | ) | 14 | (7 | ) | 44 | |||||||||||||||||||||||||||
Mortgage banking derivatives | (16 | ) | 9 | (80 | ) | 79 | |||||||||||||||||||||||||||
Total non-hedging derivative instruments | (21 | ) | 29 | (57 | ) | 142 | |||||||||||||||||||||||||||
Total | $ | (22 | ) | $ | 29 | $ | (48 | ) | $ | 106 | |||||||||||||||||||||||
Schedule of Derivative Instruments [Table Text Block] | |||||||||||||||||||||||||||||||||
Financial Assets | Financial Liabilities | ||||||||||||||||||||||||||||||||
Net Amount Recognized | Financial Instruments | Collateral | Net Amount | Net Amount Recognized | Financial Instruments | Collateral | Net Amount | ||||||||||||||||||||||||||
Derivatives: | |||||||||||||||||||||||||||||||||
Counterparty A | $ | 440 | $ | (440 | ) | $ | — | $ | — | $ | 12,976 | $ | (440 | ) | $ | (12,536 | ) | $ | — | ||||||||||||||
Counterparty B | 1,090 | (551 | ) | — | 539 | 551 | (551 | ) | — | — | |||||||||||||||||||||||
Counterparty C | 1,570 | (1,570 | ) | — | — | 1,949 | (1,570 | ) | (379 | ) | — | ||||||||||||||||||||||
Other counterparties | 450 | (1 | ) | — | 449 | 46 | (1 | ) | — | 45 | |||||||||||||||||||||||
Total derivatives | 3,550 | (2,562 | ) | — | 988 | 15,522 | (2,562 | ) | (12,915 | ) | 45 | ||||||||||||||||||||||
Repurchase agreements | — | — | — | — | 240,600 | — | (240,600 | ) | — | ||||||||||||||||||||||||
Total | $ | 3,550 | $ | (2,562 | ) | $ | — | $ | 988 | $ | 256,122 | $ | (2,562 | ) | $ | (253,515 | ) | $ | 45 | ||||||||||||||
Financial Assets | Financial Liabilities | ||||||||||||||||||||||||||||||||
Net Amount Recognized | Financial Instruments | Collateral | Net Amount | Net Amount Recognized | Financial Instruments | Collateral | Net Amount | ||||||||||||||||||||||||||
Derivatives: | |||||||||||||||||||||||||||||||||
Counterparty A | $ | 68 | $ | (68 | ) | $ | — | $ | — | $ | 25,497 | $ | (68 | ) | $ | (25,429 | ) | $ | — | ||||||||||||||
Counterparty B | 84 | (84 | ) | — | — | 633 | (84 | ) | (549 | ) | — | ||||||||||||||||||||||
Counterparty C | 36 | (36 | ) | — | — | 2,305 | (36 | ) | (2,269 | ) | — | ||||||||||||||||||||||
Other counterparties | 48 | (42 | ) | — | 6 | 395 | (42 | ) | (298 | ) | 55 | ||||||||||||||||||||||
Total derivatives | 236 | (230 | ) | — | 6 | 28,830 | (230 | ) | (28,545 | ) | 55 | ||||||||||||||||||||||
Repurchase agreements | — | — | — | — | 208,242 | — | (208,242 | ) | — | ||||||||||||||||||||||||
Total | $ | 236 | $ | (230 | ) | $ | — | $ | 6 | $ | 237,072 | $ | (230 | ) | $ | (236,787 | ) | $ | 55 | ||||||||||||||
Information about the Company's financial instruments that are eligible for offset in the consolidated balance sheet as of December 31, 2012 is summarized below (in thousands): | |||||||||||||||||||||||||||||||||
Financial Assets | Financial Liabilities | ||||||||||||||||||||||||||||||||
Gross Amount Recognized | Gross Amount Offset | Net Amount Recognized | Gross Amount Recognized | Gross Amount Offset | Net Amount Recognized | ||||||||||||||||||||||||||||
Derivatives: | |||||||||||||||||||||||||||||||||
Interest rate swaps, caps and floors | $ | 192 | $ | — | $ | 192 | $ | 27,890 | $ | — | $ | 27,890 | |||||||||||||||||||||
Foreign currency forward contracts | 43 | — | 43 | 929 | — | 929 | |||||||||||||||||||||||||||
Mortgage banking derivatives | 1 | — | 1 | 11 | — | 11 | |||||||||||||||||||||||||||
Total derivatives | 236 | — | 236 | 28,830 | — | 28,830 | |||||||||||||||||||||||||||
Repurchase agreements | — | — | — | 208,242 | — | 208,242 | |||||||||||||||||||||||||||
Total | $ | 236 | $ | — | $ | 236 | $ | 237,072 | $ | — | $ | 237,072 | |||||||||||||||||||||
Information about the Company's financial instruments that are eligible for offset in the consolidated balance sheet as of September 30, 2013 is summarized below (in thousands): | |||||||||||||||||||||||||||||||||
Financial Assets | Financial Liabilities | ||||||||||||||||||||||||||||||||
Gross Amount Recognized | Gross Amount Offset | Net Amount Recognized | Gross Amount Recognized | Gross Amount Offset | Net Amount Recognized | ||||||||||||||||||||||||||||
Derivatives: | |||||||||||||||||||||||||||||||||
Interest rate swaps, caps and floors | $ | 3,483 | $ | — | $ | 3,483 | $ | 14,724 | $ | — | $ | 14,724 | |||||||||||||||||||||
Foreign currency forward contracts | 67 | — | 67 | 764 | — | 764 | |||||||||||||||||||||||||||
Mortgage banking derivatives | — | — | — | 34 | — | 34 | |||||||||||||||||||||||||||
Total derivatives | 3,550 | — | 3,550 | 15,522 | — | 15,522 | |||||||||||||||||||||||||||
Repurchase agreements | — | — | — | 240,600 | — | 240,600 | |||||||||||||||||||||||||||
Total | $ | 3,550 | $ | — | $ | 3,550 | $ | 256,122 | $ | — | $ | 256,122 | |||||||||||||||||||||
Earnings_Per_Common_Share_Deta
Earnings Per Common Share (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, except Share data, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Basic and diluted earnings per common share: | ||||
Net income (loss) | $24,400 | $23,133 | $74,599 | $66,362 |
Less: preferred stock dividends and discount accretion | 0 | 0 | 0 | 3,269 |
Net income available to common stockholders | 24,400 | 23,133 | 74,599 | 63,093 |
Earnings allocated to common stockholders | 24,399 | 23,132 | 74,597 | 63,091 |
Weighted average shares outstanding for basic earnings per common share | 54,565,089 | 54,346,827 | 54,471,541 | 54,226,241 |
Weighted average shares outstanding for diluted earnings per common share | 55,130,653 | 54,556,517 | 54,912,352 | 54,472,617 |
Basic earnings per common share | $0.45 | $0.43 | $1.37 | $1.16 |
Diluted earnings per common share | $0.44 | $0.42 | $1.36 | $1.16 |
Common Stock | ||||
Basic and diluted earnings per common share: | ||||
Distributed earnings allocated to common stock | 6,636 | 548 | 17,653 | 1,643 |
Undistributed earnings | 17,764 | 22,585 | 56,946 | 64,719 |
Net income (loss) | 24,400 | 23,133 | 74,599 | 66,362 |
Net income available to common stockholders | 24,400 | 23,133 | 74,599 | 63,093 |
Dilutive effect of equity awards | 565,564 | 209,690 | 440,811 | 246,376 |
Participating Securities | ||||
Basic and diluted earnings per common share: | ||||
Less: earnings allocated to participating securities | $1 | $1 | $2 | $2 |
Business_Combinations_Details
Business Combinations (Details) (USD $) | 6 Months Ended | 0 Months Ended |
Jun. 30, 2013 | Dec. 28, 2012 | |
Celtic [Member] | ||
Assets Acquired and Liabilities Assumed | ||
Cash and cash equivalents | $31,647,000 | |
Investment securities available for sale | 635,000 | |
Loans and leases | 32,933,000 | |
Premises and equipment | 81,000 | |
Goodwill | 36,300,000 | |
Other intangible | 5,028,000 | |
Other assets | 27,323,000 | |
Total assets | 133,947,000 | |
Accrued expenses and other liabilities | 75,290,000 | |
Total liabilities | 75,290,000 | |
Cash paid (received) on acquisition | 58,657,000 | |
Net gain recorded on acquisition | 0 | |
Business combination, assets to be acquired | 5,900,000,000 | |
Business combination, loans to be acquired | 3,300,000,000 | |
Business combination, deposits to be acquired | $3,700,000,000 | |
Business combination, share conversion | 0.64318 | |
Business combination, amount per share | $4.08 |
Investment_Securities_Details
Investment Securities (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2012 | Dec. 31, 2012 |
Available for Sale | ||||
Amortized Cost | $1,082,076 | $1,082,076 | $1,808,521 | |
Gross Unrealized Gains | 13,989 | 13,989 | 66,005 | |
Gross Unrealized Losses | -5,942 | -5,942 | -6,355 | |
Fair Value | 1,090,123 | 1,090,123 | 1,868,171 | |
Held to Maturity | ||||
Investment securities held to maturity | 1,193,544 | 1,193,544 | 493,421 | |
Gross Unrealized Gains | 22,685 | 22,685 | 42,260 | |
Gross Unrealized Losses | -3,481 | -3,481 | 0 | |
Investment Securities held to maturity | 1,212,748 | 1,212,748 | 535,681 | |
Total Available for Sale and Held to Maturity Investment Securities | ||||
Amortized Cost | 2,275,620 | 2,275,620 | 2,301,942 | |
Gross Unrealized Gains | 36,674 | 36,674 | 108,265 | |
Gross Unrealized Losses | -9,423 | -9,423 | -6,355 | |
Fair Value | 2,302,871 | 2,302,871 | 2,403,852 | |
Transfer of investment securities available for sale to investment securities held to maturity | 656,600 | 656,617 | 0 | |
U.S. Government sponsored agencies and enterprises | ||||
Available for Sale | ||||
Amortized Cost | 50,678 | 50,678 | 38,605 | |
Gross Unrealized Gains | 1,849 | 1,849 | 2,710 | |
Gross Unrealized Losses | 0 | 0 | 0 | |
Fair Value | 52,527 | 52,527 | 41,315 | |
States and political subdivisions | ||||
Available for Sale | ||||
Amortized Cost | 19,461 | 19,461 | 679,991 | |
Gross Unrealized Gains | 52 | 52 | 45,571 | |
Gross Unrealized Losses | -201 | -201 | -543 | |
Fair Value | 19,312 | 19,312 | 725,019 | |
Held to Maturity | ||||
Investment securities held to maturity | 941,273 | 941,273 | 237,563 | |
Gross Unrealized Gains | 8,517 | 8,517 | 21,039 | |
Gross Unrealized Losses | -3,481 | -3,481 | 0 | |
Investment Securities held to maturity | 946,309 | 946,309 | 258,602 | |
Total Available for Sale and Held to Maturity Investment Securities | ||||
Percentage of securities consisting general obligation issues | 90.00% | |||
States and political subdivisions | State of Illinois | ||||
Total Available for Sale and Held to Maturity Investment Securities | ||||
Percentage of investments issued by states and political subdivisions that were within the state of Illinois | 27.00% | |||
Residential mortgage-backed securities | ||||
Available for Sale | ||||
Amortized Cost | 685,126 | 685,126 | 930,413 | |
Gross Unrealized Gains | 8,659 | 8,659 | 14,038 | |
Gross Unrealized Losses | -2,509 | -2,509 | -5,249 | |
Fair Value | 691,276 | 691,276 | 939,202 | |
Held to Maturity | ||||
Investment securities held to maturity | 252,271 | 252,271 | 255,858 | |
Gross Unrealized Gains | 14,168 | 14,168 | 21,221 | |
Gross Unrealized Losses | 0 | 0 | 0 | |
Investment Securities held to maturity | 266,439 | 266,439 | 277,079 | |
Commercial mortgage-backed securities | ||||
Available for Sale | ||||
Amortized Cost | 50,944 | 50,944 | 51,100 | |
Gross Unrealized Gains | 2,502 | 2,502 | 3,026 | |
Gross Unrealized Losses | 0 | 0 | 0 | |
Fair Value | 53,446 | 53,446 | 54,126 | |
Corporate bonds | ||||
Available for Sale | ||||
Amortized Cost | 265,293 | 265,293 | 97,014 | |
Gross Unrealized Gains | 927 | 927 | 213 | |
Gross Unrealized Losses | -3,199 | -3,199 | -553 | |
Fair Value | 263,021 | 263,021 | 96,674 | |
Equity securities | ||||
Available for Sale | ||||
Amortized Cost | 10,574 | 10,574 | 11,398 | |
Gross Unrealized Gains | 0 | 0 | 447 | |
Gross Unrealized Losses | -33 | -33 | -10 | |
Fair Value | $10,541 | $10,541 | $11,835 |
Investment_Securities_Details_
Investment Securities (Details 2) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | Security_Position | Security_Position |
Available for Sale | ||
Less Than 12 Months, Fair Value | $373,334 | |
Less Than 12 Months, Unrealized Losses | -5,473 | |
12 Months or More, Fair Value | 49,104 | |
12 Months or More, Unrealized Losses | -469 | |
Total Fair Value | 422,438 | |
Total Unrealized Losses | -5,942 | |
Held to maturity | ||
Less Than 12 Months, Fair Value | 207,613 | |
Less Than 12 Months, Unrealized Losses | -3,481 | |
Total Fair Value | 207,613 | |
Total Unrealized Losses | -3,481 | |
Total | ||
Less Than 12 Months, Fair Value | 580,947 | 386,350 |
Less Than 12 Months, Unrealized Losses | -8,954 | -6,189 |
12 Months or More, Fair Value | 49,104 | 16,434 |
12 Months or More, Unrealized Losses | -469 | -166 |
Total Fair Value | 630,051 | 402,784 |
Total Unrealized Losses | 9,423 | 6,355 |
Number of security positions in the investment portfolio in an unrealized loss position | 353 | 117 |
States and political subdivisions | ||
Available for Sale | ||
Less Than 12 Months, Fair Value | 9,050 | 57,540 |
Less Than 12 Months, Unrealized Losses | -201 | -543 |
12 Months or More, Fair Value | 0 | 0 |
12 Months or More, Unrealized Losses | 0 | 0 |
Total Fair Value | 9,050 | 57,540 |
Total Unrealized Losses | -201 | -543 |
Held to maturity | ||
Less Than 12 Months, Fair Value | 207,613 | |
Less Than 12 Months, Unrealized Losses | -3,481 | |
Total Fair Value | 207,613 | |
Total Unrealized Losses | -3,481 | |
Residential mortgage-backed securities | ||
Available for Sale | ||
Less Than 12 Months, Fair Value | 206,562 | 270,539 |
Less Than 12 Months, Unrealized Losses | -2,040 | -5,083 |
12 Months or More, Fair Value | 49,104 | 16,434 |
12 Months or More, Unrealized Losses | -469 | -166 |
Total Fair Value | 255,666 | 286,973 |
Total Unrealized Losses | -2,509 | -5,249 |
Corporate bonds | ||
Available for Sale | ||
Less Than 12 Months, Fair Value | 147,181 | 58,241 |
Less Than 12 Months, Unrealized Losses | -3,199 | -553 |
12 Months or More, Fair Value | 0 | 0 |
12 Months or More, Unrealized Losses | 0 | 0 |
Total Fair Value | 147,181 | 58,241 |
Total Unrealized Losses | -3,199 | -553 |
Equity securities | ||
Available for Sale | ||
Less Than 12 Months, Fair Value | 10,541 | 30 |
Less Than 12 Months, Unrealized Losses | -33 | -10 |
12 Months or More, Fair Value | 0 | 0 |
12 Months or More, Unrealized Losses | 0 | 0 |
Total Fair Value | 10,541 | 30 |
Total Unrealized Losses | ($33) | ($10) |
Investment_Securities_Details_1
Investment Securities (Details 3) (USD $) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Dec. 31, 2012 | |
Amortized cost and fair value of investment securities by contractual maturity | |||||
Realized gains | $1,000 | $282,000 | $15,000 | $472,000 | |
Realized losses | 0 | -1,000 | -1,000 | -4,000 | |
Impairment charges | 0 | 0 | 0 | -224,000 | |
Net gains (losses) | 1,000 | 281,000 | 14,000 | 244,000 | |
Amortized Cost, Available for sale | |||||
Due in one year or less | 0 | 0 | |||
Due after one year through five years | 319,032,000 | 319,032,000 | |||
Due after five years through ten years | 7,695,000 | 7,695,000 | |||
Due after ten years | 8,705,000 | 8,705,000 | |||
Amortized Cost | 1,082,076,000 | 1,082,076,000 | 1,808,521,000 | ||
Fair Value, Available for sale | |||||
Due in one year or less | 0 | 0 | |||
Due after one year through five years | 318,598,000 | 318,598,000 | |||
Due after five years through ten years | 7,711,000 | 7,711,000 | |||
Due after ten years | 8,551,000 | 8,551,000 | |||
Fair Value | 1,090,123,000 | 1,090,123,000 | 1,868,171,000 | ||
Amortized Cost, Held to maturity | |||||
Due in one year or less | 28,222,000 | 28,222,000 | |||
Due in after one year through five years | 245,125,000 | 245,125,000 | |||
Due after five years through ten years | 122,547,000 | 122,547,000 | |||
Due after ten years | 545,379,000 | 545,379,000 | |||
Investment securities held to maturity | 1,193,544,000 | 1,193,544,000 | 493,421,000 | ||
Fair value, Held to maturity | |||||
Due in one year or less | 28,221,000 | 28,221,000 | |||
Due in after one year through five years | 245,545,000 | 245,545,000 | |||
Due after five years through ten years | 122,533,000 | 122,533,000 | |||
Due after ten years | 550,010,000 | 550,010,000 | |||
Investment Securities held to maturity | 1,212,748,000 | 1,212,748,000 | 535,681,000 | ||
Total Available for Sale and Held to Maturity Investment Securities | |||||
Amortized Cost | 2,275,620,000 | 2,275,620,000 | 2,301,942,000 | ||
Fair Value | 2,302,871,000 | 2,302,871,000 | 2,403,852,000 | ||
Carrying amounts of investment securities available for sale pledged as collateral | 1,000,000,000 | 1,000,000,000 | 989,600,000 | ||
Equity securities | |||||
Amortized Cost, Available for sale | |||||
Amortized Cost | 10,574,000 | 10,574,000 | 11,398,000 | ||
Fair Value, Available for sale | |||||
Fair Value | 10,541,000 | 10,541,000 | 11,835,000 | ||
Residential and commercial mortgage-backed securities | |||||
Amortized Cost, Available for sale | |||||
Amortized Cost | 736,070,000 | 736,070,000 | |||
Fair Value, Available for sale | |||||
Fair Value | 744,722,000 | 744,722,000 | |||
Residential mortgage-backed securities | |||||
Amortized Cost, Available for sale | |||||
Amortized Cost | 685,126,000 | 685,126,000 | 930,413,000 | ||
Fair Value, Available for sale | |||||
Fair Value | 691,276,000 | 691,276,000 | 939,202,000 | ||
Amortized Cost, Held to maturity | |||||
Investment securities held to maturity | 252,271,000 | 252,271,000 | 255,858,000 | ||
Fair value, Held to maturity | |||||
Investment Securities held to maturity | $266,439,000 | $266,439,000 | $277,079,000 |
Loans_Details
Loans (Details) (USD $) | 9 Months Ended | ||
Sep. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | |
investmentrating | |||
Loans | |||
Total loans, excluding covered loans | $5,313,235,000 | $5,317,080,000 | |
Covered loans | 273,497,000 | 449,850,000 | |
Loans and Leases Receivable, Net of Deferred Income Including Covered Loans | 5,586,732,000 | 5,766,930,000 | 5,624,845,000 |
Net unearned income, including net deferred loan fees | 1,500,000 | 1,100,000 | |
Number of highest rating categories by rating services company | 1 | ||
Number of highest rating categories to be achieved for classification as investment grade companies | 4 | ||
Commercial loans | |||
Loans | |||
Total loans, excluding covered loans | 1,169,009,000 | 1,220,472,000 | |
Covered loans | 3,984,000 | ||
Loans and Leases Receivable, Net of Deferred Income Including Covered Loans | 1,189,861,000 | 1,133,346,000 | |
Commercial loans collateralized by assignment of lease payments | |||
Loans | |||
Total loans, excluding covered loans | 1,468,814,000 | 1,303,020,000 | |
Loans and Leases Receivable, Net of Deferred Income Including Covered Loans | 1,468,814,000 | 1,219,361,000 | |
Commercial real estate | |||
Loans | |||
Total loans, excluding covered loans | 1,638,368,000 | 1,761,832,000 | |
Covered loans | 159,799,000 | ||
Loans and Leases Receivable, Net of Deferred Income Including Covered Loans | 1,798,167,000 | 2,039,609,000 | |
Residential real estate | |||
Loans | |||
Total loans, excluding covered loans | 311,256,000 | 314,359,000 | |
Loans and Leases Receivable, Net of Deferred Income Including Covered Loans | 313,532,000 | 312,030,000 | |
Construction real estate | |||
Loans | |||
Total loans, excluding covered loans | 136,146,000 | 110,261,000 | |
Covered loans | 61,446,000 | ||
Loans and Leases Receivable, Net of Deferred Income Including Covered Loans | 197,592,000 | 275,387,000 | |
Indirect vehicle | |||
Loans | |||
Total loans, excluding covered loans | 257,740,000 | 208,633,000 | |
Loans and Leases Receivable, Net of Deferred Income Including Covered Loans | 257,740,000 | 206,973,000 | |
Home equity lines | |||
Loans | |||
Total loans, excluding covered loans | 274,484,000 | 305,186,000 | |
Loans and Leases Receivable, Net of Deferred Income Including Covered Loans | 274,594,000 | 315,286,000 | |
Other consumer | |||
Loans | |||
Total loans, excluding covered loans | 57,418,000 | 93,317,000 | |
Loans and Leases Receivable, Net of Deferred Income Including Covered Loans | $86,432,000 | $122,853,000 |
Loans_Details_2
Loans (Details 2) (USD $) | 9 Months Ended | ||||
Sep. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | |||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | $5,313,235,000 | $5,317,080,000 | |||
Loans and Leases Receivable, Net of Deferred Income Including Covered Loans | 5,586,732,000 | 5,766,930,000 | 5,624,845,000 | ||
Period past due of recorded investment in loans (in days) | 90 days | ||||
Recorded investment in nonaccrual loans and loans past due ninety days or more and still accruing | |||||
Non-performing substandard and doubtful loans | 76,500,000 | 85,500,000 | |||
Pass | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 4,165,538,000 | 4,064,532,000 | |||
Special Mention | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 73,931,000 | 134,025,000 | |||
Substandard | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 169,704,000 | 193,575,000 | |||
Doubtful | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 3,164,000 | 3,453,000 | |||
Total risk rated category | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 4,412,337,000 | 4,395,585,000 | |||
Non-performing | |||||
Contractual aging of the recorded investment in loans | |||||
Current | 53,271,000 | 69,836,000 | |||
30-59 days, past due | 3,596,000 | 3,171,000 | |||
60-89 days, past due | 6,111,000 | 3,718,000 | |||
Loans past due, 90 days or more | 39,474,000 | 40,261,000 | |||
Total, past due | 49,181,000 | 47,150,000 | |||
Loans and Leases Receivable, Net of Deferred Income Including Covered Loans | 102,452,000 | 116,986,000 | |||
Commercial loans | |||||
Contractual aging of the recorded investment in loans | |||||
Current | 1,158,326,000 | 1,215,957,000 | |||
30-59 days, past due | 2,392,000 | 639,000 | |||
60-89 days, past due | 2,580,000 | 754,000 | |||
Loans past due, 90 days or more | 5,711,000 | 3,122,000 | |||
Total, past due | 10,683,000 | 4,515,000 | |||
Total loans, excluding covered loans | 1,169,009,000 | 1,220,472,000 | |||
Loans and Leases Receivable, Net of Deferred Income Including Covered Loans | 1,189,861,000 | 1,133,346,000 | |||
Recorded investment in nonaccrual loans and loans past due ninety days or more and still accruing | |||||
Nonaccrual | 19,948,000 | 23,886,000 | |||
Loans past due 90 days or more and still accruing | 0 | 229,000 | |||
Commercial loans | Pass | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 1,091,129,000 | 1,136,294,000 | |||
Commercial loans | Special Mention | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 17,720,000 | 33,068,000 | |||
Commercial loans | Substandard | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 60,160,000 | 50,895,000 | |||
Commercial loans | Doubtful | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 0 | 215,000 | |||
Commercial loans | Total risk rated category | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 1,169,009,000 | 1,220,472,000 | |||
Commercial loans collateralized by assignment of lease payments | |||||
Contractual aging of the recorded investment in loans | |||||
Current | 1,455,296,000 | 1,288,341,000 | |||
30-59 days, past due | 10,761,000 | 11,252,000 | |||
60-89 days, past due | 1,816,000 | 2,847,000 | |||
Loans past due, 90 days or more | 941,000 | 580,000 | |||
Total, past due | 13,518,000 | 14,679,000 | |||
Total loans, excluding covered loans | 1,468,814,000 | 1,303,020,000 | |||
Loans and Leases Receivable, Net of Deferred Income Including Covered Loans | 1,468,814,000 | 1,219,361,000 | |||
Recorded investment in nonaccrual loans and loans past due ninety days or more and still accruing | |||||
Nonaccrual | 2,130,000 | 1,180,000 | |||
Loans past due 90 days or more and still accruing | 215,000 | 222,000 | |||
Commercial loans collateralized by assignment of lease payments | Pass | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 1,457,577,000 | 1,292,241,000 | |||
Commercial loans collateralized by assignment of lease payments | Special Mention | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 4,814,000 | 3,322,000 | |||
Commercial loans collateralized by assignment of lease payments | Substandard | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 6,423,000 | 7,457,000 | |||
Commercial loans collateralized by assignment of lease payments | Doubtful | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 0 | 0 | |||
Commercial loans collateralized by assignment of lease payments | Total risk rated category | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 1,468,814,000 | 1,303,020,000 | |||
Commercial real estate | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 1,638,368,000 | 1,761,832,000 | |||
Loans and Leases Receivable, Net of Deferred Income Including Covered Loans | 1,798,167,000 | 2,039,609,000 | |||
Healthcare | |||||
Contractual aging of the recorded investment in loans | |||||
Current | 212,659,000 | 192,039,000 | |||
30-59 days, past due | 0 | 0 | |||
60-89 days, past due | 0 | 0 | |||
Loans past due, 90 days or more | 3,164,000 | 3,238,000 | |||
Total, past due | 3,164,000 | 3,238,000 | |||
Total loans, excluding covered loans | 215,823,000 | 195,277,000 | |||
Recorded investment in nonaccrual loans and loans past due ninety days or more and still accruing | |||||
Nonaccrual | 3,164,000 | 3,238,000 | |||
Loans past due 90 days or more and still accruing | 0 | 0 | |||
Healthcare | Pass | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 188,946,000 | 170,265,000 | |||
Healthcare | Special Mention | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 21,556,000 | 21,774,000 | |||
Healthcare | Substandard | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 2,157,000 | 0 | |||
Healthcare | Doubtful | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 3,164,000 | 3,238,000 | |||
Healthcare | Total risk rated category | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 215,823,000 | 195,277,000 | |||
Industrial | |||||
Contractual aging of the recorded investment in loans | |||||
Current | 371,940,000 | 402,813,000 | |||
30-59 days, past due | 161,000 | 548,000 | |||
60-89 days, past due | 2,101,000 | 424,000 | |||
Loans past due, 90 days or more | 1,394,000 | 7,700,000 | |||
Total, past due | 3,656,000 | 8,672,000 | |||
Total loans, excluding covered loans | 375,596,000 | 411,485,000 | |||
Recorded investment in nonaccrual loans and loans past due ninety days or more and still accruing | |||||
Nonaccrual | 9,754,000 | 19,179,000 | |||
Loans past due 90 days or more and still accruing | 0 | 147,000 | |||
Industrial | Pass | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 335,274,000 | 355,218,000 | |||
Industrial | Special Mention | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 7,384,000 | 15,243,000 | |||
Industrial | Substandard | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 32,938,000 | 41,024,000 | |||
Industrial | Doubtful | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 0 | 0 | |||
Industrial | Total risk rated category | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 375,596,000 | 411,485,000 | |||
Multifamily | |||||
Contractual aging of the recorded investment in loans | |||||
Current | 316,495,000 | 353,966,000 | |||
30-59 days, past due | 2,808,000 | 1,282,000 | |||
60-89 days, past due | 0 | 0 | |||
Loans past due, 90 days or more | 2,387,000 | 3,103,000 | |||
Total, past due | 5,195,000 | 4,385,000 | |||
Total loans, excluding covered loans | 321,690,000 | 358,351,000 | |||
Recorded investment in nonaccrual loans and loans past due ninety days or more and still accruing | |||||
Nonaccrual | 5,087,000 | 7,225,000 | |||
Loans past due 90 days or more and still accruing | 195,000 | 0 | |||
Multifamily | Pass | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 306,691,000 | 318,991,000 | |||
Multifamily | Special Mention | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 0 | 25,297,000 | |||
Multifamily | Substandard | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 14,999,000 | 14,063,000 | |||
Multifamily | Doubtful | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 0 | 0 | |||
Multifamily | Total risk rated category | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 321,690,000 | 358,351,000 | |||
Retail | |||||
Contractual aging of the recorded investment in loans | |||||
Current | 344,390,000 | 375,900,000 | |||
30-59 days, past due | 236,000 | 6,933,000 | |||
60-89 days, past due | 449,000 | 518,000 | |||
Loans past due, 90 days or more | 8,632,000 | 9,331,000 | |||
Total, past due | 9,317,000 | 16,782,000 | |||
Total loans, excluding covered loans | 353,707,000 | 392,682,000 | |||
Recorded investment in nonaccrual loans and loans past due ninety days or more and still accruing | |||||
Nonaccrual | 3,740,000 | 17,019,000 | |||
Loans past due 90 days or more and still accruing | 0 | 0 | |||
Retail | Pass | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 324,558,000 | 340,919,000 | |||
Retail | Special Mention | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 10,373,000 | 25,096,000 | |||
Retail | Substandard | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 18,776,000 | 26,667,000 | |||
Retail | Doubtful | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 0 | 0 | |||
Retail | Total risk rated category | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 353,707,000 | 392,682,000 | |||
Office | |||||
Contractual aging of the recorded investment in loans | |||||
Current | 139,251,000 | 186,665,000 | |||
30-59 days, past due | 412,000 | 742,000 | |||
60-89 days, past due | 579,000 | 280,000 | |||
Loans past due, 90 days or more | 2,106,000 | 1,125,000 | |||
Total, past due | 3,097,000 | 2,147,000 | |||
Total loans, excluding covered loans | 142,348,000 | 188,812,000 | |||
Recorded investment in nonaccrual loans and loans past due ninety days or more and still accruing | |||||
Nonaccrual | 10,916,000 | 3,263,000 | |||
Loans past due 90 days or more and still accruing | 0 | 0 | |||
Office | Pass | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 132,490,000 | 159,056,000 | |||
Office | Special Mention | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 2,732,000 | 7,120,000 | |||
Office | Substandard | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 7,126,000 | 22,636,000 | |||
Office | Doubtful | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 0 | 0 | |||
Office | Total risk rated category | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 142,348,000 | 188,812,000 | |||
Other | |||||
Contractual aging of the recorded investment in loans | |||||
Current | 223,385,000 | 210,456,000 | |||
30-59 days, past due | 3,443,000 | 851,000 | |||
60-89 days, past due | 229,000 | 1,837,000 | |||
Loans past due, 90 days or more | 2,147,000 | 2,081,000 | |||
Total, past due | 5,819,000 | 4,769,000 | |||
Total loans, excluding covered loans | 229,204,000 | 215,225,000 | |||
Recorded investment in nonaccrual loans and loans past due ninety days or more and still accruing | |||||
Nonaccrual | 21,420,000 | 9,437,000 | |||
Loans past due 90 days or more and still accruing | 0 | 0 | |||
Other | Pass | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 201,971,000 | 193,824,000 | |||
Other | Special Mention | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 3,088,000 | 2,553,000 | |||
Other | Substandard | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 24,145,000 | 18,848,000 | |||
Other | Doubtful | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 0 | 0 | |||
Other | Total risk rated category | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 229,204,000 | 215,225,000 | |||
Residential real estate | |||||
Contractual aging of the recorded investment in loans | |||||
Current | 298,878,000 | 306,927,000 | |||
30-59 days, past due | 1,103,000 | 382,000 | |||
60-89 days, past due | 1,059,000 | 1,248,000 | |||
Loans past due, 90 days or more | 10,216,000 | 5,802,000 | |||
Total, past due | 12,378,000 | 7,432,000 | |||
Total loans, excluding covered loans | 311,256,000 | 314,359,000 | |||
Loans and Leases Receivable, Net of Deferred Income Including Covered Loans | 313,532,000 | 312,030,000 | |||
Recorded investment in nonaccrual loans and loans past due ninety days or more and still accruing | |||||
Nonaccrual | 13,041,000 | 10,943,000 | |||
Loans past due 90 days or more and still accruing | 0 | 0 | |||
Residential real estate | Performing | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 298,215,000 | 303,416,000 | |||
Residential real estate | Non-performing | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 13,041,000 | 10,943,000 | |||
Construction real estate | |||||
Contractual aging of the recorded investment in loans | |||||
Current | 133,742,000 | 106,158,000 | |||
30-59 days, past due | 0 | 1,139,000 | |||
60-89 days, past due | 89,000 | 97,000 | |||
Loans past due, 90 days or more | 2,315,000 | 2,867,000 | |||
Total, past due | 2,404,000 | 4,103,000 | |||
Total loans, excluding covered loans | 136,146,000 | 110,261,000 | |||
Loans and Leases Receivable, Net of Deferred Income Including Covered Loans | 197,592,000 | 275,387,000 | |||
Recorded investment in nonaccrual loans and loans past due ninety days or more and still accruing | |||||
Nonaccrual | 496,000 | 1,028,000 | |||
Loans past due 90 days or more and still accruing | 0 | 0 | |||
Construction real estate | Pass | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 126,902,000 | 97,724,000 | |||
Construction real estate | Special Mention | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 6,264,000 | 552,000 | |||
Construction real estate | Substandard | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 2,980,000 | 11,985,000 | |||
Construction real estate | Doubtful | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 0 | 0 | |||
Construction real estate | Total risk rated category | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 136,146,000 | 110,261,000 | |||
Indirect vehicle | |||||
Contractual aging of the recorded investment in loans | |||||
Current | 255,177,000 | 206,126,000 | |||
30-59 days, past due | 1,638,000 | 1,588,000 | |||
60-89 days, past due | 687,000 | 498,000 | |||
Loans past due, 90 days or more | 238,000 | 421,000 | |||
Total, past due | 2,563,000 | 2,507,000 | |||
Total loans, excluding covered loans | 257,740,000 | 208,633,000 | |||
Loans and Leases Receivable, Net of Deferred Income Including Covered Loans | 257,740,000 | 206,973,000 | |||
Recorded investment in nonaccrual loans and loans past due ninety days or more and still accruing | |||||
Nonaccrual | 1,516,000 | 1,494,000 | |||
Loans past due 90 days or more and still accruing | 0 | 0 | |||
Indirect vehicle | Performing | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 256,224,000 | 207,139,000 | |||
Indirect vehicle | Non-performing | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 1,516,000 | 1,494,000 | |||
Home equity lines | |||||
Contractual aging of the recorded investment in loans | |||||
Current | 260,055,000 | 291,737,000 | |||
30-59 days, past due | 4,505,000 | 3,557,000 | |||
60-89 days, past due | 2,911,000 | 1,888,000 | |||
Loans past due, 90 days or more | 7,013,000 | 8,004,000 | |||
Total, past due | 14,429,000 | 13,449,000 | |||
Total loans, excluding covered loans | 274,484,000 | 305,186,000 | |||
Loans and Leases Receivable, Net of Deferred Income Including Covered Loans | 274,594,000 | 315,286,000 | |||
Recorded investment in nonaccrual loans and loans past due ninety days or more and still accruing | |||||
Nonaccrual | 10,818,000 | 17,486,000 | |||
Loans past due 90 days or more and still accruing | 0 | 1,000,000 | |||
Home equity lines | Performing | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 263,666,000 | 286,700,000 | |||
Home equity lines | Non-performing | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 10,818,000 | 18,486,000 | |||
Other consumer | |||||
Contractual aging of the recorded investment in loans | |||||
Current | 57,357,000 | 93,266,000 | |||
30-59 days, past due | 54,000 | 47,000 | |||
60-89 days, past due | 1,000 | 0 | |||
Loans past due, 90 days or more | 6,000 | 4,000 | |||
Total, past due | 61,000 | 51,000 | |||
Total loans, excluding covered loans | 57,418,000 | 93,317,000 | |||
Loans and Leases Receivable, Net of Deferred Income Including Covered Loans | 86,432,000 | 122,853,000 | |||
Recorded investment in nonaccrual loans and loans past due ninety days or more and still accruing | |||||
Nonaccrual | 12,000 | 9,000 | |||
Loans past due 90 days or more and still accruing | 0 | 1,000 | |||
Other consumer | Performing | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 57,406,000 | 93,307,000 | |||
Other consumer | Non-performing | |||||
Contractual aging of the recorded investment in loans | |||||
Total loans, excluding covered loans | 12,000 | 10,000 | |||
Gross loans, excluding covered loans | |||||
Contractual aging of the recorded investment in loans | |||||
Current | 5,226,951,000 | 5,230,351,000 | |||
30-59 days, past due | 27,513,000 | 28,960,000 | |||
60-89 days, past due | 12,501,000 | 10,391,000 | |||
Loans past due, 90 days or more | 46,270,000 | 47,378,000 | |||
Total, past due | 86,284,000 | 86,729,000 | |||
Total loans, excluding covered loans | 5,313,235,000 | 5,317,080,000 | |||
Covered loans | |||||
Contractual aging of the recorded investment in loans | |||||
Current | 138,876,000 | 301,260,000 | |||
30-59 days, past due | 12,091,000 | 5,831,000 | |||
60-89 days, past due | 5,681,000 | 7,478,000 | |||
Loans past due, 90 days or more | 116,849,000 | 135,281,000 | |||
Total, past due | 134,621,000 | 148,590,000 | |||
Loans and Leases Receivable, Net of Deferred Income Including Covered Loans | 273,497,000 | 449,850,000 | |||
Loans | |||||
Contractual aging of the recorded investment in loans | |||||
Current | 5,365,827,000 | 5,531,611,000 | |||
30-59 days, past due | 39,604,000 | 34,791,000 | |||
60-89 days, past due | 18,182,000 | 17,869,000 | |||
Loans past due, 90 days or more | 163,119,000 | 182,659,000 | |||
Total, past due | 220,905,000 | 235,319,000 | |||
Loans and Leases Receivable, Net of Deferred Income Including Covered Loans | 5,586,732,000 | 5,766,930,000 | |||
Recorded investment in nonaccrual loans and loans past due ninety days or more and still accruing | |||||
Nonaccrual | 102,042,000 | 115,387,000 | |||
Loans past due 90 days or more and still accruing | 410,000 | 1,599,000 | |||
Non-covered loans related to FDIC transactions | |||||
Contractual aging of the recorded investment in loans | |||||
Current | 11,339,000 | [1] | 12,752,000 | [1] | |
30-59 days, past due | 222,000 | [1] | 312,000 | [1] | |
60-89 days, past due | 146,000 | [1] | 1,542,000 | [1] | |
Loans past due, 90 days or more | 6,796,000 | [1] | 7,115,000 | [1] | |
Total, past due | 7,164,000 | 8,969,000 | |||
Loans and Leases Receivable, Net of Deferred Income Including Covered Loans | $18,503,000 | $21,721,000 | |||
[1] | Loans related to the InBank FDIC-assisted transaction completed by MB Financial Bank in 2009. |
Loans_Details_3
Loans (Details 3) (USD $) | 3 Months Ended | 9 Months Ended | 12 Months Ended |
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2013 | Dec. 31, 2012 |
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | $5,313,235 | $5,313,235 | $5,317,080 |
Unpaid Principal Balance | 140,158 | 140,158 | 144,992 |
Recorded Investment | 123,623 | 123,623 | 122,264 |
Partial Charge-Offs | 16,535 | 16,535 | 22,728 |
Allowance for Loan Losses Allocated | 16,192 | 16,192 | 16,941 |
Impaired Financing Receivable, Average Recorded Investment | 140,623 | 136,004 | 119,252 |
Interest Income Recognized | 238 | 404 | 376 |
Restructured loans | 15,341 | 15,341 | |
Performing | |||
Loans individually evaluated for impairment by class of loans | |||
Restructured loans | 29,900 | 29,900 | 21,300 |
Non-performing | |||
Loans individually evaluated for impairment by class of loans | |||
Restructured loans | 22,300 | 22,300 | 28,400 |
Commercial loans | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 1,169,009 | 1,169,009 | 1,220,472 |
Restructured loans | 1,251 | 1,251 | |
Commercial loans collateralized by assignment of lease payments | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 1,468,814 | 1,468,814 | 1,303,020 |
Restructured loans | 0 | 0 | |
Commercial real estate | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 1,638,368 | 1,638,368 | 1,761,832 |
Healthcare | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 215,823 | 215,823 | 195,277 |
Restructured loans | 3,164 | 3,164 | |
Industrial | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 375,596 | 375,596 | 411,485 |
Restructured loans | 2,570 | 2,570 | |
Multifamily | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 321,690 | 321,690 | 358,351 |
Restructured loans | 1,224 | 1,224 | |
Retail | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 353,707 | 353,707 | 392,682 |
Restructured loans | 862 | 862 | |
Office | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 142,348 | 142,348 | 188,812 |
Restructured loans | 0 | 0 | |
Other | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 229,204 | 229,204 | 215,225 |
Restructured loans | 84 | 84 | |
Residential real estate | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 311,256 | 311,256 | 314,359 |
Restructured loans | 2,004 | 2,004 | |
Residential real estate | Performing | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 298,215 | 298,215 | 303,416 |
Residential real estate | Non-performing | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 13,041 | 13,041 | 10,943 |
Construction real estate | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 136,146 | 136,146 | 110,261 |
Restructured loans | 0 | 0 | |
Indirect vehicle | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 257,740 | 257,740 | 208,633 |
Restructured loans | 127 | 127 | |
Indirect vehicle | Performing | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 256,224 | 256,224 | 207,139 |
Indirect vehicle | Non-performing | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 1,516 | 1,516 | 1,494 |
Home equity lines | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 274,484 | 274,484 | 305,186 |
Restructured loans | 4,055 | 4,055 | |
Home equity lines | Performing | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 263,666 | 263,666 | 286,700 |
Home equity lines | Non-performing | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 10,818 | 10,818 | 18,486 |
Other consumer | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 57,418 | 57,418 | 93,317 |
Restructured loans | 0 | 0 | |
Other consumer | Performing | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 57,406 | 57,406 | 93,307 |
Other consumer | Non-performing | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 12 | 12 | 10 |
Other loans | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 900,898 | 900,898 | 921,495 |
Other loans | Performing | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 875,511 | 875,511 | 890,562 |
Other loans | Non-performing | |||
Loans individually evaluated for impairment by class of loans | |||
Total loans, excluding covered loans | 25,387 | 25,387 | 30,933 |
Impaired financing receivable with no allowance | Commercial loans | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 6,236 | 6,236 | 10,993 |
Recorded Investment | 5,364 | 5,364 | 9,505 |
Partial Charge-Offs | 872 | 872 | 1,488 |
Allowance for Loan Losses Allocated | 0 | 0 | 0 |
Impaired Financing Receivable, Average Recorded Investment | 6,509 | 7,378 | 14,089 |
Interest Income Recognized | 0 | 0 | 105 |
Impaired financing receivable with no allowance | Commercial loans collateralized by assignment of lease payments | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 681 | 681 | 390 |
Recorded Investment | 681 | 681 | 390 |
Partial Charge-Offs | 0 | 0 | 0 |
Allowance for Loan Losses Allocated | 0 | 0 | 0 |
Impaired Financing Receivable, Average Recorded Investment | 666 | 256 | 278 |
Interest Income Recognized | 6 | 6 | 9 |
Impaired financing receivable with no allowance | Healthcare | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 0 | 0 | 10,943 |
Recorded Investment | 0 | 0 | 3,238 |
Partial Charge-Offs | 0 | 0 | 7,705 |
Allowance for Loan Losses Allocated | 0 | 0 | 0 |
Impaired Financing Receivable, Average Recorded Investment | 0 | 3,608 | 2,751 |
Interest Income Recognized | 0 | 0 | 0 |
Impaired financing receivable with no allowance | Industrial | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 7,547 | 7,547 | 16,891 |
Recorded Investment | 6,927 | 6,927 | 14,940 |
Partial Charge-Offs | 620 | 620 | 1,951 |
Allowance for Loan Losses Allocated | 0 | 0 | 0 |
Impaired Financing Receivable, Average Recorded Investment | 7,902 | 9,316 | 16,374 |
Interest Income Recognized | 0 | 0 | 29 |
Impaired financing receivable with no allowance | Multifamily | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 546 | 546 | 800 |
Recorded Investment | 546 | 546 | 800 |
Partial Charge-Offs | 0 | 0 | 0 |
Allowance for Loan Losses Allocated | 0 | 0 | 0 |
Impaired Financing Receivable, Average Recorded Investment | 665 | 739 | 1,340 |
Interest Income Recognized | 0 | 0 | 14 |
Impaired financing receivable with no allowance | Retail | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 3,002 | 3,002 | 5,372 |
Recorded Investment | 3,002 | 3,002 | 4,917 |
Partial Charge-Offs | 0 | 0 | 455 |
Allowance for Loan Losses Allocated | 0 | 0 | 0 |
Impaired Financing Receivable, Average Recorded Investment | 3,233 | 3,123 | 9,241 |
Interest Income Recognized | 0 | 0 | 0 |
Impaired financing receivable with no allowance | Office | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 685 | 685 | 1,568 |
Recorded Investment | 527 | 527 | 1,568 |
Partial Charge-Offs | 158 | 158 | 0 |
Allowance for Loan Losses Allocated | 0 | 0 | 0 |
Impaired Financing Receivable, Average Recorded Investment | 705 | 986 | 1,151 |
Interest Income Recognized | 0 | 0 | 0 |
Impaired financing receivable with no allowance | Other | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 3,149 | 3,149 | 4,860 |
Recorded Investment | 3,139 | 3,139 | 4,860 |
Partial Charge-Offs | 10 | 10 | 0 |
Allowance for Loan Losses Allocated | 0 | 0 | 0 |
Impaired Financing Receivable, Average Recorded Investment | 3,353 | 4,785 | 6,005 |
Interest Income Recognized | 0 | 0 | 0 |
Impaired financing receivable with no allowance | Residential real estate | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 4,174 | 4,174 | 3,097 |
Recorded Investment | 3,788 | 3,788 | 2,711 |
Partial Charge-Offs | 386 | 386 | 386 |
Allowance for Loan Losses Allocated | 0 | 0 | 0 |
Impaired Financing Receivable, Average Recorded Investment | 4,082 | 2,835 | 6,476 |
Interest Income Recognized | 0 | 0 | 0 |
Impaired financing receivable with no allowance | Construction real estate | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 0 | 0 | 0 |
Recorded Investment | 0 | 0 | 0 |
Partial Charge-Offs | 0 | 0 | 0 |
Allowance for Loan Losses Allocated | 0 | 0 | 0 |
Impaired Financing Receivable, Average Recorded Investment | 0 | 0 | 577 |
Interest Income Recognized | 0 | 0 | 0 |
Impaired financing receivable with no allowance | Indirect vehicle | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 0 | 0 | 0 |
Recorded Investment | 0 | 0 | 0 |
Partial Charge-Offs | 0 | 0 | 0 |
Allowance for Loan Losses Allocated | 0 | 0 | 0 |
Impaired Financing Receivable, Average Recorded Investment | 0 | 0 | 0 |
Interest Income Recognized | 0 | 0 | 0 |
Impaired financing receivable with no allowance | Home equity lines | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 577 | 577 | 2,558 |
Recorded Investment | 577 | 577 | 2,558 |
Partial Charge-Offs | 0 | 0 | 0 |
Allowance for Loan Losses Allocated | 0 | 0 | 0 |
Impaired Financing Receivable, Average Recorded Investment | 577 | 872 | 8,976 |
Interest Income Recognized | 0 | 0 | 0 |
Impaired financing receivable with no allowance | Other consumer | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 0 | 0 | 0 |
Recorded Investment | 0 | 0 | 0 |
Partial Charge-Offs | 0 | 0 | 0 |
Allowance for Loan Losses Allocated | 0 | 0 | 0 |
Impaired Financing Receivable, Average Recorded Investment | 0 | 0 | 182 |
Interest Income Recognized | 0 | 0 | 0 |
Impaired financing receivable with allowance | Commercial loans | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 14,472 | 14,472 | 14,484 |
Recorded Investment | 14,472 | 14,472 | 14,381 |
Partial Charge-Offs | 0 | 0 | 103 |
Allowance for Loan Losses Allocated | 4,389 | 4,389 | 3,620 |
Impaired Financing Receivable, Average Recorded Investment | 15,680 | 14,839 | 8,455 |
Interest Income Recognized | 0 | 0 | 0 |
Impaired financing receivable with allowance | Commercial loans collateralized by assignment of lease payments | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 1,649 | 1,649 | 885 |
Recorded Investment | 1,649 | 1,649 | 885 |
Partial Charge-Offs | 0 | 0 | 0 |
Allowance for Loan Losses Allocated | 285 | 285 | 188 |
Impaired Financing Receivable, Average Recorded Investment | 1,659 | 1,347 | 1,130 |
Interest Income Recognized | 109 | 158 | 73 |
Impaired financing receivable with allowance | Healthcare | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 10,868 | 10,868 | 0 |
Recorded Investment | 3,164 | 3,164 | 0 |
Partial Charge-Offs | 7,704 | 7,704 | 0 |
Allowance for Loan Losses Allocated | 495 | 495 | 0 |
Impaired Financing Receivable, Average Recorded Investment | 10,869 | 7,302 | 3,901 |
Interest Income Recognized | 0 | 0 | 0 |
Impaired financing receivable with allowance | Industrial | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 2,826 | 2,826 | 5,525 |
Recorded Investment | 2,826 | 2,826 | 4,238 |
Partial Charge-Offs | 0 | 0 | 1,287 |
Allowance for Loan Losses Allocated | 1,047 | 1,047 | 1,255 |
Impaired Financing Receivable, Average Recorded Investment | 3,078 | 3,611 | 2,443 |
Interest Income Recognized | 0 | 0 | 0 |
Impaired financing receivable with allowance | Multifamily | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 6,334 | 6,334 | 8,233 |
Recorded Investment | 5,944 | 5,944 | 7,249 |
Partial Charge-Offs | 390 | 390 | 984 |
Allowance for Loan Losses Allocated | 1,876 | 1,876 | 2,284 |
Impaired Financing Receivable, Average Recorded Investment | 6,408 | 6,642 | 5,847 |
Interest Income Recognized | 115 | 224 | 130 |
Impaired financing receivable with allowance | Retail | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 15,323 | 15,323 | 23,144 |
Recorded Investment | 13,031 | 13,031 | 17,257 |
Partial Charge-Offs | 2,292 | 2,292 | 5,887 |
Allowance for Loan Losses Allocated | 1,855 | 1,855 | 3,604 |
Impaired Financing Receivable, Average Recorded Investment | 13,778 | 13,572 | 10,058 |
Interest Income Recognized | 0 | 0 | 0 |
Impaired financing receivable with allowance | Office | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 3,607 | 3,607 | 1,706 |
Recorded Investment | 3,214 | 3,214 | 1,695 |
Partial Charge-Offs | 393 | 393 | 11 |
Allowance for Loan Losses Allocated | 1,047 | 1,047 | 522 |
Impaired Financing Receivable, Average Recorded Investment | 3,735 | 4,391 | 1,904 |
Interest Income Recognized | 0 | 0 | 0 |
Impaired financing receivable with allowance | Other | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 18,493 | 18,493 | 4,661 |
Recorded Investment | 18,280 | 18,280 | 4,577 |
Partial Charge-Offs | 213 | 213 | 84 |
Allowance for Loan Losses Allocated | 1,144 | 1,144 | 1,263 |
Impaired Financing Receivable, Average Recorded Investment | 19,790 | 11,104 | 6,082 |
Interest Income Recognized | 8 | 16 | 16 |
Impaired financing receivable with allowance | Residential real estate | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 12,690 | 12,690 | 10,565 |
Recorded Investment | 12,063 | 12,063 | 10,565 |
Partial Charge-Offs | 627 | 627 | 0 |
Allowance for Loan Losses Allocated | 3,033 | 3,033 | 2,858 |
Impaired Financing Receivable, Average Recorded Investment | 12,494 | 12,965 | 3,417 |
Interest Income Recognized | 0 | 0 | 0 |
Impaired financing receivable with allowance | Construction real estate | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 3,990 | 3,990 | 4,552 |
Recorded Investment | 1,622 | 1,622 | 2,167 |
Partial Charge-Offs | 2,368 | 2,368 | 2,385 |
Allowance for Loan Losses Allocated | 240 | 240 | 497 |
Impaired Financing Receivable, Average Recorded Investment | 1,736 | 1,938 | 3,775 |
Interest Income Recognized | 0 | 0 | 0 |
Impaired financing receivable with allowance | Indirect vehicle | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 138 | 138 | 0 |
Recorded Investment | 106 | 106 | 0 |
Partial Charge-Offs | 32 | 32 | 0 |
Allowance for Loan Losses Allocated | 0 | 0 | 0 |
Impaired Financing Receivable, Average Recorded Investment | 146 | 54 | 0 |
Interest Income Recognized | 0 | 0 | 0 |
Impaired financing receivable with allowance | Home equity lines | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 23,171 | 23,171 | 13,765 |
Recorded Investment | 22,701 | 22,701 | 13,763 |
Partial Charge-Offs | 470 | 470 | 2 |
Allowance for Loan Losses Allocated | 781 | 781 | 850 |
Impaired Financing Receivable, Average Recorded Investment | 23,558 | 24,341 | 4,800 |
Interest Income Recognized | 0 | 0 | 0 |
Impaired financing receivable with allowance | Other consumer | |||
Loans individually evaluated for impairment by class of loans | |||
Unpaid Principal Balance | 0 | 0 | 0 |
Recorded Investment | 0 | 0 | 0 |
Partial Charge-Offs | 0 | 0 | 0 |
Allowance for Loan Losses Allocated | 0 | 0 | 0 |
Impaired Financing Receivable, Average Recorded Investment | 0 | 0 | 0 |
Interest Income Recognized | $0 | $0 | $0 |
Loans_Details_4
Loans (Details 4) (USD $) | 3 Months Ended | 9 Months Ended | 12 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 9 Months Ended | 3 Months Ended | 3 Months Ended | 9 Months Ended | 9 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | |||||||||||||||||||||||||||||||
Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2012 | Dec. 31, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | |
note | loan | loan | loan | Performing | Performing | Performing | Performing | Non-performing | Non-performing | Non-performing | Non-performing | Commercial loans | Commercial loans | Commercial loans | Commercial loans collateralized by assignment of lease payments | Commercial loans collateralized by assignment of lease payments | Healthcare | Healthcare | Healthcare | Industrial | Industrial | Multifamily | Multifamily | Multifamily | Multifamily | Multifamily | Multifamily | Retail | Retail | Retail | Retail | Retail | Retail | Office | Other | Other | Other | Residential real estate | Residential real estate | Residential real estate | Residential real estate | Residential real estate | Residential real estate | Residential real estate | Residential real estate | Construction real estate | Indirect vehicle | Indirect vehicle | Indirect vehicle | Home equity lines | Home equity lines | Home equity lines | Home equity lines | Home equity lines | Home equity lines | Home equity lines | Home equity lines | Home equity lines | Other consumer | |
loan | loan | loan | loan | loan | loan | loan | loan | Non-performing | Non-performing | Non-performing | Non-performing | Non-performing | Non-performing | Performing | Performing | Non-performing | Non-performing | Non-performing | Performing | Non-performing | Non-performing | Non-performing | Non-performing | Non-performing | Non-performing | Performing | Performing | Performing | Non-performing | Non-performing | Non-performing | Non-performing | Non-performing | Non-performing | Performing | Performing | Performing | Performing | Non-performing | Non-performing | Non-performing | Non-performing | ||||||||||||||||||
loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | loan | ||||||||||||||||||||||||||
Restructured loans | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of separate notes restructured into A/B by the company | 2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Minimum period of sustained repayment required to return the note to accrual status (in months) | 6 months | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructured loans representing A/B structures | $3,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of A/B structures represented by restructured loans | 0 | 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of loans | 1 | 2 | 7 | 13 | 42 | 26 | 14 | 64 | 58 | 2 | 4 | 1 | 1 | 1 | 4 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 3 | 4 | 1 | 1 | 1 | 5 | 2 | 1 | 7 | 6 | 13 | 17 | 20 | 1 | 7 | 7 | 38 | 5 | 5 | 25 | 34 | ||||||||||||||||
Pre-Modification Recorded Investment | 202,000 | 114,000 | 401,000 | 2,178,000 | 7,208,000 | 4,709,000 | 924,000 | 13,163,000 | 7,684,000 | 1,251,000 | 292,000 | 202,000 | 3,164,000 | 3,164,000 | 2,570,000 | 601,000 | 155,000 | 436,000 | 623,000 | 149,000 | 236,000 | 205,000 | 202,000 | 862,000 | 923,000 | 84,000 | 157,000 | 95,000 | 854,000 | 808,000 | 394,000 | 173,000 | 1,149,000 | 637,000 | 113,000 | 127,000 | 19,000 | 401,000 | 723,000 | 6,009,000 | 397,000 | 347,000 | 3,333,000 | 5,324,000 | ||||||||||||||||
Post-Modification Recorded Investment | 202,000 | 114,000 | 325,000 | 2,178,000 | 7,132,000 | 4,685,000 | 704,000 | 13,139,000 | 7,023,000 | 1,251,000 | 292,000 | 202,000 | 3,164,000 | 3,164,000 | 2,570,000 | 601,000 | 155,000 | 436,000 | 623,000 | 149,000 | 236,000 | 205,000 | 202,000 | 862,000 | 923,000 | 84,000 | 157,000 | 95,000 | 854,000 | 808,000 | 394,000 | 68,000 | 1,149,000 | 401,000 | 89,000 | 103,000 | 19,000 | 325,000 | 723,000 | 5,933,000 | 397,000 | 232,000 | 3,333,000 | 4,899,000 | ||||||||||||||||
Charge-offs and Specific Reserves | 168,000 | 0 | 76,000 | 0 | 76,000 | 695,000 | 588,000 | 3,045,000 | 1,247,000 | 673,000 | 96,000 | 168,000 | 496,000 | 496,000 | 1,425,000 | 0 | 0 | 119,000 | 169,000 | 40,000 | 0 | 56,000 | 200,000 | 235,000 | 232,000 | 23,000 | 50,000 | 0 | 0 | 0 | 0 | 105,000 | 0 | 236,000 | 24,000 | 24,000 | 0 | 76,000 | 0 | 76,000 | 0 | 115,000 | 0 | 425,000 | ||||||||||||||||
Redefaulted loans | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Period past due of recorded redefaulted loans (in days) | 90 days | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Troubled Debt Restructuring Activity [Roll Forward] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Beginning balance | 21,256,000 | 28,418,000 | 1,251,000 | 0 | 3,164,000 | 2,570,000 | 1,224,000 | 862,000 | 0 | 84,000 | 2,004,000 | 0 | 127,000 | 4,055,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
Additions | 2,178,000 | 13,163,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Charge-offs | 0 | -3,127,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Principal payments, net | -883,000 | -8,008,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Removals | 0 | -565,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transfer to other real estate owned | 0 | -206,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transfer from/to performing | 8,458,000 | 1,098,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transfer from/to nonperforming | -1,098,000 | -8,458,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ending balance | $15,341,000 | $15,341,000 | $29,911,000 | $29,911,000 | $22,315,000 | $22,315,000 | $1,251,000 | $0 | $3,164,000 | $2,570,000 | $1,224,000 | $862,000 | $0 | $84,000 | $2,004,000 | $0 | $127,000 | $4,055,000 | $0 |
Loans_Details_5
Loans (Details 5) (USD $) | Sep. 30, 2013 |
In Thousands, unless otherwise specified | |
Activity in the allowance for loan losses, balance in allowance for loan losses and recorded investment in loans by portfolio segment and based on impairment method | |
Extended Maturity and Amortization and Reduction of Interest Rate | $3,464 |
Extended Maturity, Delay in Payments and Reduction of Interest Rate | 205 |
Extended Maturity and Reduction of Interest Rate | 2,318 |
Extended Maturity and Delay in Payments and Reduction of Amount | 3,164 |
Extended Maturity | 3,398 |
Delay in Payments or Reduction of Interest Rate | 2,792 |
Total | 15,341 |
Commercial loans | |
Activity in the allowance for loan losses, balance in allowance for loan losses and recorded investment in loans by portfolio segment and based on impairment method | |
Extended Maturity and Amortization and Reduction of Interest Rate | 42 |
Extended Maturity, Delay in Payments and Reduction of Interest Rate | 0 |
Extended Maturity and Reduction of Interest Rate | 1,209 |
Extended Maturity and Delay in Payments and Reduction of Amount | 0 |
Extended Maturity | 0 |
Delay in Payments or Reduction of Interest Rate | 0 |
Total | 1,251 |
Commercial loans collateralized by assignment of lease payments | |
Activity in the allowance for loan losses, balance in allowance for loan losses and recorded investment in loans by portfolio segment and based on impairment method | |
Extended Maturity and Amortization and Reduction of Interest Rate | 0 |
Extended Maturity, Delay in Payments and Reduction of Interest Rate | 0 |
Extended Maturity and Reduction of Interest Rate | 0 |
Extended Maturity and Delay in Payments and Reduction of Amount | 0 |
Extended Maturity | 0 |
Delay in Payments or Reduction of Interest Rate | 0 |
Total | 0 |
Healthcare | |
Activity in the allowance for loan losses, balance in allowance for loan losses and recorded investment in loans by portfolio segment and based on impairment method | |
Extended Maturity and Amortization and Reduction of Interest Rate | 0 |
Extended Maturity, Delay in Payments and Reduction of Interest Rate | 0 |
Extended Maturity and Reduction of Interest Rate | 0 |
Extended Maturity and Delay in Payments and Reduction of Amount | 3,164 |
Extended Maturity | 0 |
Delay in Payments or Reduction of Interest Rate | 0 |
Total | 3,164 |
Industrial | |
Activity in the allowance for loan losses, balance in allowance for loan losses and recorded investment in loans by portfolio segment and based on impairment method | |
Extended Maturity and Amortization and Reduction of Interest Rate | 0 |
Extended Maturity, Delay in Payments and Reduction of Interest Rate | 0 |
Extended Maturity and Reduction of Interest Rate | 0 |
Extended Maturity and Delay in Payments and Reduction of Amount | 0 |
Extended Maturity | 2,570 |
Delay in Payments or Reduction of Interest Rate | 0 |
Total | 2,570 |
Multifamily | |
Activity in the allowance for loan losses, balance in allowance for loan losses and recorded investment in loans by portfolio segment and based on impairment method | |
Extended Maturity and Amortization and Reduction of Interest Rate | 187 |
Extended Maturity, Delay in Payments and Reduction of Interest Rate | 0 |
Extended Maturity and Reduction of Interest Rate | 0 |
Extended Maturity and Delay in Payments and Reduction of Amount | 0 |
Extended Maturity | 601 |
Delay in Payments or Reduction of Interest Rate | 436 |
Total | 1,224 |
Retail | |
Activity in the allowance for loan losses, balance in allowance for loan losses and recorded investment in loans by portfolio segment and based on impairment method | |
Extended Maturity and Amortization and Reduction of Interest Rate | 256 |
Extended Maturity, Delay in Payments and Reduction of Interest Rate | 205 |
Extended Maturity and Reduction of Interest Rate | 401 |
Extended Maturity and Delay in Payments and Reduction of Amount | 0 |
Extended Maturity | 0 |
Delay in Payments or Reduction of Interest Rate | 0 |
Total | 862 |
Office | |
Activity in the allowance for loan losses, balance in allowance for loan losses and recorded investment in loans by portfolio segment and based on impairment method | |
Extended Maturity and Amortization and Reduction of Interest Rate | 0 |
Extended Maturity, Delay in Payments and Reduction of Interest Rate | 0 |
Extended Maturity and Reduction of Interest Rate | 0 |
Extended Maturity and Delay in Payments and Reduction of Amount | 0 |
Extended Maturity | 0 |
Delay in Payments or Reduction of Interest Rate | 0 |
Total | 0 |
Other | |
Activity in the allowance for loan losses, balance in allowance for loan losses and recorded investment in loans by portfolio segment and based on impairment method | |
Extended Maturity and Amortization and Reduction of Interest Rate | 84 |
Extended Maturity, Delay in Payments and Reduction of Interest Rate | 0 |
Extended Maturity and Reduction of Interest Rate | 0 |
Extended Maturity and Delay in Payments and Reduction of Amount | 0 |
Extended Maturity | 0 |
Delay in Payments or Reduction of Interest Rate | 0 |
Total | 84 |
Residential real estate | |
Activity in the allowance for loan losses, balance in allowance for loan losses and recorded investment in loans by portfolio segment and based on impairment method | |
Extended Maturity and Amortization and Reduction of Interest Rate | 1,386 |
Extended Maturity, Delay in Payments and Reduction of Interest Rate | 0 |
Extended Maturity and Reduction of Interest Rate | 0 |
Extended Maturity and Delay in Payments and Reduction of Amount | 0 |
Extended Maturity | 0 |
Delay in Payments or Reduction of Interest Rate | 618 |
Total | 2,004 |
Construction real estate | |
Activity in the allowance for loan losses, balance in allowance for loan losses and recorded investment in loans by portfolio segment and based on impairment method | |
Extended Maturity and Amortization and Reduction of Interest Rate | 0 |
Extended Maturity, Delay in Payments and Reduction of Interest Rate | 0 |
Extended Maturity and Reduction of Interest Rate | 0 |
Extended Maturity and Delay in Payments and Reduction of Amount | 0 |
Extended Maturity | 0 |
Delay in Payments or Reduction of Interest Rate | 0 |
Total | 0 |
Indirect vehicle | |
Activity in the allowance for loan losses, balance in allowance for loan losses and recorded investment in loans by portfolio segment and based on impairment method | |
Extended Maturity and Amortization and Reduction of Interest Rate | 0 |
Extended Maturity, Delay in Payments and Reduction of Interest Rate | 0 |
Extended Maturity and Reduction of Interest Rate | 0 |
Extended Maturity and Delay in Payments and Reduction of Amount | 0 |
Extended Maturity | 0 |
Delay in Payments or Reduction of Interest Rate | 127 |
Total | 127 |
Home equity lines | |
Activity in the allowance for loan losses, balance in allowance for loan losses and recorded investment in loans by portfolio segment and based on impairment method | |
Extended Maturity and Amortization and Reduction of Interest Rate | 1,509 |
Extended Maturity, Delay in Payments and Reduction of Interest Rate | 0 |
Extended Maturity and Reduction of Interest Rate | 708 |
Extended Maturity and Delay in Payments and Reduction of Amount | 0 |
Extended Maturity | 227 |
Delay in Payments or Reduction of Interest Rate | 1,611 |
Total | 4,055 |
Other consumer | |
Activity in the allowance for loan losses, balance in allowance for loan losses and recorded investment in loans by portfolio segment and based on impairment method | |
Extended Maturity and Amortization and Reduction of Interest Rate | 0 |
Extended Maturity, Delay in Payments and Reduction of Interest Rate | 0 |
Extended Maturity and Reduction of Interest Rate | 0 |
Extended Maturity and Delay in Payments and Reduction of Amount | 0 |
Extended Maturity | 0 |
Delay in Payments or Reduction of Interest Rate | 0 |
Total | $0 |
Loans_Details_6
Loans (Details 6) (USD $) | 3 Months Ended | 9 Months Ended | |||||||
Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Dec. 31, 2012 | |||||
Allowance for credit losses [Roll Forward] | |||||||||
Beginning Balance | $124,204,000 | ||||||||
Transfer to (from) allowance for unfunded credit commitments | 0 | -500,000 | -1,132,000 | ||||||
Allowance for unfunded credit commitments, ending balance | 1,694,000 | 3,744,000 | 1,694,000 | 3,744,000 | |||||
Allowance for credit losses, ending balance | 119,725,000 | 124,926,000 | 119,725,000 | 124,926,000 | |||||
Ending Balance | 118,031,000 | 118,031,000 | |||||||
Ending allowance balance attributable to loans: | |||||||||
Acquired and accounted for under ASC 310-30 | 2,857,000 | 2,546,000 | 2,857,000 | 2,546,000 | |||||
Loans: | |||||||||
Individually evaluated for impairment | 123,623,000 | 102,769,000 | 123,623,000 | 102,769,000 | |||||
Collectively evaluated for impairment | 5,171,109,000 | 5,003,052,000 | 5,171,109,000 | 5,003,052,000 | |||||
Acquired and accounted for under ASC 310-30 | 292,000,000 | 519,024,000 | 292,000,000 | 519,024,000 | |||||
Unfunded Commitments | |||||||||
Allowance for unfunded credit commitments, beginning balance | 1,812,000 | 7,084,000 | 4,075,000 | 9,177,000 | |||||
Transfer to (from) allowance for unfunded credit commitments | 0 | -500,000 | -1,132,000 | ||||||
Allowance for unfunded commitments, Provision | -118,000 | -3,340,000 | -1,881,000 | -4,301,000 | |||||
Unfunded commitments collectively evaluated for impairment | 1,037,000 | 2,018,000 | 1,037,000 | 2,018,000 | |||||
Individually evaluated for impairment for unfunded commitments | 657,000 | 1,726,000 | 657,000 | 1,726,000 | |||||
Allowance for unfunded credit commitments, ending balance | 1,694,000 | 3,744,000 | 1,694,000 | 3,744,000 | |||||
Allowance for credit losses | |||||||||
Allowance for loan losses and unfunded commitments charge offs | 5,155,000 | 5,588,000 | 17,068,000 | 23,681,000 | |||||
Allowance for loan losses and unfunded commitments recoveries | 2,687,000 | 14,674,000 | 11,318,000 | 22,532,000 | |||||
Allowance for loan losses and unfunded commitments provision | -3,304,000 | -13,000,000 | -2,804,000 | -9,900,000 | |||||
Allowance for credit losses, beginning balance | 125,497,000 | 128,840,000 | 128,279,000 | 135,975,000 | |||||
Allowance for credit losses, ending balance | 119,725,000 | 124,926,000 | 119,725,000 | 124,926,000 | |||||
Allowance for credit losses, individually evaluated for impairment | 16,849,000 | 13,026,000 | 16,849,000 | 13,026,000 | |||||
Allowance for credit losses, collectively evaluated for impairment | 100,019,000 | 109,354,000 | 100,019,000 | 109,354,000 | |||||
Total loans | 5,586,732,000 | 5,624,845,000 | 5,586,732,000 | 5,624,845,000 | 5,766,930,000 | ||||
Commercial loans | |||||||||
Allowance for credit losses [Roll Forward] | |||||||||
Beginning Balance | 27,277,000 | 20,789,000 | 24,943,000 | 21,106,000 | |||||
Transfer to (from) allowance for unfunded credit commitments | |||||||||
Charge-offs | 1,686,000 | 75,000 | 3,030,000 | 2,065,000 | |||||
Provision | -45,000 | 1,181,000 | 2,404,000 | 430,000 | |||||
Ending Balance | 26,125,000 | 22,201,000 | 26,125,000 | 22,201,000 | |||||
Ending allowance balance attributable to loans: | |||||||||
Individually evaluated for impairment | 4,389,000 | 2,570,000 | 4,389,000 | 2,570,000 | |||||
Collectively evaluated for impairment | 20,871,000 | 19,345,000 | 20,871,000 | 19,345,000 | |||||
Acquired and accounted for under ASC 310-30 | 865,000 | [1] | 286,000 | 865,000 | [1] | 286,000 | |||
Loans: | |||||||||
Individually evaluated for impairment | 19,836,000 | 21,537,000 | 19,836,000 | 21,537,000 | |||||
Collectively evaluated for impairment | 1,134,376,000 | 1,033,534,000 | 1,134,376,000 | 1,033,534,000 | |||||
Acquired and accounted for under ASC 310-30 | 35,649,000 | [1] | 78,275,000 | [1] | 35,649,000 | [1] | 78,275,000 | [1] | |
Unfunded Commitments | |||||||||
Transfer to (from) allowance for unfunded credit commitments | |||||||||
Allowance for credit losses | |||||||||
Financing receivable, allowance for credit losses, recovery | 579,000 | 306,000 | 1,808,000 | 2,730,000 | |||||
Total loans | 1,189,861,000 | 1,133,346,000 | 1,189,861,000 | 1,133,346,000 | |||||
Commercial loans collateralized by assignment of lease payments | |||||||||
Allowance for credit losses [Roll Forward] | |||||||||
Beginning Balance | 8,529,000 | 7,490,000 | 7,755,000 | 7,561,000 | |||||
Transfer to (from) allowance for unfunded credit commitments | |||||||||
Charge-offs | 0 | 0 | 1,720,000 | ||||||
Provision | 721,000 | -149,000 | 364,000 | 1,151,000 | |||||
Ending Balance | 9,250,000 | 7,452,000 | 9,250,000 | 7,452,000 | |||||
Ending allowance balance attributable to loans: | |||||||||
Individually evaluated for impairment | 285,000 | 180,000 | 285,000 | 180,000 | |||||
Collectively evaluated for impairment | 8,965,000 | 7,272,000 | 8,965,000 | 7,272,000 | |||||
Acquired and accounted for under ASC 310-30 | [1] | [1] | |||||||
Loans: | |||||||||
Individually evaluated for impairment | 2,330,000 | 1,168,000 | 2,330,000 | 1,168,000 | |||||
Collectively evaluated for impairment | 1,466,484,000 | 1,218,193,000 | 1,466,484,000 | 1,218,193,000 | |||||
Unfunded Commitments | |||||||||
Transfer to (from) allowance for unfunded credit commitments | |||||||||
Allowance for credit losses | |||||||||
Financing receivable, allowance for credit losses, recovery | 0 | 111,000 | 1,131,000 | 460,000 | |||||
Total loans | 1,468,814,000 | 1,219,361,000 | 1,468,814,000 | 1,219,361,000 | |||||
Commercial real estate | |||||||||
Allowance for credit losses [Roll Forward] | |||||||||
Beginning Balance | 60,014,000 | 68,713,000 | 61,056,000 | 68,695,000 | |||||
Transfer to (from) allowance for unfunded credit commitments | 0 | 0 | |||||||
Charge-offs | 1,236,000 | 2,994,000 | 5,131,000 | 8,412,000 | |||||
Provision | -3,983,000 | -12,253,000 | -5,517,000 | -10,040,000 | |||||
Ending Balance | 55,761,000 | 66,359,000 | 55,761,000 | 66,359,000 | |||||
Ending allowance balance attributable to loans: | |||||||||
Individually evaluated for impairment | 7,464,000 | 7,567,000 | 7,464,000 | 7,567,000 | |||||
Collectively evaluated for impairment | 46,412,000 | 56,851,000 | 46,412,000 | 56,851,000 | |||||
Acquired and accounted for under ASC 310-30 | 1,885,000 | [1] | 1,941,000 | [1] | 1,885,000 | [1] | 1,941,000 | [1] | |
Loans: | |||||||||
Individually evaluated for impairment | 60,600,000 | 56,037,000 | 60,600,000 | 56,037,000 | |||||
Collectively evaluated for impairment | 1,577,768,000 | 1,714,224,000 | 1,577,768,000 | 1,714,224,000 | |||||
Acquired and accounted for under ASC 310-30 | 159,799,000 | [1] | 269,348,000 | [1] | 159,799,000 | [1] | 269,348,000 | [1] | |
Unfunded Commitments | |||||||||
Transfer to (from) allowance for unfunded credit commitments | 0 | 0 | |||||||
Allowance for credit losses | |||||||||
Financing receivable, allowance for credit losses, recovery | 966,000 | 12,893,000 | 5,353,000 | 16,116,000 | |||||
Total loans | 1,798,167,000 | 2,039,609,000 | 1,798,167,000 | 2,039,609,000 | |||||
Allowance for loan losses and unfunded commitments acquired with deteriorated credit quality | 2,900,000 | 2,900,000 | 4,500,000 | ||||||
Residential real estate | |||||||||
Allowance for credit losses [Roll Forward] | |||||||||
Beginning Balance | 8,121,000 | 3,592,000 | 6,941,000 | 3,935,000 | |||||
Transfer to (from) allowance for unfunded credit commitments | |||||||||
Charge-offs | 713,000 | 474,000 | 2,074,000 | 1,876,000 | |||||
Provision | 347,000 | 738,000 | 2,475,000 | 1,575,000 | |||||
Ending Balance | 7,803,000 | 3,864,000 | 7,803,000 | 3,864,000 | |||||
Ending allowance balance attributable to loans: | |||||||||
Individually evaluated for impairment | 3,033,000 | 401,000 | 3,033,000 | 401,000 | |||||
Collectively evaluated for impairment | 4,663,000 | 3,144,000 | 4,663,000 | 3,144,000 | |||||
Acquired and accounted for under ASC 310-30 | 107,000 | [1] | 319,000 | [1] | 107,000 | [1] | 319,000 | [1] | |
Loans: | |||||||||
Individually evaluated for impairment | 15,851,000 | 11,127,000 | 15,851,000 | 11,127,000 | |||||
Collectively evaluated for impairment | 291,699,000 | 293,787,000 | 291,699,000 | 293,787,000 | |||||
Acquired and accounted for under ASC 310-30 | 5,982,000 | [1] | 7,116,000 | [1] | 5,982,000 | [1] | 7,116,000 | [1] | |
Unfunded Commitments | |||||||||
Transfer to (from) allowance for unfunded credit commitments | |||||||||
Allowance for credit losses | |||||||||
Financing receivable, allowance for credit losses, recovery | 48,000 | 8,000 | 461,000 | 230,000 | |||||
Total loans | 313,532,000 | 312,030,000 | 313,532,000 | 312,030,000 | |||||
Construction real estate | |||||||||
Allowance for credit losses [Roll Forward] | |||||||||
Beginning Balance | 8,695,000 | 10,586,000 | 11,222,000 | 15,639,000 | |||||
Transfer to (from) allowance for unfunded credit commitments | 0 | 500,000 | 1,132,000 | ||||||
Charge-offs | 26,000 | 71,000 | 855,000 | 3,951,000 | |||||
Provision | -735,000 | -393,000 | -3,340,000 | -3,404,000 | |||||
Ending Balance | 8,354,000 | 10,874,000 | 8,354,000 | 10,874,000 | |||||
Ending allowance balance attributable to loans: | |||||||||
Individually evaluated for impairment | 240,000 | 582,000 | 240,000 | 582,000 | |||||
Collectively evaluated for impairment | 8,114,000 | 10,292,000 | 8,114,000 | 10,292,000 | |||||
Acquired and accounted for under ASC 310-30 | [1] | [1] | |||||||
Loans: | |||||||||
Individually evaluated for impairment | 1,622,000 | 2,372,000 | 1,622,000 | 2,372,000 | |||||
Collectively evaluated for impairment | 134,524,000 | 147,500,000 | 134,524,000 | 147,500,000 | |||||
Acquired and accounted for under ASC 310-30 | 61,446,000 | [1] | 125,515,000 | [1] | 61,446,000 | [1] | 125,515,000 | [1] | |
Unfunded Commitments | |||||||||
Transfer to (from) allowance for unfunded credit commitments | 0 | 500,000 | 1,132,000 | ||||||
Allowance for credit losses | |||||||||
Financing receivable, allowance for credit losses, recovery | 420,000 | 752,000 | 827,000 | 1,458,000 | |||||
Total loans | 197,592,000 | 275,387,000 | 197,592,000 | 275,387,000 | |||||
Indirect vehicle | |||||||||
Allowance for credit losses [Roll Forward] | |||||||||
Beginning Balance | 1,537,000 | 1,941,000 | 1,324,000 | 1,834,000 | |||||
Transfer to (from) allowance for unfunded credit commitments | |||||||||
Charge-offs | 572,000 | 433,000 | 1,930,000 | 1,636,000 | |||||
Provision | 293,000 | 288,000 | 1,125,000 | 987,000 | |||||
Ending Balance | 1,630,000 | 2,020,000 | 1,630,000 | 2,020,000 | |||||
Ending allowance balance attributable to loans: | |||||||||
Individually evaluated for impairment | 0 | 0 | |||||||
Collectively evaluated for impairment | 1,630,000 | 2,020,000 | 1,630,000 | 2,020,000 | |||||
Acquired and accounted for under ASC 310-30 | [1] | [1] | |||||||
Loans: | |||||||||
Individually evaluated for impairment | 106,000 | 106,000 | |||||||
Collectively evaluated for impairment | 257,634,000 | 206,973,000 | 257,634,000 | 206,973,000 | |||||
Unfunded Commitments | |||||||||
Transfer to (from) allowance for unfunded credit commitments | |||||||||
Allowance for credit losses | |||||||||
Financing receivable, allowance for credit losses, recovery | 372,000 | 224,000 | 1,111,000 | 835,000 | |||||
Total loans | 257,740,000 | 206,973,000 | 257,740,000 | 206,973,000 | |||||
Home equity lines | |||||||||
Allowance for credit losses [Roll Forward] | |||||||||
Beginning Balance | 8,206,000 | 7,617,000 | 9,401,000 | 7,333,000 | |||||
Transfer to (from) allowance for unfunded credit commitments | |||||||||
Charge-offs | 437,000 | 1,209,000 | 2,547,000 | 3,157,000 | |||||
Provision | -152,000 | 370,000 | 549,000 | 2,482,000 | |||||
Ending Balance | 7,845,000 | 7,081,000 | 7,845,000 | 7,081,000 | |||||
Ending allowance balance attributable to loans: | |||||||||
Individually evaluated for impairment | 781,000 | 0 | 781,000 | 0 | |||||
Collectively evaluated for impairment | 7,064,000 | 7,081,000 | 7,064,000 | 7,081,000 | |||||
Acquired and accounted for under ASC 310-30 | [1] | [1] | |||||||
Loans: | |||||||||
Individually evaluated for impairment | 23,278,000 | 10,280,000 | 23,278,000 | 10,280,000 | |||||
Collectively evaluated for impairment | 251,206,000 | 304,438,000 | 251,206,000 | 304,438,000 | |||||
Acquired and accounted for under ASC 310-30 | 110,000 | [1] | 568,000 | [1] | 110,000 | [1] | 568,000 | [1] | |
Unfunded Commitments | |||||||||
Transfer to (from) allowance for unfunded credit commitments | |||||||||
Allowance for credit losses | |||||||||
Financing receivable, allowance for credit losses, recovery | 228,000 | 303,000 | 442,000 | 423,000 | |||||
Total loans | 274,594,000 | 315,286,000 | 274,594,000 | 315,286,000 | |||||
Other consumer | |||||||||
Allowance for credit losses [Roll Forward] | |||||||||
Beginning Balance | 1,306,000 | 1,028,000 | 1,562,000 | 695,000 | |||||
Transfer to (from) allowance for unfunded credit commitments | |||||||||
Charge-offs | 485,000 | 332,000 | 1,501,000 | 864,000 | |||||
Provision | 368,000 | 558,000 | 1,017,000 | 1,220,000 | |||||
Allowance for unfunded credit commitments, ending balance | 3,744,000 | 3,744,000 | |||||||
Ending Balance | 1,263,000 | 1,331,000 | 1,263,000 | 1,331,000 | |||||
Ending allowance balance attributable to loans: | |||||||||
Individually evaluated for impairment | 0 | 0 | |||||||
Collectively evaluated for impairment | 1,263,000 | 1,331,000 | 1,263,000 | 1,331,000 | |||||
Acquired and accounted for under ASC 310-30 | [1] | [1] | |||||||
Loans: | |||||||||
Individually evaluated for impairment | 0 | 248,000 | 0 | 248,000 | |||||
Collectively evaluated for impairment | 57,418,000 | 84,403,000 | 57,418,000 | 84,403,000 | |||||
Acquired and accounted for under ASC 310-30 | 29,014,000 | [1] | 38,202,000 | [1] | 29,014,000 | [1] | 38,202,000 | [1] | |
Unfunded Commitments | |||||||||
Transfer to (from) allowance for unfunded credit commitments | |||||||||
Allowance for unfunded credit commitments, ending balance | 3,744,000 | 3,744,000 | |||||||
Allowance for credit losses | |||||||||
Financing receivable, allowance for credit losses, recovery | 74,000 | 77,000 | 185,000 | 280,000 | |||||
Total loans | 86,432,000 | 122,853,000 | 86,432,000 | 122,853,000 | |||||
Purchased loans | |||||||||
Allowance for credit losses [Roll Forward] | |||||||||
Provision | -1,500,000 | -2,500,000 | |||||||
Allowance for credit losses | |||||||||
Provision and charge-offs related to the number of pools | 15 | ||||||||
Allowance for loan losses and unfunded commitments write offs net of recoveries | -677,000 | -830,000 | |||||||
Total loans | $219,100,000 | $219,100,000 | |||||||
[1] | Loans acquired in FDIC-assisted transactions and accounted for under ASC Subtopic 310-30 “Receivables — Loans and Debt Securities Acquired with Deteriorated Credit Quality.†|
Loans_Details_7
Loans (Details 7) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Changes in the accretable yield for purchased credit-impaired loans | ||||
Balance at beginning of period | $6,360 | $9,411 | $5,685 | $18,703 |
Accretion | -2,427 | -3,406 | -2,859 | -12,812 |
Other | 0 | 403 | 1,107 | 517 |
Balance at end of period | $3,933 | $6,408 | $3,933 | $6,408 |
Loans_Details_8
Loans (Details 8) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 | |
Purchased credit-impaired loans and non-credit-impaired loans | |||
Covered loans | $273,497,000 | $449,850,000 | |
Estimated receivable amount from the FDIC under the loss-share agreement | 10,049,000 | ||
Non covered loans | 18,503,000 | ||
Outstanding balances on purchased loans from the FDIC | 305,000,000 | 515,700,000 | |
Carrying amount on loans purchased from the FDIC | 292,000,000 | 471,600,000 | |
Purchased Credit Impaired Loans Receivable | |||
Purchased credit-impaired loans and non-credit-impaired loans | |||
Covered loans | 130,589,000 | ||
Estimated receivable amount from the FDIC under the loss-share agreement | 36,000 | [1] | |
Non covered loans | 4,446,000 | ||
Purchased Non-Credit Impaired Loans Receivable | |||
Purchased credit-impaired loans and non-credit-impaired loans | |||
Covered loans | 142,908,000 | ||
Estimated receivable amount from the FDIC under the loss-share agreement | 10,013,000 | [1] | |
Non covered loans | 14,057,000 | ||
Commercial related | |||
Purchased credit-impaired loans and non-credit-impaired loans | |||
Covered loans | 16,868,000 | ||
Non covered loans | 14,797,000 | ||
Commercial related | Purchased Credit Impaired Loans Receivable | |||
Purchased credit-impaired loans and non-credit-impaired loans | |||
Reimbursable Amount Covered Other Real Estate Owned | 1,000,000 | ||
Covered loans | 11,130,000 | [2] | |
Non covered loans | 4,357,000 | [3] | |
Commercial related | Purchased Non-Credit Impaired Loans Receivable | |||
Purchased credit-impaired loans and non-credit-impaired loans | |||
Covered loans | 5,738,000 | [2] | |
Non covered loans | 10,440,000 | [3] | |
Commercial loans | |||
Purchased credit-impaired loans and non-credit-impaired loans | |||
Covered loans | 3,984,000 | ||
Commercial loans | Purchased Credit Impaired Loans Receivable | |||
Purchased credit-impaired loans and non-credit-impaired loans | |||
Covered loans | 457,000 | ||
Commercial loans | Purchased Non-Credit Impaired Loans Receivable | |||
Purchased credit-impaired loans and non-credit-impaired loans | |||
Covered loans | 3,527,000 | ||
Commercial real estate | |||
Purchased credit-impaired loans and non-credit-impaired loans | |||
Covered loans | 159,799,000 | ||
Commercial real estate | Purchased Credit Impaired Loans Receivable | |||
Purchased credit-impaired loans and non-credit-impaired loans | |||
Covered loans | 62,576,000 | ||
Commercial real estate | Purchased Non-Credit Impaired Loans Receivable | |||
Purchased credit-impaired loans and non-credit-impaired loans | |||
Covered loans | 97,223,000 | ||
Construction real estate | |||
Purchased credit-impaired loans and non-credit-impaired loans | |||
Covered loans | 61,446,000 | ||
Construction real estate | Purchased Credit Impaired Loans Receivable | |||
Purchased credit-impaired loans and non-credit-impaired loans | |||
Covered loans | 53,444,000 | ||
Construction real estate | Purchased Non-Credit Impaired Loans Receivable | |||
Purchased credit-impaired loans and non-credit-impaired loans | |||
Covered loans | 8,002,000 | ||
Other | |||
Purchased credit-impaired loans and non-credit-impaired loans | |||
Covered loans | 31,400,000 | ||
Non covered loans | 3,706,000 | ||
Other | Purchased Credit Impaired Loans Receivable | |||
Purchased credit-impaired loans and non-credit-impaired loans | |||
Covered loans | 2,982,000 | ||
Non covered loans | 89,000 | ||
Other | Purchased Non-Credit Impaired Loans Receivable | |||
Purchased credit-impaired loans and non-credit-impaired loans | |||
Covered loans | 28,418,000 | ||
Non covered loans | $3,617,000 | ||
[1] | Estimated reimbursable amounts from the FDIC under the loss-share agreement exclude $1.0 million in reimbursable amounts related to covered other real estate owned. | ||
[2] | Covered commercial related loans include commercial, commercial real estate and construction real estate loans acquired in connection with the Heritage and Benchmark FDIC-assisted transactions. | ||
[3] | Non covered commercial related loans include commercial, commercial real estate and construction real estate for InBank. |
Goodwill_and_Intangibles_Detai
Goodwill and Intangibles (Details) (USD $) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Dec. 31, 2012 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |||||
Goodwill, impairment loss | $0 | $0 | |||
Carrying amount of goodwill | 423,369,000 | 423,369,000 | 423,369,000 | ||
Weighted average amortization period (in years) | 4 | ||||
Changes in the carrying amount of core deposit and client relationship intangibles | |||||
Balance at beginning of period | 29,512,000 | ||||
Amortization expense | -1,513,000 | -1,251,000 | -4,595,000 | -3,759,000 | |
Balance at end of period | 24,917,000 | 24,917,000 | |||
Gross carrying amount | 61,429,000 | 61,429,000 | |||
Accumulated amortization | -36,512,000 | -36,512,000 | |||
Net book value | 24,917,000 | 24,917,000 | |||
Estimated future amortization expense | |||||
2013 | 1,489,000 | 1,489,000 | |||
2014 | 4,748,000 | 4,748,000 | |||
2015 | 4,030,000 | 4,030,000 | |||
2016 | 3,418,000 | 3,418,000 | |||
2017 | 3,071,000 | 3,071,000 | |||
Thereafter | 8,161,000 | 8,161,000 | |||
Total estimated future amortization expense | $24,917,000 | $24,917,000 |
Deposits_Details
Deposits (Details) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
Deposits, by Type [Abstract] | ||
Demand deposit accounts, noninterest bearing | $2,269,367,000 | $2,164,547,000 |
NOW and money market accounts | 2,680,127,000 | 2,747,273,000 |
Savings accounts | 843,671,000 | 811,333,000 |
Certificates of deposit, $100,000 or more | 838,606,000 | 1,020,033,000 |
Other certificates of deposit | 666,915,000 | 799,511,000 |
Total | 7,298,686,000 | 7,542,697,000 |
Brokered deposits | $238,500,000 | $294,200,000 |
ShortTerm_Borrowings_Details
Short-Term Borrowings (Details) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2013 | Sep. 30, 2013 |
Customer repurchase agreements | Customer repurchase agreements | Federal Home Loan Bank advances | Federal Home Loan Bank advances | Line of credit | Libor [Member] | |||
Line of credit | ||||||||
Short-term borrowings | ||||||||
Weighted Average Cost | 0.22% | 0.42% | 0.22% | 0.23% | 0.00% | 3.58% | ||
Amount | $240,600,000 | $220,602,000 | $240,600,000 | $208,242,000 | $0 | $12,360,000 | ||
Fixed interest rate Federal Home Loan Bank advances | 12,400,000 | |||||||
Unsecured Line of Credit | $35,000,000 | |||||||
Description of interest rate basis | one month LIBOR | |||||||
Debt Instrument, Basis Spread on Variable Rate | 2.00% |
Longterm_Borrowings_Details
Long-term Borrowings (Details) (USD $) | 9 Months Ended | |
Sep. 30, 2013 | Dec. 31, 2012 | |
Long-term borrowings | ||
Federal Home Loan Bank advances | $4,300,000 | $4,300,000 |
Effective interest rates on Federal Home Loan Bank advances, low end of range (as a percent) | 3.23% | |
Effective interest rates on Federal Home Loan Bank advances, high end of range (as a percent) | 5.87% | |
Loans pledged as collateral for long-term Federal Home Loan Bank advances | 7,300,000 | 28,400,000 |
Investment securities pledged as collateral for long-term Federal Home Loan Bank advances | 29,200,000 | 32,100,000 |
Principal payments due on long-term borrowings | ||
Long-term Debt | 62,428,000 | 116,050,000 |
Notes payable to banks | ||
Long-term borrowings | ||
Minimum interest rates (as a percent) | 2.50% | |
Maximum interest rates (as a percent) | 12.00% | |
Equipment pledged as collateral | 25,900,000 | 29,700,000 |
Principal payments due on long-term borrowings | ||
Long-term Debt | 17,700,000 | 21,100,000 |
Structured repurchase agreement | ||
Long-term borrowings | ||
Term of structured repurchase agreement (in years) | 10 years | |
Fixed interest rate, if option not exercised (as a percent) | 4.75% | |
Principal payments due on long-term borrowings | ||
Long-term Debt | 40,000,000 | |
Subordinated debt facility | ||
Principal payments due on long-term borrowings | ||
Long-term Debt | $50,000,000 | |
Description of interest rate basis | 3-month LIBOR | |
Interest rate, basis spread (as a percent) | 1.70% | |
Minimum | ||
Long-term borrowings | ||
Percentage of collateral pledge of first mortgage loans as per agreement | 133.00% | |
Percentage of collateral pledge of home equity loans as per agreement | 250.00% |
Junior_Subordinated_Notes_Issu2
Junior Subordinated Notes Issued to Capital Trusts (Details) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 |
In Thousands, unless otherwise specified | Junior Subordinated Notes | Coal City Capital Trust I | MB Financial Capital Trust II | MB Financial Capital Trust III | MB Financial Capital Trust IV | MB Financial Capital Trust V | MB Financial Capital Trust VI | FOBB Statutory Trust III | ||
Maximum | Junior Subordinated Notes | Junior Subordinated Notes | Junior Subordinated Notes | Junior Subordinated Notes | Junior Subordinated Notes | Junior Subordinated Notes | Junior Subordinated Notes | |||
Outstanding junior subordinated notes | ||||||||||
Principal balance | $152,065 | $152,065 | $25,774 | $36,083 | $10,310 | $20,619 | $30,928 | $23,196 | $5,155 | |
Debt Instrument, Basis Spread on Variable Rate | 1.80% | 1.40% | 1.50% | 1.52% | 1.30% | 1.30% | 2.80% | |||
Description of annual interest rate basis | 3-mo LIBOR | 3-mo LIBOR | 3-mo LIBOR | 3-mo LIBOR | 3-mo LIBOR | 3-mo LIBOR | 3-mo LIBOR | |||
Period for deferment of payment of interest on notes (in years) | 5 years |
Junior_Subordinated_Notes_Issu3
Junior Subordinated Notes Issued to Capital Trusts (Details 2) (Trust preferred securities issued by each trust, USD $) | 3 Months Ended |
In Thousands, unless otherwise specified | Sep. 30, 2013 |
Coal City Capital Trust I | |
Trust preferred securities issued by each trust | |
Debt Instrument, Basis Spread on Variable Rate | 1.80% |
Description of annual interest rate basis | 3-mo LIBOR |
Face Value | $25,000 |
MB Financial Capital Trust II | |
Trust preferred securities issued by each trust | |
Debt Instrument, Basis Spread on Variable Rate | 1.40% |
Description of annual interest rate basis | 3-mo LIBOR |
Face Value | 35,000 |
MB Financial Capital Trust III | |
Trust preferred securities issued by each trust | |
Debt Instrument, Basis Spread on Variable Rate | 1.50% |
Description of annual interest rate basis | 3-mo LIBOR |
Face Value | 10,000 |
MB Financial Capital Trust IV | |
Trust preferred securities issued by each trust | |
Debt Instrument, Basis Spread on Variable Rate | 1.52% |
Description of annual interest rate basis | 3-mo LIBOR |
Face Value | 20,000 |
MB Financial Capital Trust V | |
Trust preferred securities issued by each trust | |
Debt Instrument, Basis Spread on Variable Rate | 1.30% |
Description of annual interest rate basis | 3-mo LIBOR |
Face Value | 30,000 |
MB Financial Capital Trust VI | |
Trust preferred securities issued by each trust | |
Debt Instrument, Basis Spread on Variable Rate | 1.30% |
Description of annual interest rate basis | 3-mo LIBOR |
Face Value | 22,500 |
FOBB Statutory Trust III | |
Trust preferred securities issued by each trust | |
Debt Instrument, Basis Spread on Variable Rate | 2.80% |
Description of annual interest rate basis | 3-mo LIBOR |
Face Value | $5,000 |
Commitments_and_Contingencies_1
Commitments and Contingencies (Details) (USD $) | 3 Months Ended | 9 Months Ended | |
Sep. 30, 2013 | Sep. 30, 2013 | Dec. 31, 2012 | |
Commitments [Abstract] | |||
Maximum maturity period for letters of credit (in years) | 5 years | ||
Increase (decrease) in maximum potential amount of future payments under letters of credit | $6,700,000 | ||
Dollar amount of letters of credit outstanding | 73,400,000 | 73,400,000 | 66,700,000 |
Letters of credit issued or renewed | 52,600,000 | ||
Capital expenditure commitments outstanding | 1,400,000 | ||
Home equity lines | |||
Commitments and contingencies | |||
Dollar amount of line of credit outstanding | 216,992,000 | 216,992,000 | 239,771,000 |
Other commitments | |||
Commitments and contingencies | |||
Dollar amount of line of credit outstanding | 1,139,255,000 | 1,139,255,000 | 911,166,000 |
Standby | |||
Commitments and contingencies | |||
Dollar amount of line of credit outstanding | 70,720,000 | 70,720,000 | 66,247,000 |
Commercial | |||
Commitments and contingencies | |||
Dollar amount of line of credit outstanding | $2,705,000 | $2,705,000 | $465,000 |
Commitments_and_Contingencies_2
Commitments and Contingencies (Details 2) (States and political subdivisions, State of Illinois) | 9 Months Ended |
Sep. 30, 2013 | |
States and political subdivisions | State of Illinois | |
Concentrations of credit risk | |
Percentage of investments issued by states and political subdivisions that were within the state of Illinois | 27.00% |
Fair_Value_Measurements_Detail
Fair Value Measurements (Details) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 | ||
In Thousands, unless otherwise specified | ||||
Financial assets and financial liabilities measured at fair value on a recurring basis | ||||
Loans held for sale | $1,120 | $7,492 | ||
Derivative financial instruments, assets | 3,550 | 236 | ||
Derivative financial instrument, liabilities | 15,522 | 28,830 | ||
Recurring basis | Total Fair Value | ||||
Financial assets and financial liabilities measured at fair value on a recurring basis | ||||
Loans held for sale | 1,120 | 7,492 | ||
Assets held in trust for deferred compensation | 10,077 | 7,746 | ||
Derivative financial instruments, assets | 19,112 | 29,096 | ||
Other liabilities | 9,892 | 7,746 | ||
Derivative financial instrument, liabilities | 19,060 | 29,055 | ||
Recurring basis | Total Fair Value | U.S. Government sponsored agencies and enterprises | ||||
Financial assets and financial liabilities measured at fair value on a recurring basis | ||||
Securities available for sale | 52,527 | 41,315 | ||
Recurring basis | Total Fair Value | States and political subdivisions | ||||
Financial assets and financial liabilities measured at fair value on a recurring basis | ||||
Securities available for sale | 19,312 | 725,019 | ||
Recurring basis | Total Fair Value | Residential mortgage-backed securities | ||||
Financial assets and financial liabilities measured at fair value on a recurring basis | ||||
Securities available for sale | 691,276 | 939,202 | ||
Recurring basis | Total Fair Value | Commercial mortgage-backed securities | ||||
Financial assets and financial liabilities measured at fair value on a recurring basis | ||||
Securities available for sale | 53,446 | 54,126 | ||
Recurring basis | Total Fair Value | Corporate bonds | ||||
Financial assets and financial liabilities measured at fair value on a recurring basis | ||||
Securities available for sale | 263,021 | 96,674 | ||
Recurring basis | Total Fair Value | Equity securities | ||||
Financial assets and financial liabilities measured at fair value on a recurring basis | ||||
Securities available for sale | 10,541 | 11,835 | ||
Recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||
Financial assets and financial liabilities measured at fair value on a recurring basis | ||||
Securities available for sale | 10,541 | 11,835 | ||
Loans held for sale | 0 | 0 | ||
Assets held in trust for deferred compensation | 10,077 | 7,746 | ||
Derivative financial instruments, assets | 0 | 0 | ||
Other liabilities | 9,892 | [1] | 7,746 | [1] |
Derivative financial instrument, liabilities | 0 | 0 | ||
Recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | Equity securities | ||||
Financial assets and financial liabilities measured at fair value on a recurring basis | ||||
Securities available for sale | 10,541 | 11,835 | ||
Recurring basis | Significant Other Observable Inputs (Level 2) | ||||
Financial assets and financial liabilities measured at fair value on a recurring basis | ||||
Securities available for sale | 1,073,688 | 1,850,265 | ||
Loans held for sale | 1,120 | 7,492 | ||
Derivative financial instruments, assets | 19,112 | 29,096 | ||
Derivative financial instrument, liabilities | 19,060 | 29,055 | ||
Recurring basis | Significant Other Observable Inputs (Level 2) | U.S. Government sponsored agencies and enterprises | ||||
Financial assets and financial liabilities measured at fair value on a recurring basis | ||||
Securities available for sale | 52,527 | 41,315 | ||
Recurring basis | Significant Other Observable Inputs (Level 2) | States and political subdivisions | ||||
Financial assets and financial liabilities measured at fair value on a recurring basis | ||||
Securities available for sale | 19,312 | 725,019 | ||
Recurring basis | Significant Other Observable Inputs (Level 2) | Residential mortgage-backed securities | ||||
Financial assets and financial liabilities measured at fair value on a recurring basis | ||||
Securities available for sale | 690,546 | 938,354 | ||
Recurring basis | Significant Other Observable Inputs (Level 2) | Commercial mortgage-backed securities | ||||
Financial assets and financial liabilities measured at fair value on a recurring basis | ||||
Securities available for sale | 53,446 | 54,126 | ||
Recurring basis | Significant Other Observable Inputs (Level 2) | Corporate bonds | ||||
Financial assets and financial liabilities measured at fair value on a recurring basis | ||||
Securities available for sale | 257,857 | 91,451 | ||
Recurring basis | Significant Unobservable Inputs (Level 3) | ||||
Financial assets and financial liabilities measured at fair value on a recurring basis | ||||
Securities available for sale | 5,894 | 6,071 | ||
Loans held for sale | 0 | 0 | ||
Derivative financial instruments, assets | 0 | 0 | ||
Derivative financial instrument, liabilities | 0 | 0 | ||
Recurring basis | Significant Unobservable Inputs (Level 3) | Residential mortgage-backed securities | ||||
Financial assets and financial liabilities measured at fair value on a recurring basis | ||||
Securities available for sale | 730 | 848 | ||
Recurring basis | Significant Unobservable Inputs (Level 3) | Corporate bonds | ||||
Financial assets and financial liabilities measured at fair value on a recurring basis | ||||
Securities available for sale | $5,164 | $5,223 | ||
[1] | Liabilities associated with assets held in trust for deferred compensation |
Fair_Value_Measurements_Detail1
Fair Value Measurements (Details 2) (USD $) | 3 Months Ended | 9 Months Ended | 9 Months Ended | 9 Months Ended | ||||||||||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Dec. 31, 2012 | Sep. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 |
Significant Unobservable Inputs (Level 3) | Significant Unobservable Inputs (Level 3) | Significant Unobservable Inputs (Level 3) | Significant Unobservable Inputs (Level 3) | Significant Unobservable Inputs (Level 3) | Significant Unobservable Inputs (Level 3) | Significant Unobservable Inputs (Level 3) | Significant Unobservable Inputs (Level 3) | Significant Unobservable Inputs (Level 3) | Significant Unobservable Inputs (Level 3) | Significant Unobservable Inputs (Level 3) | ||||
Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Nonrecurring basis | Nonrecurring basis | ||||
Residential mortgage-backed securities | Residential mortgage-backed securities | Corporate bonds | Corporate bonds | Minimum | Maximum | Minimum | Maximum | |||||||
Residential mortgage-backed securities | Residential mortgage-backed securities | |||||||||||||
Assets measured at fair value on a nonrecurring basis | ||||||||||||||
Constant prepayment rates (as a percent) | 1.00% | 3.00% | ||||||||||||
Credit assumption (as a percent) | 20.00% | |||||||||||||
Appraisal adjustment impaired loans (as a percent) | 5.00% | 10.00% | ||||||||||||
Appraisal adjustment foreclosed assets (as a percent) | 5.00% | 10.00% | ||||||||||||
Securities available for sale | $5,894 | $6,071 | $730 | $848 | $5,164 | $5,223 | ||||||||
Financial assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) | ||||||||||||||
Balance at the beginning of the period | 6,071 | 6,992 | ||||||||||||
Other comprehensive income | -59 | 89 | ||||||||||||
Principal payments | -118 | -846 | ||||||||||||
Impairment Charge | 0 | -117 | ||||||||||||
Balance at the end of the period | $5,894 | $5,894 | $6,118 | |||||||||||
Fair value assumption, allowance for impaired real estate loans percentage | 85.00% |
Fair_Value_Measurements_Detail2
Fair Value Measurements (Details 3) (Nonrecurring basis, USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Total Fair Value | ||
Financial Assets: | ||
Impaired loans | $84,500 | $62,258 |
Foreclosed assets | 57,009 | 60,228 |
Non-financial long-lived assets | 2,314 | |
Significant Unobservable Inputs (Level 3) | ||
Financial Assets: | ||
Impaired loans | 84,500 | 62,258 |
Foreclosed assets | 57,009 | 60,228 |
Non-financial long-lived assets | $2,314 |
Fair_Value_Measurements_Detail3
Fair Value Measurements (Details 4) (USD $) | 9 Months Ended | |
In Thousands, unless otherwise specified | Sep. 30, 2013 | Dec. 31, 2012 |
Fair Value Disclosures [Abstract] | ||
Maximum maturity period of short-term borrowings where carrying value approximates fair value (in days) | 90 days | |
Minimum maturity period of short-term borrowings where fair value is based on discounted value of conctractual cash flows (in days) | 90 days | |
Financial Assets: | ||
Cash and due from banks | $215,017 | $176,010 |
Interest bearing deposits with banks | 41,700 | 111,533 |
Securities available for sale, at fair value | 1,090,123 | 1,868,171 |
Investment securities held to maturity | 1,193,544 | 493,421 |
Investment securities held to maturity | 1,212,748 | 535,681 |
Non-marketable securities - FHLB and FRB stock | 50,870 | 55,385 |
Loans held for sale | 1,120 | 7,492 |
Loans, net | 5,468,701 | 5,642,726 |
Derivative financial instruments | 3,550 | 236 |
Financial Liabilities: | ||
Non-interest bearing deposits | 2,269,367 | 2,164,547 |
Interest bearing deposits | 5,029,319 | 5,378,150 |
Short-term borrowings | 240,600 | 220,602 |
Long-term borrowings | 62,428 | 116,050 |
Junior subordinated notes issued to capital trusts | 152,065 | 152,065 |
Derivative financial instruments | 15,522 | 28,830 |
Carrying Amount | ||
Financial Assets: | ||
Cash and due from banks | 215,017 | 176,010 |
Interest bearing deposits with banks | 41,700 | 111,533 |
Securities available for sale, at fair value | 1,090,123 | |
Securities available for sale | 1,868,171 | |
Investment securities held to maturity | 1,193,544 | |
Investment securities held to maturity | 493,421 | |
Non-marketable securities - FHLB and FRB stock | 50,870 | 55,385 |
Loans held for sale | 1,120 | 7,492 |
Loans, net | 5,468,701 | |
Loans, net | 5,642,726 | |
Accrued interest receivable | 35,938 | 36,040 |
Derivative financial instruments | 19,112 | 29,096 |
Financial Liabilities: | ||
Non-interest bearing deposits | 2,269,367 | 2,164,547 |
Interest bearing deposits | 5,029,319 | 5,378,150 |
Short-term borrowings | 240,600 | 220,602 |
Long-term borrowings | 62,428 | |
Long-term borrowings | 116,050 | |
Junior subordinated notes issued to capital trusts | 152,065 | 152,065 |
Accrued interest payable | 1,908 | 2,828 |
Derivative financial instruments | 19,060 | 29,055 |
Total Fair Value | ||
Financial Assets: | ||
Cash and due from banks | 215,017 | 176,010 |
Interest bearing deposits with banks | 41,700 | 111,533 |
Securities available for sale | 1,090,123 | 1,868,171 |
Investment securities held to maturity | 1,212,748 | 535,681 |
Non-marketable securities - FHLB and FRB stock | 50,870 | 55,385 |
Loans held for sale | 1,120 | 7,492 |
Loans, net | 5,470,567 | 5,659,598 |
Accrued interest receivable | 35,938 | 36,040 |
Derivative financial instruments | 19,112 | 29,096 |
Financial Liabilities: | ||
Non-interest bearing deposits | 2,269,367 | 2,164,547 |
Interest bearing deposits | 5,039,175 | 5,399,709 |
Short-term borrowings | 240,595 | 220,683 |
Long-term borrowings | 67,425 | 117,809 |
Junior subordinated notes issued to capital trusts | 105,967 | 104,009 |
Accrued interest payable | 1,908 | 2,828 |
Derivative financial instruments | 19,060 | 29,055 |
Recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Financial Assets: | ||
Cash and due from banks | 215,017 | 176,010 |
Interest bearing deposits with banks | 41,700 | 111,533 |
Securities available for sale | 10,541 | 11,835 |
Investment securities held to maturity | 0 | 0 |
Non-marketable securities - FHLB and FRB stock | 0 | 0 |
Loans held for sale | 0 | 0 |
Loans, net | 0 | 0 |
Accrued interest receivable | 35,938 | 36,040 |
Derivative financial instruments | 0 | 0 |
Financial Liabilities: | ||
Non-interest bearing deposits | 2,269,367 | 2,164,547 |
Interest bearing deposits | 0 | 0 |
Short-term borrowings | 0 | 0 |
Long-term borrowings | 0 | 0 |
Junior subordinated notes issued to capital trusts | 0 | 0 |
Accrued interest payable | 1,908 | 2,828 |
Derivative financial instruments | 0 | 0 |
Recurring basis | Significant Other Observable Inputs (Level 2) | ||
Financial Assets: | ||
Cash and due from banks | 0 | 0 |
Interest bearing deposits with banks | 0 | 0 |
Securities available for sale | 1,073,688 | 1,850,265 |
Investment securities held to maturity | 1,212,748 | 535,681 |
Non-marketable securities - FHLB and FRB stock | 0 | 0 |
Loans held for sale | 1,120 | 7,492 |
Loans, net | 0 | 0 |
Accrued interest receivable | 0 | 0 |
Derivative financial instruments | 19,112 | 29,096 |
Financial Liabilities: | ||
Non-interest bearing deposits | 0 | 0 |
Interest bearing deposits | 0 | 0 |
Short-term borrowings | 0 | 0 |
Long-term borrowings | 0 | 0 |
Junior subordinated notes issued to capital trusts | 0 | 0 |
Accrued interest payable | 0 | 0 |
Derivative financial instruments | 19,060 | 29,055 |
Recurring basis | Significant Unobservable Inputs (Level 3) | ||
Financial Assets: | ||
Cash and due from banks | 0 | 0 |
Interest bearing deposits with banks | 0 | 0 |
Securities available for sale | 5,894 | 6,071 |
Investment securities held to maturity | 0 | 0 |
Non-marketable securities - FHLB and FRB stock | 50,870 | 55,385 |
Loans held for sale | 0 | 0 |
Loans, net | 5,470,567 | 5,659,598 |
Accrued interest receivable | 0 | 0 |
Derivative financial instruments | 0 | 0 |
Financial Liabilities: | ||
Non-interest bearing deposits | 0 | 0 |
Interest bearing deposits | 5,039,175 | 5,399,709 |
Short-term borrowings | 240,595 | 220,683 |
Long-term borrowings | 67,425 | 117,809 |
Junior subordinated notes issued to capital trusts | 105,967 | 104,009 |
Accrued interest payable | 0 | 0 |
Derivative financial instruments | $0 | $0 |
Stock_Incentive_Plans_Details
Stock Incentive Plans (Details) (USD $) | 3 Months Ended | 9 Months Ended | 9 Months Ended | 12 Months Ended | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Jun. 30, 2011 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2012 | Dec. 31, 2011 | Dec. 31, 2010 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | |
Omnibus Incentive Plan (the "Omnibus Plan") | Omnibus Incentive Plan (the "Omnibus Plan") | Stock options | Stock options | Stock options | Restricted stock and restricted stock units | Restricted stock | Performance-based restricted stock units | Performance-based restricted stock units | Market-based restricted stock | Market-based restricted stock | Salary Stock | Minimum | Minimum | Maximum | Maximum | |||||
Director | Director | Restricted stock and restricted stock units | Performance-based restricted stock units | Restricted stock and restricted stock units | Performance-based restricted stock units | |||||||||||||||
Impact of the share-based payment plans in the financial statements | ||||||||||||||||||||
Total cost of share-based payment plans during the period | $1,388,000 | $1,080,000 | $3,860,000 | $3,581,000 | ||||||||||||||||
Amount of related income tax benefit recognized in income | 548,000 | 430,000 | 1,530,000 | 1,431,000 | ||||||||||||||||
Stock-based compensation | ||||||||||||||||||||
Number of additional authorized shares | 2,300,000 | |||||||||||||||||||
Number of common shares authorized for issuance | 8,300,000 | |||||||||||||||||||
Numerator of shares granted beyond threshold limit | 2 | |||||||||||||||||||
Denominator of shares granted beyond threshold limit | 1 | |||||||||||||||||||
Number of shares available for future grants | 1,617,262 | |||||||||||||||||||
Continuous service period for vesting of option awards (in years) | 4 years | |||||||||||||||||||
Contractual terms of option awards (in years) | 10 years | |||||||||||||||||||
Minimum vesting period (in years) | 5 years | 1 year | 2 years | 4 years | ||||||||||||||||
Maximum percentage of fees with an option to be received in equity-based incentive awards | 70.00% | 100.00% | ||||||||||||||||||
Period of restriction for sale of underlying shares (in months) | 6 months | |||||||||||||||||||
Number of shares issued | 56,752 | 65,333 | 92,717 | 66,193 | 876 | |||||||||||||||
Share-Based Compensation Arrangement By Share Based Payment Award, Percentage Of Shares Earned To Number Of Units Issued | 0.00% | 175.00% | ||||||||||||||||||
Performance based restricted units performance period (in years) | 3 years | |||||||||||||||||||
Share based compensation restricted stock units multiplier (in percent) | 100.00% | |||||||||||||||||||
Number of consecutive trading days over which a specified closing price of the entity's stock is maintained | 10 days | 10 days | ||||||||||||||||||
Minimum closing price of the entity's stock (in dollars per share) | $27 | $25.80 | ||||||||||||||||||
Period of restriction for sale of shares of Salary Stock (in years) | 2 years | |||||||||||||||||||
Weighted average issuance price of Salary Stock (in dollars per share) | $22.39 | |||||||||||||||||||
Unrecognized compensation cost | 14,200,000 | |||||||||||||||||||
Expected weighted-average period for recognition of unrecognized compensation expense (in years) | 2 years 10 months 9 days | |||||||||||||||||||
Options outstanding activity | ||||||||||||||||||||
Options outstanding at the beginning of the period (in shares) | 2,739,753 | |||||||||||||||||||
Granted (in shares) | 211,501 | |||||||||||||||||||
Exercised (in shares) | -330,832 | |||||||||||||||||||
Expired or cancelled (in shares) | -113,290 | |||||||||||||||||||
Forfeited (in shares) | -17,857 | |||||||||||||||||||
Options outstanding at the end of the period (in shares) | 2,489,275 | |||||||||||||||||||
Options exercisable at end of the period (in shares) | 1,809,183 | |||||||||||||||||||
Weighted Average Exercise Price | ||||||||||||||||||||
Options outstanding at the beginning of the period (in dollars per share) | $27.34 | |||||||||||||||||||
Granted (in dollars per share) | $27.03 | |||||||||||||||||||
Exercised (in dollars per share) | $25.51 | |||||||||||||||||||
Expired or cancelled (in dollars per share) | $30.91 | |||||||||||||||||||
Forfeited (in dollars per share) | $20.18 | |||||||||||||||||||
Options outstanding at the end of the period (in dollars per share) | $27.44 | |||||||||||||||||||
Options exercisable at end of the period (in dollars per share) | $29.72 | |||||||||||||||||||
Weighted Average Remaining Contractual Term (In Years) | ||||||||||||||||||||
Options outstanding at the end of the period | 4 years 11 months 9 days | |||||||||||||||||||
Options exercisable at end of the period | 3 years 8 months 1 day | |||||||||||||||||||
Aggregate Intrinsic Value | ||||||||||||||||||||
Options outstanding at the end of the period | 9,407,000 | |||||||||||||||||||
Options exercisable at end of the period | 4,764,000 | |||||||||||||||||||
Fair value assumptions | ||||||||||||||||||||
Risk free interest rate (as a percent) | 1.96% | |||||||||||||||||||
Expected volatility of Company's stock (as a percent) | 25.60% | |||||||||||||||||||
Expected dividend yield (as a percent) | 1.74% | |||||||||||||||||||
Expected life of options (in years) | 5 years 7 months 6 days | |||||||||||||||||||
Weighted average fair value per option of options granted during the year (in dollars per share) | $5.97 | |||||||||||||||||||
Total intrinsic value of options exercised | $929,000 | $203,000 | ||||||||||||||||||
Changes in restricted shares | ||||||||||||||||||||
Nonvested shares of restricted stock and nonvested restricted stock units at the beginning of the period | 634,211 | |||||||||||||||||||
Granted (in shares) | 270,983 | |||||||||||||||||||
Vested (in shares) | -201,178 | |||||||||||||||||||
Forfeited (in shares) | -13,983 | |||||||||||||||||||
Nonvested shares of restricted stock and nonvested restricted stock units at the end of the period | 690,033 | |||||||||||||||||||
Weighted Average Grant Date Fair Value, restricted shares | ||||||||||||||||||||
Shares Outstanding at the beginning of the period (in dollars per share) | $18.82 | |||||||||||||||||||
Granted (in dollars per share) | $26.91 | |||||||||||||||||||
Vested (in dollars per share) | $16.79 | |||||||||||||||||||
Forfeited (in dollars per share) | $20.52 | |||||||||||||||||||
Nonvested shares of restricted stock and nonvested restricted stock units at the end of the period (in dollars per share) | $22.55 |
Derivative_Financial_Instrumen2
Derivative Financial Instruments (Details) (USD $) | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||||
Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Dec. 31, 2012 | ||||
Derivative [Line Items] | ||||||||
Net amount receivable under interest rate swap | $24,000 | |||||||
Net amount payable under interest rate swap | 30,000 | |||||||
Interest rate swap credit risk exposure | 17,900,000 | 17,900,000 | ||||||
Asset Derivatives, Notional Amount | 675,473,000 | 675,473,000 | 562,735,000 | |||||
Asset Derivatives, Estimated Fair Value | 19,112,000 | 19,112,000 | 29,096,000 | |||||
Liability Derivatives, Notional Amount | 673,927,000 | 673,927,000 | 559,402,000 | |||||
Liability Derivatives, Estimated Fair Value | -19,060,000 | -19,060,000 | -29,055,000 | |||||
Derivative Instruments, Gain (Loss) Recognized in Income, Net [Abstract] | ||||||||
Amounts of gain or (loss) recognized in income on derivatives | -22,000 | 29,000 | -48,000 | 106,000 | ||||
Stand-alone derivative instruments | ||||||||
Derivative [Line Items] | ||||||||
Asset Derivatives, Notional Amount | 675,473,000 | 675,473,000 | 562,735,000 | |||||
Asset Derivatives, Estimated Fair Value | 19,112,000 | 19,112,000 | 29,096,000 | |||||
Liability Derivatives, Notional Amount | 673,679,000 | 673,679,000 | 555,695,000 | |||||
Liability Derivatives, Estimated Fair Value | -19,034,000 | -19,034,000 | -28,961,000 | |||||
Derivative Instruments, Gain (Loss) Recognized in Income, Net [Abstract] | ||||||||
Amounts of gain or (loss) recognized in income on derivatives | -21,000 | 29,000 | -57,000 | 142,000 | ||||
Commercial loan interest rate swaps | ||||||||
Derivative [Line Items] | ||||||||
Liability Derivatives, Notional Amount | 248,000 | 248,000 | ||||||
Interest rate swap contracts | Derivative instruments designated as hedges of fair value | ||||||||
Derivative [Line Items] | ||||||||
Liability Derivatives, Notional Amount | 248,000 | [1] | 248,000 | [1] | 3,707,000 | [1] | ||
Liability Derivatives, Estimated Fair Value | -26,000 | [1] | -26,000 | [1] | -94,000 | [1] | ||
Derivative Instruments, Gain (Loss) Recognized in Income, Net [Abstract] | ||||||||
Amounts of gain or (loss) recognized in income on derivatives | -1,000 | 0 | 9,000 | -36,000 | ||||
Interest rate swap contracts | Stand-alone derivative instruments | ||||||||
Derivative [Line Items] | ||||||||
Asset Derivatives, Notional Amount | 570,472,000 | [2] | 570,472,000 | [2] | 460,956,000 | [2] | ||
Asset Derivatives, Estimated Fair Value | 17,813,000 | [2] | 17,813,000 | [2] | 27,740,000 | [2] | ||
Liability Derivatives, Notional Amount | 571,445,000 | [2] | 571,445,000 | [2] | 462,012,000 | [2] | ||
Liability Derivatives, Estimated Fair Value | -17,875,000 | [2] | -17,875,000 | [2] | -27,832,000 | [2] | ||
Derivative Instruments, Gain (Loss) Recognized in Income, Net [Abstract] | ||||||||
Amounts of gain or (loss) recognized in income on derivatives | 7,000 | 6,000 | 30,000 | 19,000 | ||||
Interest rate options contracts | Stand-alone derivative instruments | ||||||||
Derivative [Line Items] | ||||||||
Asset Derivatives, Notional Amount | 84,095,000 | [2] | 84,095,000 | [2] | 70,346,000 | [2] | ||
Asset Derivatives, Estimated Fair Value | 307,000 | [2] | 307,000 | [2] | 157,000 | [2] | ||
Liability Derivatives, Notional Amount | 84,095,000 | [2] | 84,095,000 | [2] | 70,346,000 | [2] | ||
Liability Derivatives, Estimated Fair Value | -307,000 | [2] | -307,000 | [2] | -157,000 | [2] | ||
Derivative Instruments, Gain (Loss) Recognized in Income, Net [Abstract] | ||||||||
Amounts of gain or (loss) recognized in income on derivatives | 0 | 0 | 0 | 0 | ||||
Foreign exchange contracts | Stand-alone derivative instruments | ||||||||
Derivative [Line Items] | ||||||||
Asset Derivatives, Notional Amount | 16,112,000 | [2] | 16,112,000 | [2] | 20,033,000 | [2] | ||
Asset Derivatives, Estimated Fair Value | 912,000 | [2] | 912,000 | [2] | 1,062,000 | [2] | ||
Liability Derivatives, Notional Amount | 15,536,000 | [2] | 15,536,000 | [2] | 19,337,000 | [2] | ||
Liability Derivatives, Estimated Fair Value | -818,000 | [2] | -818,000 | [2] | -961,000 | [2] | ||
Derivative Instruments, Gain (Loss) Recognized in Income, Net [Abstract] | ||||||||
Amounts of gain or (loss) recognized in income on derivatives | -12,000 | 14,000 | -7,000 | 44,000 | ||||
Mortgage banking derivatives | Stand-alone derivative instruments | ||||||||
Derivative [Line Items] | ||||||||
Asset Derivatives, Notional Amount | 4,794,000 | [2] | 4,794,000 | [2] | 11,400,000 | [2] | ||
Asset Derivatives, Estimated Fair Value | 80,000 | [2] | 80,000 | [2] | 137,000 | [2] | ||
Liability Derivatives, Notional Amount | 2,603,000 | [2] | 2,603,000 | [2] | 4,000,000 | [2] | ||
Liability Derivatives, Estimated Fair Value | -34,000 | [2] | -34,000 | [2] | -11,000 | [2] | ||
Derivative Instruments, Gain (Loss) Recognized in Income, Net [Abstract] | ||||||||
Amounts of gain or (loss) recognized in income on derivatives | ($16,000) | $9,000 | ($80,000) | $79,000 | ||||
[1] | Hedged fixed-rate commercial real estate loans | |||||||
[2] | These portfolio swaps are not designated as hedging instruments under ASC Topic 815. |
Derivative_Financial_Instrumen3
Derivative Financial Instruments (Details 2) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Derivative [Line Items] | ||
Financial Assets, Gross Amount Recognized | $3,550 | $236 |
Financial Assets, Gross Amount Offset | 0 | 0 |
Financial Assets, Net Amount Recognized | 3,550 | 236 |
Financial Liabilities, Gross Amount Recognized | 15,522 | 28,830 |
Financial Liabilities, Gross Amount Offset | 0 | 0 |
Financial Liabilities, Net Amount Recognized | 15,522 | 28,830 |
Repurchase Agreements, Financial Assets, Gross Amount Recognized | 0 | 0 |
Repurchase Agreements, Financial Assets, Gross Amount Offset | 0 | 0 |
Repurchase Agreements, Financial Assets, Net Amount Recognized | 0 | 0 |
Repurchase Agreements, Financial Liabilities, Gross Amount Recognized | 240,600 | 208,242 |
Repurchase Agreements, Financial Liabilities, Gross Amount Offset | 0 | 0 |
Repurchase Agreements, Financial Liabilities, Net Amount Recognized | 240,600 | 208,242 |
Total Financial Assets, Gross Amount Recognized | 3,550 | 236 |
Total Financial Assets, Gross Amount Offset | 0 | 0 |
Total Financial Assets, Net Amount Recognized | 3,550 | 236 |
Total Financial Liabilities, Gross Amount Recognized | 256,122 | 237,072 |
Total Financial Liabilities, Gross Amount Offset | 0 | 0 |
Total Financial Liabilities, Net Amount Recognized | 256,122 | 237,072 |
Interest rate swaps, caps and floors | ||
Derivative [Line Items] | ||
Financial Assets, Gross Amount Recognized | 3,483 | 192 |
Financial Assets, Gross Amount Offset | 0 | 0 |
Financial Assets, Net Amount Recognized | 3,483 | 192 |
Financial Liabilities, Gross Amount Recognized | 14,724 | 27,890 |
Financial Liabilities, Gross Amount Offset | 0 | 0 |
Financial Liabilities, Net Amount Recognized | 14,724 | 27,890 |
Foreign currency forward contracts | ||
Derivative [Line Items] | ||
Financial Assets, Gross Amount Recognized | 67 | 43 |
Financial Assets, Gross Amount Offset | 0 | 0 |
Financial Assets, Net Amount Recognized | 67 | 43 |
Financial Liabilities, Gross Amount Recognized | 764 | 929 |
Financial Liabilities, Gross Amount Offset | 0 | 0 |
Financial Liabilities, Net Amount Recognized | 764 | 929 |
Mortgage banking derivatives | ||
Derivative [Line Items] | ||
Financial Assets, Gross Amount Recognized | 0 | 1 |
Financial Assets, Gross Amount Offset | 0 | 0 |
Financial Assets, Net Amount Recognized | 0 | 1 |
Financial Liabilities, Gross Amount Recognized | 34 | 11 |
Financial Liabilities, Gross Amount Offset | 0 | 0 |
Financial Liabilities, Net Amount Recognized | $34 | $11 |
Derivative_Financial_Instrumen4
Derivative Financial Instruments (Details 3) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Derivative [Line Items] | ||
Financial Assets, Net Amount Recognized | $3,550 | $236 |
Financial Assets, Financial Instruments | -2,562 | -230 |
Financial Assets, Collateral | 0 | 0 |
Financial Assets, Net Amount | 988 | 6 |
Financial Liabilities, Net Amount Recognized | 15,522 | 28,830 |
Financial Liabilities, Financial Instruments | -2,562 | -230 |
Financial Liabilities, Collateral | -12,915 | -28,545 |
Financial Liabilities, Net Amount | 45 | 55 |
Repurchase Agreements, Financial Assets, Net Amount Recognized | 0 | 0 |
Repurchase Agreements, Financial Assets, Financial Instruments | 0 | 0 |
Repurchase Agreements, Financial Assets, Collateral | 0 | 0 |
Repurchase Agreements, Financial Assets, Net Amount | 0 | 0 |
Repurchase Agreements, Financial Liabilities, Net Amount Recognized | 240,600 | 208,242 |
Repurchase Agreements, Financial Liabilities, Financial Instruments | 0 | 0 |
Repurchase Agreements, Financial Liabilities, Financial Instruments | -240,600 | -208,242 |
Repurchase Agreements, Financial Liabilities, Collateral | 0 | 0 |
Total Financial Assets, Net Amount Recognized | 3,550 | 236 |
Total Financial Assets, Financial Instruments | -2,562 | -230 |
Total Financial Assets, Collateral | 0 | 0 |
Total Financial Assets, Net Amount | 988 | 6 |
Total Financial Liabilities, Net Amount Recognized | 256,122 | 237,072 |
Total Financial Liabilities, Financial Instruments | -2,562 | -230 |
Total Financial Liabilities, Collateral | -253,515 | -236,787 |
Total Financial Liabilities, Net Amount | 45 | 55 |
Counterparty A | ||
Derivative [Line Items] | ||
Financial Assets, Net Amount Recognized | 440 | 68 |
Financial Assets, Financial Instruments | -440 | -68 |
Financial Assets, Collateral | 0 | 0 |
Financial Assets, Net Amount | 0 | 0 |
Financial Liabilities, Net Amount Recognized | 12,976 | 25,497 |
Financial Liabilities, Financial Instruments | -440 | -68 |
Financial Liabilities, Collateral | -12,536 | -25,429 |
Financial Liabilities, Net Amount | 0 | 0 |
Counterparty B | ||
Derivative [Line Items] | ||
Financial Assets, Net Amount Recognized | 1,090 | 84 |
Financial Assets, Financial Instruments | -551 | -84 |
Financial Assets, Collateral | 0 | 0 |
Financial Assets, Net Amount | 539 | 0 |
Financial Liabilities, Net Amount Recognized | 551 | 633 |
Financial Liabilities, Financial Instruments | -551 | -84 |
Financial Liabilities, Collateral | 0 | -549 |
Financial Liabilities, Net Amount | 0 | 0 |
Counterparty C | ||
Derivative [Line Items] | ||
Financial Assets, Net Amount Recognized | 1,570 | 36 |
Financial Assets, Financial Instruments | -1,570 | -36 |
Financial Assets, Collateral | 0 | 0 |
Financial Assets, Net Amount | 0 | 0 |
Financial Liabilities, Net Amount Recognized | 1,949 | 2,305 |
Financial Liabilities, Financial Instruments | -1,570 | -36 |
Financial Liabilities, Collateral | -379 | -2,269 |
Financial Liabilities, Net Amount | 0 | 0 |
Other counterparties | ||
Derivative [Line Items] | ||
Financial Assets, Net Amount Recognized | 450 | 48 |
Financial Assets, Financial Instruments | -1 | -42 |
Financial Assets, Collateral | 0 | 0 |
Financial Assets, Net Amount | 449 | 6 |
Financial Liabilities, Net Amount Recognized | 46 | 395 |
Financial Liabilities, Financial Instruments | -1 | -42 |
Financial Liabilities, Collateral | 0 | -298 |
Financial Liabilities, Net Amount | $45 | $55 |
Common_and_Preferred_Stock_Det
Common and Preferred Stock (Details) (USD $) | 0 Months Ended | 1 Months Ended | 9 Months Ended | 12 Months Ended | 1 Months Ended | 9 Months Ended | |||
In Millions, except Share data, unless otherwise specified | 2-May-12 | Mar. 14, 2012 | Sep. 30, 2009 | Sep. 30, 2013 | Dec. 31, 2008 | Sep. 30, 2009 | Sep. 30, 2013 | Sep. 17, 2009 | Dec. 31, 2008 |
Series A Preferred Stock | Series A Preferred Stock | Common Stock | Common Stock | Common Stock | Common Stock | ||||
Common and preferred stock | |||||||||
Preferred Stock, Shares Issued | 196,000 | ||||||||
Share Price | $1,000 | ||||||||
Series A Preferred Stock, cumulative dividends rate for the first five years (as a percent) | 5.00% | ||||||||
Series A Preferred Stock, cumulative dividends rate after five years (as a percent) | 9.00% | ||||||||
Warrants, term (in years) | 10 years | ||||||||
Warrants to purchase the Company's common stock, initially authorized (in shares) | 1,012,048 | ||||||||
Warrants to purchase the Company's common stock, as adjusted (in shares) | 506,024 | ||||||||
Warrants, exercise price (in dollars per share) | 29.05 | ||||||||
Common stock issued (in shares) | 12,578,125 | ||||||||
Gross proceeds from public offering of common stock | $201.30 | ||||||||
Proceeds from public offering of common stock, net of underwriting discounts, commissions and offering expenses | 190.9 | ||||||||
Aggregate gross proceeds from "Qualified Equity Offerings" | 196 | 196 | |||||||
Percentage of reduction in number of common shares to be purchased under the warrant | 50.00% | ||||||||
Payments for repurchase of preferred stock and preference stock | 196 | ||||||||
Payments for repurchase of warrants | $1.50 |